UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________

FORM 8-K
______________
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 28, 2016
______________
MOLINA HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
______________
Delaware
(State of Incorporation)
 
1-31719
(Commission
File Number)
 
13-4204626
(IRS Employer
Identification Number)
200 Oceangate, Suite 100, Long Beach, California 90802
(Address of principal executive offices)
Registrant’s telephone number, including area code: (562) 435-3666
______________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



    




Item 8.01.    Other Events.
On November 10, 2015, Molina Healthcare, Inc. (the “Company”) issued $700 million aggregate principal amount of its 5.375% Senior Notes due 2022 (the “Original Notes”) in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The Original Notes were, upon issuance, guaranteed by two of the Company’s wholly-owned subsidiaries—Molina Information Systems, LLC and Molina Medical Management, Inc. (collectively, the “Original Subsidiary Guarantors”). On November 2, 2015, the Company completed the acquisition of Providence Human Services, LLC and Providence Community Services, LLC, which included the indirect acquisition of a number of subsidiaries (the “Providence Acquisition”). As a result of the Providence Acquisition, certain newly acquired subsidiaries also became subsidiary guarantors of the Original Notes (collectively, the “New Subsidiary Guarantors” and, together with the Original Subsidiary Guarantors, the “Subsidiary Guarantors”). The New Subsidiary Guarantors (a) were, pursuant to Instruction (iii) to Rule 3-10(g) of Regulation S-X, deemed to be related prior to the Providence Acquisition and (b) have not been included in the audited consolidated results of the Company for at least nine months of the fiscal year ended December 31, 2015 (i.e., the most recent fiscal year). In addition, the purchase price for the Providence Acquisition was more than 20% of the principal amount of the Exchange Notes (as defined below).
In accordance with the requirements of Rule 3-10(f) of Regulation S-X, each of the Subsidiary Guarantors is 100% owned by the Company (as defined by Rule 3-10(h)(1) of Regulation S-X), the guarantees provided by the Subsidiary Guarantors are full and unconditional (as defined by Rule 3-10(h)(2) of Regulation S-X) and the guarantees provided by the Subsidiary Guarantors are joint and several.
Concurrently herewith, the Company is filing a Registration Statement on Form S-4 (the “S-4 Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating to an offer to exchange (the “Exchange Offer”) up to $700 million aggregate principal amount of the Original Notes for up to $700 million aggregate principal amount of 5.375% Senior Notes due 2022 that will be registered under the Securities Act (the “Exchange Notes”). The terms of the Exchange Notes will be substantially identical to the Original Notes, except that the Exchange Notes will not be subject to transfer restrictions, registration rights or additional interest relating to the Original Notes.
In connection with the Exchange Offer, the Company and the Subsidiary Guarantors will become subject to the requirements of Rule 3-10 of Regulation S-X under the Securities Act regarding financial statements of guarantors and issuers of guaranteed securities registered or being registered with the SEC. The Company is filing this Current Report on Form 8-K to provide the financial statements required by Rule 3-10 of Regulation S-X. Those financial statements are attached to this Current Report on Form 8-K as Exhibits 99.1, 99.2, 99.3 and 99.4 (collectively, the “Updated Financial Information”). Specifically, Exhibit 99.1 updates the Company’s Annual Report on Form 10-K as of and for the year ended December 31, 2015 filed with the SEC on February 26, 2016 (the “2015 Form 10-K”) to include Note 23—Supplemental Condensed Consolidating Financial Information, which presents the financial position of the parent company

-2-




(issuer), the Subsidiary Guarantors, and the non-guarantor subsidiaries as of December 31, 2015 and 2014, and the respective results of operations and cash flows for each of the three years in the period ended December 31, 2015 as permitted by Rule 3-10(f)(4) of Regulation S-X. Exhibit 99.2 updates the Company's Quarterly Report on Form 10-Q as of and for the six months ended June 30, 2016 filed with the SEC on July 27, 2016 (the "Q2 Form 10-Q") to include Note 17—Supplemental Condensed Consolidating Financial Information, which presents the financial position of the parent company (issuer), the Subsidiary Guarantors, and the non-guarantor subsidiaries as of June 30, 2016 and December 31, 2015, and the respective results of operations and cash flows for the three and six months ended June 30, 2016 and 2015 as permitted by Rule 3-10(f)(4) of Regulation S-X. Exhibit 99.3 contains the audited consolidated financial statements of the New Subsidiary Guarantors as of and for the year ended December 31, 2014 (i.e., the New Subsidiary Guarantors’ fiscal year immediately prior to the Providence Acquisition), as required by Rule 3-10(g)(2)(i) of Regulation S-X. Exhibit 99.4 contains the unaudited consolidated financial statements of the New Subsidiary Guarantors as of and for the nine months ended September 30, 2015 and 2014, as required by Rule 3-10(g)(2)(i) of Regulation S-X.
The Updated Financial Information will be incorporated by reference into the S-4 Registration Statement.
Item 9.01. Financial Statements and Exhibits.
(d)    Exhibits:
Capitalized terms used in the following list of Exhibits shall have the meanings given to such terms in Item 8.01 above.
Exhibit No.
Description
23.1
Consent of Independent Registered Public Accounting Firm.
99.1
Updated Item 8. Financial Statements and Supplementary Data, from the 2015 Form 10-K.
99.2
Updated Item 1. Financial Statements, from the Q2 Form 10-Q.
99.3
Audited Special-Purpose Consolidated Financial Statements of the New Subsidiary Guarantors as of and for the year ended December 31, 2014.
99.4
Unaudited Special-Purpose Consolidated Financial Statements of the New Subsidiary Guarantors as of and for the nine months ended September 30, 2015 and 2014.




-3-




SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
MOLINA HEALTHCARE, INC.
 
 
 
Date:
July 28, 2016
By:
/s/ Jeff D. Barlow
 
 
Jeff D. Barlow
 
 
Chief Legal Officer and Secretary



-4-




EXHIBIT INDEX

Capitalized terms used in the following list of Exhibits shall have the meanings given to such terms in Item 8.01 above.
Exhibit No.
Description
23.1
Consent of Independent Registered Public Accounting Firm.
99.1
Updated Item 8. Financial Statements and Supplementary Data, from the 2015 Form 10-K.
99.2
Updated Item 1. Financial Statements, from the Q2 Form 10-Q.
99.3
Audited Special-Purpose Consolidated Financial Statements of the New Subsidiary Guarantors as of and for the year ended December 31, 2014.
99.4
Unaudited Special-Purpose Consolidated Financial Statements of the New Subsidiary Guarantors as of and for the nine months ended September 30, 2015 and 2014.


-1-


Exhibit
EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-108317, No. 333-138552, No. 333-153246, No. 333-170571, and No. 333-174912 on Form S-8 pertaining to the Molina Healthcare, Inc. 2000 Omnibus Stock and Incentive Plan; 2002 Equity Incentive Plan; 2002 Employee Stock Purchase Plan; 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan; and Registration Statement No. 333-204558 on Form S-3, of our report dated February 26, 2016, (except for Note 23, as to which the date is July 28, 2016), with respect to the consolidated financial statements of Molina Healthcare, Inc., included in this Current Report on Form 8-K.

/s/ERNST & YOUNG LLP

Los Angeles, California
July 28, 2016





Exhibit
Table of Contents

Item 8.  Financial Statements and Supplementary Data
INDEX TO FINANCIAL STATEMENTS
 
 
Page
MOLINA HEALTHCARE, INC.
 


1

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
of Molina Healthcare, Inc.
We have audited the accompanying consolidated balance sheets of Molina Healthcare, Inc. (the Company) as of December 31, 2015 and 2014, and the related consolidated statements of income, comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Molina Healthcare, Inc. at December 31, 2015 and 2014, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2015, in conformity with U.S. generally accepted accounting principles.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Molina Healthcare, Inc.’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 26, 2016 expressed an unqualified opinion thereon.
/s/ ERNST & YOUNG LLP
Los Angeles, California
February 26, 2016, except for Note 23, as to which the date is July 28, 2016


2

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
 
December 31,
 
2015
 
2014
 
(Amounts in millions,
except per-share data)
ASSETS
Current assets:
 
 
 
Cash and cash equivalents
$
2,329

 
$
1,539

Investments
1,801

 
1,019

Receivables
597

 
596

Income taxes refundable
13

 

Prepaid expenses and other current assets
192

 
49

Derivative asset
374

 

Total current assets
5,306

 
3,203

Property, equipment, and capitalized software, net
393

 
341

Deferred contract costs
81

 
54

Intangible assets, net
122

 
89

Goodwill
519

 
272

Restricted investments
109

 
102

Derivative asset

 
329

Deferred income taxes
18

 
15

Other assets
28

 
30

 
$
6,576

 
$
4,435

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Medical claims and benefits payable
$
1,685

 
$
1,201

Amounts due government agencies
729

 
527

Accounts payable and accrued liabilities
362

 
242

Deferred revenue
223

 
196

Income taxes payable

 
9

Current portion of long-term debt
449

 

Derivative liability
374

 

Total current liabilities
3,822

 
2,175

Senior notes
962

 
690

Lease financing obligations
198

 
157

Lease financing obligations - related party

 
40

Derivative liability

 
329

Other long-term liabilities
37

 
34

Total liabilities
5,019

 
3,425

Stockholders’ equity:
 
 
 
Common stock, $0.001 par value; 150 shares authorized; outstanding: 56 shares at December 31, 2015 and 50 shares at December 31, 2014

 

Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding

 

Additional paid-in capital
803

 
396

Accumulated other comprehensive loss
(4
)
 
(1
)
Retained earnings
758

 
615

Total stockholders’ equity
1,557

 
1,010

 
$
6,576

 
$
4,435

 

See accompanying notes.

3

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF INCOME
 
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions, except per-share data)
Revenue:
 
 
 
 
 
Premium revenue
$
13,241

 
$
9,023

 
$
6,179

Service revenue
253

 
210

 
205

Premium tax revenue
397

 
294

 
172

Health insurer fee revenue
264

 
120

 

Investment income
18

 
8

 
7

Other revenue
5

 
12

 
26

Total revenue
14,178

 
9,667

 
6,589

Operating expenses:
 
 
 
 
 
Medical care costs
11,794

 
8,076

 
5,380

Cost of service revenue
193

 
157

 
161

General and administrative expenses
1,146

 
765

 
666

Premium tax expenses
397

 
294

 
172

Health insurer fee expenses
157

 
89

 

Depreciation and amortization
104

 
93

 
73

Total operating expenses
13,791

 
9,474

 
6,452

Operating income
387

 
193

 
137

Other expenses, net:
 
 
 
 
 
Interest expense
66

 
57

 
52

Other (income) expense, net
(1
)
 
1

 
4

Total other expenses, net
65

 
58

 
56

Income from continuing operations before income tax expense
322

 
135

 
81

Income tax expense
179

 
73

 
36

Income from continuing operations
143

 
62

 
45

Income from discontinued operations, net of tax expense (benefit) of $0, $0, and $(10), respectively

 

 
8

Net income
$
143

 
$
62

 
$
53

 
 
 
 
 
 
 
 
 
 
 
 
Basic net income per share:
 
 
 
 
 
Income from continuing operations
$
2.75

 
$
1.34

 
$
0.98

(Loss) income from discontinued operations

 
(0.01
)
 
0.18

Basic net income per share
$
2.75

 
$
1.33

 
$
1.16

Diluted net income per share:
 
 
 
 
 
Income from continuing operations
$
2.58

 
$
1.30

 
$
0.96

(Loss) income from discontinued operations

 
(0.01
)
 
0.17

Diluted net income per share
$
2.58

 
$
1.29

 
$
1.13

Weighted average shares outstanding:
 
 
 
 
 
Basic
52

 
47

 
46

Diluted
56

 
48

 
47

 
See accompanying notes.

4

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Net income
$
143

 
$
62

 
$
53

Other comprehensive income (loss):
 
 
 
 
 
Unrealized investment loss
(5
)
 

 
(1
)
Effect of income tax benefit
2

 

 

Other comprehensive loss, net of tax
(3
)
 

 
(1
)
Comprehensive income
$
140

 
$
62

 
$
52


See accompanying notes.










































5

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
 
 
Common Stock
 
Additional
Paid-in
Capital
 
Accumulated
Other
Comprehensive
Loss
 
Retained
Earnings
 
Treasury
Stock
 
 
 
Outstanding
 
Amount
 
 
 
 
 
Total
 
(In millions)
Balance at January 1, 2013
47

 
$

 
$
285

 
$

 
$
500

 
$
(3
)
 
$
782

Net income

 

 

 

 
53

 

 
53

Other comprehensive loss, net

 

 

 
(1
)
 

 

 
(1
)
Purchase of treasury stock
(2
)
 

 

 

 

 
(53
)
 
(53
)
Retirement of treasury stock

 

 
(56
)
 

 

 
56

 

Issuance of warrants

 

 
79

 

 

 

 
79

Share-based compensation
1

 

 
31

 

 

 

 
31

Tax benefit from share-based compensation

 

 
2

 

 

 

 
2

Balance at December 31, 2013
46

 

 
341

 
(1
)
 
553

 

 
893

Net income

 

 

 

 
62

 

 
62

Convertible senior notes transactions, including issuance costs
2

 

 
22

 

 

 

 
22

Share-based compensation
2

 

 
30

 

 

 

 
30

Tax benefit from share-based compensation

 

 
3

 

 

 

 
3

Balance at December 31, 2014
50

 

 
396

 
(1
)
 
615

 

 
1,010

Net income

 

 

 

 
143

 

 
143

Other comprehensive loss, net

 

 

 
(3
)
 

 

 
(3
)
Common stock offering, including issuance costs
6

 

 
373

 

 

 

 
373

Share-based compensation

 

 
26

 

 

 

 
26

Tax benefit from share-based compensation

 

 
8

 

 

 

 
8

Balance at December 31, 2015
56

 
$

 
$
803

 
$
(4
)
 
$
758

 
$

 
$
1,557


See accompanying notes.

6

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Operating activities:
 
 
 
 
 
Net income
$
143

 
$
62

 
$
53

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
Depreciation and amortization
126

 
134

 
94

Deferred income taxes
(7
)
 
(2
)
 
(32
)
Share-based compensation
23

 
22

 
29

Amortization of convertible senior notes and lease financing obligations
30

 
27

 
23

Other, net
19

 
7

 
18

Changes in operating assets and liabilities, net of effects from acquisitions:
 
 
 
 
 
Receivables
56

 
(298
)
 
(149
)
Prepaid expenses and other current assets
(35
)
 
(20
)
 
(23
)
Medical claims and benefits payable
482

 
531

 
175

Amounts due government agencies
202

 
470

 
28

Accounts payable and accrued liabilities
84

 
11

 
33

Deferred revenue
24

 
74

 
(20
)
Income taxes
(22
)
 
42

 
(39
)
Net cash provided by operating activities
1,125

 
1,060

 
190

Investing activities:
 
 
 
 
 
Purchases of investments
(1,923
)
 
(953
)
 
(770
)
Proceeds from sales and maturities of investments
1,126

 
633

 
400

Purchases of equipment
(132
)
 
(115
)
 
(98
)
Increase in restricted investments
(6
)
 
(34
)
 
(19
)
Net cash paid in business combinations
(450
)
 
(44
)
 
(62
)
Other, net
(35
)
 
(23
)
 
6

Net cash used in investing activities
(1,420
)
 
(536
)
 
(543
)
Financing activities:
 
 
 
 
 
Proceeds from senior notes offerings, net of issuance costs
689

 
123

 
538

Proceeds from common stock offering, net of issuance costs
373

 

 

Proceeds from sale-leaseback transactions

 

 
159

Purchase of call option

 

 
(149
)
Proceeds from issuance of warrants

 

 
75

Contingent consideration liabilities settled

 
(50
)
 

Treasury stock purchases

 

 
(53
)
Principal payments on term loan

 

 
(48
)
Repayment of amount borrowed under credit facility

 

 
(40
)
Proceeds from employee stock plans
18

 
14

 
9

Principal payments on convertible senior notes

 
(10
)
 

Other, net
5

 
2

 
2

Net cash provided by financing activities
1,085

 
79

 
493

Net increase in cash and cash equivalents
790

 
603

 
140

Cash and cash equivalents at beginning of period
1,539

 
936

 
796

Cash and cash equivalents at end of period
$
2,329

 
$
1,539

 
$
936


See accompanying notes.


7

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(continued)
 
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(Amounts in millions)
 
 
Supplemental cash flow information:
 
 
 
 
 
 
 
 
 
 
 
Cash paid during the period for:
 
 
 
 
 
Income taxes
$
197

 
$
30

 
$
95

Interest
$
38

 
$
29

 
$
35

 
 
 
 
 
 
Schedule of non-cash investing and financing activities:
 
 
 
 
 
Senior notes exchange transaction
$

 
$
177

 
$

Retirement of treasury stock
$

 
$

 
$
56

Increase in non-cash lease financing obligation - related party
$

 
$
14

 
$
27

Common stock used for stock-based compensation
$
(15
)
 
$
(9
)
 
$
(8
)
 
 
 
 
 
 
Details of business combinations:
 
 
 
 
 
Fair value of assets acquired
$
(389
)
 
$
(52
)
 
$
(122
)
Fair value of liabilities assumed
41

 

 

Fair value of contingent consideration liabilities incurred

 

 
60

Payable to seller

 
8

 

Amounts advanced for acquisitions
(102
)
 

 

Net cash paid in business combinations
$
(450
)
 
$
(44
)
 
$
(62
)
 
 
 
 
 
 
Details of change in fair value of derivatives, net:
 
 
 
 
 
Gain on 1.125% Notes Call Option
$
45

 
$
143

 
$
37

Loss on 1.125% Notes Conversion Option
(45
)
 
(143
)
 
(37
)
Loss on 1.125% Warrants

 

 
(4
)
Change in fair value of derivatives, net
$

 
$

 
$
(4
)

See accompanying notes.


8

Table of Contents

MOLINA HEALTHCARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
Organization and Operations
Molina Healthcare, Inc. provides quality health care to people receiving government assistance. We offer cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist government agencies in their administration of the Medicaid program. We have three reportable segments. These segments include our Health Plans and Molina Medicaid Solutions segments, which comprise the vast majority of our operations, and our Other segment. As of December 31, 2015, we changed our reporting structure as a result of the Pathways acquisition in November 2015, which is reported in Other. See Note 20, "Segment Information," for further details.
Our Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico, and includes our direct delivery business. As of December 31, 2015, these health plans served over 3.5 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. Additionally, we serve Health Insurance Marketplace members, most of whom receive government premium subsidies. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization (HMO). Our direct delivery business consists primarily of the operation of primary care clinics in several states in which we operate.
Our health plans’ state Medicaid contracts generally have terms of three to four years. These contracts typically contain renewal options exercisable by the state Medicaid agency, and allow either the state or the health plan to terminate the contract with or without cause. Our health plan subsidiaries have generally been successful in retaining their contracts, but such contracts are subject to risk of loss when a state issues a new request for proposals (RFP) open to competitive bidding by other health plans. If one of our health plans is not a successful responsive bidder to a state RFP, its contract may be subject to non-renewal.
In addition to contract renewal, our state Medicaid contracts may be periodically amended to include or exclude certain health benefits (such as pharmacy services, behavioral health services, or long-term care services); populations such as the aged, blind or disabled (ABD); and regions or service areas.
Our Molina Medicaid Solutions segment provides business processing and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, West Virginia, and the U.S. Virgin Islands, and drug rebate administration services in Florida.
Our Other segment includes other businesses, such as our Pathways behavioral health and social services provider, that do not meet the quantitative thresholds for a reportable segment as defined by U.S. generally accepted accounting principles (GAAP), as well as corporate amounts not allocated to other reportable segments.
Market Update—Other
Pathways. On November 1, 2015, we acquired all of the outstanding ownership interests in Pathways Health and Community Support LLC (Pathways), formerly known as Providence Human Services, LLC. Pathways is one of the largest national providers of accessible, outcome-based behavioral/mental health and social services with operations in 23 states and the District of Columbia. See Note 4, "Business Combinations," for further information.
Market Updates—Health Plans
Medicare-Medicaid Plans. To coordinate care for those who qualify to receive both Medicare and Medicaid services (the "dual eligible"), and to deliver services to these individuals in a more financially efficient manner, some states have undertaken demonstration programs to integrate Medicare and Medicaid services for dual eligible individuals. The health plans participating in such demonstrations are referred to as Medicare-Medicaid Plans (MMPs). We operate MMPs in six states. Our MMPs in California, Illinois, and Ohio offered coverage beginning in 2014; our MMPs in South Carolina and Texas offered coverage beginning in the first quarter of 2015; and our MMP in Michigan offered coverage beginning in the second quarter of 2015. At December 31, 2015, our membership included approximately 51,000 integrated MMP members.
Florida. On November 1, 2015, our Florida health plan closed on its acquisition of the Medicaid contracts, and certain assets related to operation of the Medicaid business, of Integral Health Plan, Inc. See Note 4, "Business Combinations," for further information.
On August 1, 2015, our Florida health plan closed on its acquisition of the Medicaid contracts, and certain assets related to the operation of the Medicaid business, of Preferred Medical Plan, Inc. See Note 4, "Business Combinations," for further information.

9

Table of Contents

Illinois. On January 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business of, Accountable Care Chicago, LLC, also known as MyCare Chicago. We assumed approximately 58,000 Medicaid members in this acquisition.
On January 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business, of Loyola Physician Partners, LLC. We assumed approximately 21,000 Medicaid members in this acquisition.
On November 30, 2015, we announced that our Illinois health plan entered into an agreement to assume the membership and certain Medicaid assets of Better Health Network, LLC (Better Health). As of November 30, 2015, Better Health served approximately 40,000 members in the Medicaid Family Health program in Cook County. Subject to regulatory approvals and the satisfaction of other closing conditions, we expect the transaction to close during the first half of 2016.
Michigan. On January 1, 2016, our Michigan health plan closed on its acquisition of the Medicaid and MIChild membership, and certain Medicaid and MIChild assets, of HAP Midwest Health Plan, Inc. We assumed approximately 81,000 Medicaid and MIChild members in this acquisition.
In October 2015, the Michigan Department of Health and Human Services announced that Molina Healthcare of Michigan was recommended to serve the state's Medicaid members under Michigan's Comprehensive Health Plan, which commenced on January 1, 2016. The new contract has a five-year term with three one-year extensions, and covers Regions 2 through 6, and 8 through 10 of the state, representing an expansion into 18 additional counties compared with the previous Michigan Medicaid contract.
On September 1, 2015, our Michigan health plan closed on its acquisition of the Medicaid and MIChild contracts, and certain provider agreements, of HealthPlus of Michigan and its subsidiary, HealthPlus Partners, Inc. See Note 4, "Business Combinations," for further information.
Puerto Rico. Effective April 1, 2015, our Puerto Rico health plan served its first members. As of December 31, 2015, our Puerto Rico plan enrollment amounted to approximately 348,000 members.
Washington. In November 2015, our Washington health plan was selected by the Washington State Health Care Authority (HCA) to negotiate and enter into managed care contracts for the Southwest region of the state's Apple Health Fully Integrated Managed Care Program. Molina Healthcare of Washington was selected by HCA pursuant to the request for proposal HCA issued in August 2015. The start date for the new contract is scheduled for April 1, 2016.
On January 1, 2016, our Washington health plan closed on its acquisition of the Medicaid membership and certain Medicaid assets of Columbia United Providers, Inc. We assumed approximately 57,000 Medicaid members in this acquisition.
Market Update—Molina Medicaid Solutions
New Jersey. On April 9, 2015, the state of New Jersey announced its selection of Molina Medicaid Solutions to design and operate that state's new Medicaid management information system (MMIS). The new contract was effective May 1, 2015, and has a term of 10 years with three one-year renewal options. Molina Medicaid Solutions was the state's incumbent MMIS provider, and was awarded the new contract as a result of Molina Medicaid Solutions' submission in response to the state of New Jersey's request for proposals.
Consolidation
The consolidated financial statements include the accounts of Molina Healthcare, Inc., its subsidiaries, and variable interest entities in which Molina Healthcare, Inc. is considered to be the primary beneficiary. See Note 18, "Variable Interest Entities (VIEs)," for more information regarding these variable interest entities. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments. All significant inter-company balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition.
Presentation and Reclassifications
Beginning in 2013, after our Medicaid contract with the state of Missouri expired, we have reported the results relating to the Missouri health plan as discontinued operations for all periods presented. Additionally, we abandoned our equity interests in the Missouri health plan during the second quarter of 2013, resulting in the recognition of a tax benefit of $10 million, which is also included in discontinued operations in the consolidated statements of income. The Missouri health plan's premium revenues were insignificant for all periods presented.

10

Table of Contents

We have reclassified certain amounts in the 2014 consolidated balance sheet to conform to the 2015 presentation relating to the presentation of deferred taxes and debt issuance costs. Both reclassifications are a result of recently adopted accounting pronouncements. See Note 2, "Significant Accounting Policies," for further information.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:
The determination of medical claims and benefits payable of our Health Plans segment;
Health plan contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;
Health plan quality incentives that allow us to recognize incremental revenue if certain quality standards are met;
Molina Medicaid Solutions segment revenue and cost recognition;
Settlements under risk or savings sharing programs;
The assessment of deferred contract costs, deferred revenue, long-lived and intangible assets, and goodwill for impairment;
The determination of professional and general liability claims, and reserves for potential absorption of claims unpaid by insolvent providers;
The determination of reserves for the outcome of litigation;
The determination of valuation allowances for deferred tax assets; and
The determination of unrecognized tax benefits.
2. Significant Accounting Policies
Cash and Cash Equivalents
Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase.
Investments
Our investments are principally held in debt securities, which are grouped into two separate categories for accounting and reporting purposes: available-for-sale securities, and held-to-maturity securities. Available-for-sale securities are recorded at fair value and unrealized gains and losses, if any, are recorded in stockholders’ equity as other comprehensive income, net of applicable income taxes. Held-to-maturity securities are recorded at amortized cost, which approximates fair value, and unrealized holding gains or losses are not generally recognized. Realized gains and losses and unrealized losses judged to be other than temporary with respect to available-for-sale and held-to-maturity securities are included in the determination of net income. The cost of securities sold is determined using the specific-identification method.
Our investment policy requires that all of our investments have final maturities of 10 years or less (excluding variable rate securities where interest rates may be periodically reset), and that the average maturity be three years or less. Investments and restricted investments are subject to interest rate risk and will decrease in value if market rates increase. Declines in interest rates over time will reduce our investment income.
In general, our available-for-sale securities are classified as current assets without regard to the securities’ contractual maturity dates because they may be readily liquidated. We monitor our investments for other-than-temporary impairment. For comprehensive discussions of the fair value and classification of our current and non-current investments, see Note 5, "Fair Value Measurements," Note 6, "Investments," and Note 10, "Restricted Investments."
Receivables
Receivables are readily determinable and because our creditors are primarily state governments, our allowance for doubtful accounts is immaterial. Any amounts determined to be uncollectible are charged to expense when such determination is made. See Note 7, "Receivables."

11

Table of Contents

Property, Equipment, and Capitalized Software
Property and equipment are stated at historical cost. Replacements and major improvements are capitalized, and repairs and maintenance are charged to expense as incurred. Furniture and equipment are generally depreciated using the straight-line method over estimated useful lives ranging from three to seven years. Software developed for internal use is capitalized. Software is generally amortized over its estimated useful life of three years. Leasehold improvements are amortized over the term of the lease, or over their useful lives from five to 10 years, whichever is shorter. Buildings are depreciated over their estimated useful lives of 31.5 to 40 years. See Note 8, "Property, Equipment, and Capitalized Software."
As discussed below, the costs associated with certain of our Molina Medicaid Solutions segment equipment and software are capitalized and recorded as deferred contract costs. Such costs are amortized on a straight-line basis over the shorter of the useful life or the contract period.
Depreciation and Amortization
Depreciation and amortization related to our Health Plans segment is all recorded in "Depreciation and amortization" in the consolidated statements of income. Depreciation and amortization related to our Molina Medicaid Solutions segment is recorded within three different headings in the consolidated statements of income as follows:
Amortization of purchased intangibles relating to customer relationships is reported as amortization within the heading "Depreciation and amortization;"
Amortization of purchased intangibles relating to contract backlog is recorded as a reduction of "Service revenue;" and
Amortization of capitalized software is recorded within the heading "Cost of service revenue."
The following table presents all depreciation and amortization recorded in our consolidated statements of income, regardless of whether the item appears as depreciation and amortization, a reduction of revenue, or as cost of service revenue.
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Depreciation, and amortization of capitalized software, continuing operations
$
87

 
$
75

 
$
55

Amortization of intangible assets, continuing operations
17

 
18

 
18

Depreciation and amortization, continuing operations
104

 
93

 
73

Amortization recorded as reduction of service revenue
1

 
3

 
3

Amortization of capitalized software recorded as cost of service revenue
21

 
38

 
18

Depreciation and amortization reported in the statement of cash flows
$
126

 
$
134

 
$
94

Long-Lived Assets, including Intangible Assets
Long-lived assets consist primarily of property, equipment, capitalized software and intangible assets. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts). Intangible assets are initially recorded at fair value and are then amortized on a straight-line basis over their expected useful lives, generally between two and 15 years.
Our intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset’s (or asset group’s) carrying value may not be recoverable. Consideration is given to a number of potential impairment indicators. For example, our health plan subsidiaries have generally been successful in obtaining the renewal by amendment of their contracts in each state prior to the actual expiration of their contracts. However, there can be no assurance that these contracts will continue to be renewed.
Following the identification of any potential impairment indicators, to determine whether an impairment exists, we would compare the carrying amount of a finite-lived intangible asset with the undiscounted cash flows that are expected to result from the use of the asset or related group of assets. If it is determined that the carrying amount of the asset is not recoverable, the amount by which the carrying value exceeds the estimated fair value is recorded as an impairment.
No significant impairment charges relating to long-lived assets, including intangible assets, were recorded in the years ended December 31, 2015, 2014, and 2013.

12

Table of Contents

Goodwill
Goodwill represents the amount of the purchase price in excess of the fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is not amortized, but is subject to an annual impairment test. Tests are performed more frequently if events occur or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount.
To determine whether goodwill is impaired, we measure the fair values of our reporting units and compare them to the carrying values of the respective units, including goodwill. If the fair value is less than the carrying value of the reporting unit, then the implied value of goodwill would be calculated and compared with the carrying amount of goodwill to determine whether goodwill is impaired.
We estimate the fair values of our reporting units using discounted cash flows. To determine fair values, we must make assumptions about a wide variety of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of free cash flow (including significant assumptions about operations, capital requirements and income taxes), long-term growth rates for determining terminal value, and discount rates.
No impairment charges relating to goodwill were recorded in the years ended December 31, 2015, 2014, and 2013.
Business Combinations
Accounting for acquisitions requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of income. Refer to Note 4, "Business Combinations," for further details regarding our 2015 acquisitions.
Restricted Investments
Restricted investments, which consist of certificates of deposit and U.S. treasury securities, are designated as held-to-maturity and are carried at amortized cost, which approximates fair value. The use of these funds is limited to specific purposes as required by regulation in the various states in which we operate, or as protection against the insolvency of capitated providers. We have the ability to hold our restricted investments until maturity and, as a result, we would not expect the value of these investments to decline significantly due to a sudden change in market interest rates. See Note 10, "Restricted Investments."
Delegated Provider Insolvency
Circumstances may arise where providers to whom we have delegated risk are unable to pay claims they have incurred with third parties in connection with referral services (including hospital inpatient services) provided to our members. The inability of delegated providers to pay referral claims presents us with both immediate financial risk and potential disruption to member care. Depending on states’ laws, we may be held liable for such unpaid referral claims even though the delegated provider has contractually assumed such risk. Additionally, competitive pressures may force us to pay such claims even when we have no legal obligation to do so. To reduce the risk that delegated providers are unable to pay referral claims, we monitor the operational and financial performance of such providers. We also maintain contingency plans that include transferring members to other providers in response to potential network instability.
In certain instances, we have required providers to place funds on deposit with us as protection against their potential insolvency. These reserves are frequently in the form of segregated funds received from the provider and held by us or placed in a third-party financial institution. These funds may be used to pay claims that are the financial responsibility of the provider in the event the provider is unable to meet these obligations. Additionally, we have recorded liabilities for estimated losses arising from provider instability or insolvency in excess of provider funds on deposit with us. Such liabilities were not material at December 31, 2015 and 2014.
Premium Revenue - Health Plans
Premium revenue is generated primarily from our Medicaid, Medicare and Marketplace contracts, including agreements with other managed care organizations for which we operate as a subcontractor. Premium revenue is generally received based on per member per month (PMPM) rates established in advance of the periods covered. These premium revenues are recognized in the month that members are entitled to receive health care services, and premiums collected in advance are deferred. The state Medicaid programs and the federal Medicare program periodically adjust premium. Additionally, many of our contracts contain provisions that may adjust or limit revenue or profit, as described below. Consequently, we recognize premium revenue as it is

13

Table of Contents

earned under such provisions.
The following table summarizes premium revenue from continuing operations for the periods indicated:
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
Amount
 
% of Total
 
Amount
 
% of Total
 
Amount
 
% of Total
 
(Dollars in millions)
California
$
2,200

 
16.6
%
 
$
1,523

 
16.9
%
 
$
750

 
12.1
%
Florida
1,199

 
9.0

 
439

 
4.9

 
265

 
4.3

Illinois
397

 
3.0

 
153

 
1.7

 
8

 
0.1

Michigan
1,067

 
8.1

 
781

 
8.7

 
676

 
11.0

New Mexico
1,237

 
9.3

 
1,076

 
11.9

 
447

 
7.2

Ohio
2,034

 
15.4

 
1,553

 
17.2

 
1,099

 
17.8

Puerto Rico
567

 
4.3

 

 

 

 

South Carolina
348

 
2.6

 
381

 
4.2

 

 

Texas
1,961

 
14.8

 
1,318

 
14.6

 
1,291

 
20.9

Utah
331

 
2.5

 
310

 
3.4

 
311

 
5.0

Washington
1,602

 
12.1

 
1,305

 
14.5

 
1,168

 
18.9

Wisconsin
261

 
2.0

 
156

 
1.7

 
143

 
2.3

Direct delivery
37

 
0.3

 
28

 
0.3

 
21

 
0.4

 
$
13,241

 
100.0
%
 
$
9,023

 
100.0
%
 
$
6,179

 
100.0
%
Certain components of premium revenue are subject to accounting estimates and fall into the following categories:
Contractual Provisions That May Adjust or Limit Revenue or Profit
Medicaid
Medical Cost Floors (Minimums), Medical Cost Corridors, and Administrative Cost Ceilings (Maximums): A portion of certain premiums received by our health plans may be returned if certain minimum amounts are not spent on defined medical care costs. In the aggregate, we recorded a liability under the terms of such contract provisions of $224 million and $392 million at December 31, 2015 and December 31, 2014, respectively, to amounts due government agencies. Approximately $208 million of the liability accrued at December 31, 2015 relates to our participation in Medicaid expansion programs.
In certain circumstances, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold. We had $3 million recorded at December 31, 2015 relating to such provisions. No such receivables were recorded at December 31, 2014.
Profit Sharing and Profit Ceiling: Our contracts with certain states contain profit-sharing or profit ceiling provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage, in some cases in accordance with a tiered rebate schedule. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any. As a result of profits in excess of the amount we are allowed to retain, we recorded a liability of $10 million at December 31, 2015. The amount recorded at December 31, 2014 was insignificant.
Retroactive Premium Adjustments: In New Mexico, when members are retroactively enrolled into our health plan we earn revenue only to the extent of the actual medical costs incurred by us for services provided during those retroactive periods, plus a small percentage of that medical cost for administration and profit. This cost plus arrangement for members retroactively enrolled in our health plan first became effective July 1, 2014 (retroactive to January 1, 2014). We are paid normal monthly capitation rates for the retroactive eligibility periods, and the difference between those capitation rates and the amounts due us on a cost plus basis are periodically settled with the state. To date, no such settlement has been made with the state. Our New Mexico contract is not specific as to the definition of retroactive membership, and the amount we owe the state (or that the state owes us) for the difference between capitation received and amounts due us under the cost plus arrangement varies widely depending upon the definition of retroactive membership. 
In August 2015 the state provided us with a request for payment under the terms of this contract provision for the period January 1, 2014 through December 31, 2014. That request was based upon definitions of retroactive membership that were at odds with our interpretations of that term. The New Mexico health plan reduced revenue by approximately $24 million in 2015

14

Table of Contents

as a result of aligning more closely our definition of retroactive membership with the state's definition. Using the state's definition of retroactive membership, however, we estimate that the state will ultimately seek repayment of an amount that ranges from $15 million to $20 million higher than what we have accrued. We do not believe that any reasonable definition of retroactive membership supports the state's position, and expect to resolve this matter with payment of the amount we have accrued at December 31, 2015. We are currently engaged in discussions with the state regarding the appropriate amount, if any, owed to the state under this contract term.
Medicare
Risk Adjustment: Based on member encounter data that we submit to the Centers for Medicare and Medicaid Services (CMS), our Medicare premiums are subject to retroactive increase or decrease based upon member medical conditions for up to two years after the original year of service. We estimate the amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ health care utilization patterns and CMS practices. Based on our knowledge of member health care utilization patterns and expenses, we have recorded a net payable of $4 million and a net receivable of $8 million for anticipated Medicare risk adjustment premiums at December 31, 2015 and December 31, 2014, respectively.
Marketplace
Premium Stabilization Programs: The Affordable Care Act (ACA) established Marketplace premium stabilization programs effective January 1, 2014. These programs, commonly referred to as the "3R's," include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program.
Permanent risk adjustment program: Under this permanent program, our health plans' risk scores are compared to the overall average risk score for the relevant state and market pool. Generally, our health plans will pay into the pool if their risk scores are below the average risk score, and will receive funds from the pool if their risk scores are above the average risk score. We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income.
Transitional reinsurance program: This program is designed to provide reimbursement to insurers for high cost members. Our health plans pay an annual contribution on a per-member basis, and are eligible for recoveries if claims for individual members exceed a specified threshold, up to a maximum amount. This three-year program will end on December 31, 2016. We recognize the assessments to fund the transitional reinsurance program as a reduction to premium revenue in our consolidated statements of income. We recognize recoveries under the reinsurance program as a reduction to medical care costs in our consolidated statements of income.
Temporary risk corridor program: This program is intended to limit gains and losses of insurers by comparing allowable costs to a target amount as defined by the U.S. Department of Health and Human Services (HHS). Variances from the target amount exceeding certain thresholds may result in amounts due to or receivables due from HHS. This three-year program will end on December 31, 2016. Due to uncertainties as to the amount of federal funding available to support the risk corridor program, we do not recognize amounts receivable under this program. All liabilities are recognized as incurred. We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk corridor program as an adjustment to premium revenue in our consolidated statements of income.
Additionally, the ACA established a minimum annual medical loss ratio (Minimum MLR) of 80% for the Marketplace. The medical loss ratio represents medical costs as a percentage of premium revenue. What constitutes medical costs and premium revenue are specifically defined by federal regulations. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. Each of the 3R programs is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.
We record receivables or payables related to the 3R programs and the Minimum MLR when the amounts are reasonably estimable as described above, and, for receivables, collection is reasonably assured.

15

Table of Contents

Our receivables (payables) for each of these programs, as of the dates indicated, were as follows (in millions):
 
December 31, 2015
 
December 31, 2014
Risk adjustment
$
(214
)
 
$
(5
)
Reinsurance
36

 
5

Risk corridor
(10
)
 

Minimum MLR
(3
)
 

Quality Incentives
At several of our health plans, revenue ranging from approximately 1% to 4% of certain health plan premiums is earned if certain performance measures are met.
The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the period presented and prior periods. Although the reasonably possible effects of a change in estimate related to quality incentive premium revenue as of December 31, 2015 are not known, we have no reason to believe that the adjustments to prior years noted below are not indicative of the potential future changes in our estimates as of December 31, 2015.
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Maximum available quality incentive premium - current period
$
118

 
$
90

 
$
63

 
 
 
 
 
 
Amount of quality incentive premium revenue recognized in current period:
 
 
 
 
 
Earned current period
$
66

 
$
40

 
$
46

Earned prior periods
13

 
4

 
9

Total
$
79

 
$
44

 
$
55

 
 
 
 
 
 
Total premium revenue recognized for state health plans with quality incentive premiums
$
11,107

 
$
7,084

 
$
2,980

Medical Care Costs - Health Plans
Expenses related to medical care services are captured in the following categories:
Fee-for-service expenses: Nearly all hospital services and the majority of our primary care and physician specialist services and LTSS costs are paid on a fee-for-service basis. Under fee-for-service arrangements, we retain the financial responsibility for medical care provided and incur costs based on actual utilization of services. Such expenses are recorded in the period in which the related services are dispensed. The costs of drugs administered in a physician or hospital setting that are not billed through our pharmacy benefit manager are included in fee-for-service costs.
Pharmacy expenses: All drug, injectibles, and immunization costs paid through our pharmacy benefit manager are classified as pharmacy expenses. As noted above, drugs and injectibles not paid through our pharmacy benefit manager are included in fee-for-service costs, except in those limited instances where we capitate drug and injectible costs.
Capitation expenses: Many of our primary care physicians and a small portion of our specialists and hospitals are paid on a capitated basis. Under capitation arrangements, we pay a fixed amount PMPM to the provider without regard to the frequency, extent, or nature of the medical services actually furnished. Under capitated arrangements, we remain liable for the provision of certain health care services. Capitation payments are fixed in advance of the periods covered and are not subject to significant accounting estimates. These payments are expensed in the period the providers are obligated to provide services. The financial risk for pharmacy services for a small portion of our membership is delegated to capitated providers.
Direct delivery expenses: All costs associated with our direct delivery of medical care are separately identified.
Other medical expenses: All medically related administrative costs, certain provider incentive costs, and other health care expenses are classified as other medical expenses. Medically related administrative costs include, for example, expenses relating to health education, quality assurance, case management, care coordination, disease management,

16

Table of Contents

and 24-hour on-call nurses. Salary and benefit costs are a substantial portion of these expenses. For the years ended December 31, 2015, 2014, and 2013, medically related administrative costs were $398 million, $263 million, and $153 million, respectively.
The following table provides the details of our consolidated medical care costs from continuing operations for the periods indicated (dollars in millions, except PMPM amounts): 
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
Amount
 
PMPM
 
% of
Total
 
Amount
 
PMPM
 
% of
Total
 
Amount
 
PMPM
 
% of
Total
Fee-for-service
$
8,572

 
$
218.35

 
72.7
%
 
$
5,673

 
$
202.87

 
70.2
%
 
$
3,612

 
$
160.43

 
67.1
%
Pharmacy
1,610

 
41.01

 
13.7

 
1,273

 
45.54

 
15.8

 
935

 
41.54

 
17.4

Capitation
982

 
25.02

 
8.3

 
748

 
26.77

 
9.3

 
604

 
26.83

 
11.2

Direct delivery
128

 
3.26

 
1.1

 
96

 
3.44

 
1.2

 
48

 
2.14

 
0.9

Other
502

 
12.79

 
4.2

 
286

 
10.22

 
3.5

 
181

 
8.05

 
3.4

Total
$
11,794

 
$
300.43

 
100.0
%
 
$
8,076

 
$
288.84

 
100.0
%
 
$
5,380

 
$
238.99

 
100.0
%
Our medical care costs include amounts that have been paid by us through the reporting date, as well as estimated liabilities for medical care costs incurred but not paid by us as of the reporting date. Such medical care cost liabilities include, among other items, unpaid fee-for-service claims, capitation payments owed providers, unpaid pharmacy invoices, and various medically related administrative costs that have been incurred but not paid. We use judgment to determine the appropriate assumptions for determining the required estimates.
The most important element in estimating our medical care costs is our estimate for fee-for-service claims which have been incurred but not paid by us. These fee-for-service costs that have been incurred but have not been paid at the reporting date are collectively referred to as medical costs that are incurred but not paid (IBNP). Our IBNP claims reserve, as reported in our balance sheet, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors. For further information, see Note 11, "Medical Claims and Benefits Payable."
We report reinsurance premiums as a reduction to premium revenue, while related reinsurance recoveries are reported as a reduction to medical care costs. We limit our risk of catastrophic losses by maintaining high deductible reinsurance coverage. Such reinsurance coverage does not relieve us of our primary obligation to our policyholders. We do not consider this coverage to be material because the cost is not significant and the likelihood that coverage will apply is low.
Taxes Based on Premiums
Health Insurer Fee. The federal government under the ACA imposes an annual fee, or excise tax, on health insurers for each calendar year. The HIF is based on a company's share of the industry's net premiums written during the preceding calendar year, and is non-deductible for income tax purposes. We recognize expense for the HIF over the year on a straight-line basis. Because we primarily serve individuals in government-sponsored programs, we must secure additional reimbursement from our state partners for this added cost. We recognize the related revenue when we have obtained a contractual commitment or payment from a state to reimburse us for the HIF; such HIF revenue is recognized ratably throughout the year.
Premium and Use Tax. Certain of our health plans are assessed a tax based on premium revenue collected. The premium revenues we receive from these states include the premium tax assessment. We have reported these taxes on a gross basis, as premium tax revenue and as premium tax expense in the consolidated statements of income.
Premium Deficiency Reserves on Loss Contracts
We assess the profitability of our contracts for providing medical care services to our members and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future premiums are compared to anticipated medical care costs, including the cost of processing claims. If the anticipated future costs exceed the premiums, a loss contract accrual is recognized. No such accrual was recorded as of December 31, 2015 or 2014.

17

Table of Contents

Service Revenue and Cost of Service Revenue — Molina Medicaid Solutions
The payments received by our Molina Medicaid Solutions segment under its state contracts are based on the performance of multiple services. The first of these is the design, development and implementation (DDI) of a Medicaid management information system (MMIS). An additional service, following completion of DDI, is the operation of the MMIS under a business process outsourcing (BPO) arrangement. When providing BPO services (which include claims payment and eligibility processing) we also provide the state with other services including both hosting and support, and maintenance.
We have evaluated our Molina Medicaid Solutions contracts to determine if such arrangements include a software element. Based on this evaluation, we have concluded that these arrangements do not include a software element, and are therefore multiple-element service arrangements.
Additionally, we evaluate each required deliverable under our multiple-element service arrangements to determine whether it qualifies as a separate unit of accounting. Such evaluation is generally based on whether the deliverable has standalone value to the customer. If the deliverable has standalone value, the arrangement’s consideration that is fixed or determinable is then allocated to each separate unit of accounting based on the relative selling price of each deliverable. In general, the consideration allocated to each unit of accounting is recognized as the related goods or services are delivered, limited to the consideration that is not contingent.
We have concluded that the various service elements in our Molina Medicaid Solutions contracts represent a single unit of accounting due to the fact that DDI, which is the only service performed in advance of the other services (all other services are performed over an identical period), does not have standalone value because our DDI services are not sold separately by any vendor and the customer could not resell our DDI services. Further, we have no objective and reliable evidence of fair value for any of the individual elements in these contracts, and at no point in the contract will we have objective and reliable evidence of fair value for the undelivered elements in the contracts. We lack objective and reliable evidence of the fair value of the individual elements of our Molina Medicaid Solutions contracts for the following reasons:
Each contract calls for the provision of its own specific set of services. While all contracts support the system of record for state MMIS, the actual services we provide vary significantly between contracts; and
The nature of the MMIS installed varies significantly between our older contracts (proprietary mainframe systems) and our new contracts (commercial off-the-shelf technology solutions).
Because we have determined the services provided under our Molina Medicaid Solutions contracts represent a single unit of accounting, and because we are unable to determine a pattern of performance of services during the contract period, we recognize all revenue (both the DDI and BPO elements) associated with such contracts on a straight-line basis over the period during which BPO, hosting, and support and maintenance services are delivered. Therefore, absent any contingencies as discussed in the following paragraph, or contract extensions, we would recognize all revenue associated with those contracts over the initial contract period. When a contract is extended, we generally consider the extension to be a continuation of the single unit of accounting; therefore, the deferred revenue as of the extension date is recognized prospectively over the new remaining term of the contract. In cases where there is no DDI element associated with our contracts, BPO revenue is recognized on a monthly basis as specified in the applicable contract or contract extension.
Provisions specific to each contract may, however, lead us to modify this general principle. In those circumstances, the right of the state to refuse acceptance of services, as well as the related obligation to compensate us, may require us to delay recognition of all or part of our revenue until that contingency (the right of the state to refuse acceptance) has been removed. In those circumstances, we defer recognition of any contingent revenue (whether DDI, BPO services, hosting, and support and maintenance services) until the contingency has been removed. These types of contingency features are present in our Maine and Idaho contracts, for example. In those states, we deferred recognition of revenue until the contingencies were removed.
Costs associated with our Molina Medicaid Solutions contracts include software related costs and other costs. With respect to software related costs, we apply the guidance for internal-use software and capitalize external direct costs of materials and services consumed in developing or obtaining the software, and payroll and payroll-related costs associated with employees who are directly associated with and who devote time to the computer software project. With respect to all other direct costs, such costs are expensed as incurred, unless corresponding revenue is being deferred. If revenue is being deferred, direct costs relating to delivered service elements are deferred as well and are recognized on a straight-line basis over the period of revenue recognition, in a manner consistent with our recognition of revenue that has been deferred. Such direct costs can include:
Transaction processing costs;
Employee costs incurred in performing transaction services;
Vendor costs incurred in performing transaction services;
Costs incurred in performing required monitoring of and reporting on contract performance;

18

Table of Contents

Costs incurred in maintaining and processing member and provider eligibility; and
Costs incurred in communicating with members and providers.
The recoverability of deferred contract costs associated with a particular contract is analyzed on a periodic basis using the undiscounted estimated cash flows of the whole contract over its remaining contract term. If such undiscounted cash flows are insufficient to recover the long-lived assets and deferred contract costs, the deferred contract costs are written down by the amount of the cash flow deficiency. If a cash flow deficiency remains after reducing the balance of the deferred contract costs to zero, any remaining long-lived assets are evaluated for impairment. Any such impairment recognized would equal the amount by which the carrying value of the long-lived assets exceeds the fair value of those assets.
Income Taxes
The provision for income taxes is determined using an estimated annual effective tax rate, which is generally greater than the U.S. federal statutory rate primarily because of state and Puerto Rico taxes, nondeductible expenses under the Affordable Care Act Health Insurer Fee (HIF), nondeductible compensation and other general and administrative expenses. The effective tax rate may be subject to fluctuations during the year, particularly as a result of the level of pretax earnings, and also as new information is obtained. Such information may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pretax earnings in the various tax jurisdictions in which we operate, valuation allowances against deferred tax assets, the recognition or the reversal of the recognition of tax benefits related to uncertain tax positions, and changes in or the interpretation of tax laws in jurisdictions where we conduct business. We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities, along with net operating loss and tax credit carryovers. For further discussion and disclosure, see Note 14, "Income Taxes."
Concentrations of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Funds Prime Series — Institutional Class, and the PFM Funds Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. As of December 31, 2015 and 2014, our investments with PFM amounted to approximately $605 million and $321 million, respectively. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. Our portfolio managers must obtain our prior approval before selling investments where the loss position of those investments exceeds certain levels. Our investments consist primarily of investment-grade debt securities with a maximum maturity of 10 years and an average duration of three years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited because our payors consist principally of the governments of each state in which our health plan subsidiaries operate.
Risks and Uncertainties
Our profitability depends in large part on our ability to accurately predict and effectively manage medical care costs. We continually review our medical costs in light of our underlying claims experience and revised actuarial data. However, several factors could adversely affect medical care costs. These factors, which include changes in health care practices, inflation, new technologies, major epidemics, natural disasters, and malpractice litigation, are beyond our control and may have an adverse effect on our ability to accurately predict and effectively control medical care costs. Costs in excess of those anticipated could have a material adverse effect on our financial condition, results of operations, or cash flows.
We operate health plans primarily as a direct contractor with the states (or Commonwealth), and in Los Angeles County, California, as a subcontractor to another health plan holding a direct contract with the state. We are therefore dependent upon a small number of contracts to support our revenue. The loss of any one of those contracts could have a material adverse effect on our financial position, results of operations, or cash flows. Our ability to arrange for the provision of medical services to our members is dependent upon our ability to develop and maintain adequate provider networks. Our inability to develop or maintain such networks might, in certain circumstances, have a material adverse effect on our financial position, results of operations, or cash flows.
Recent Accounting Pronouncements Not Yet Adopted
Leases. In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) ASU 2016-02, Leases. ASU 2016-02 amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets and making targeted changes to lessor accounting. The ASU is effective for us beginning in the first quarter of 2019, and requires a modified retrospective transition approach. Early adoption is permitted; we are currently evaluating the potential effects of the adoption to our financial statements.

19

Table of Contents

Financial Instruments. In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, which will require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. Also, entities will have to assess the realizability of a deferred tax asset related to an available for sale debt security in combination with the entity’s other deferred tax assets. Effective for us in the first quarter of 2018, ASU 2016-01 is applied prospectively with a cumulative-effect adjustment to beginning retained earnings as of the beginning of the first reporting period in which the guidance is adopted. Early adoption is permitted in regards to certain provisions of the standard; we are evaluating the potential effects of the adoption to our financial statements.
Revenue Recognition. In July 2015, the FASB affirmed its proposal to defer the effective date of ASU 2014-09, Revenue from Contracts with Customers, for all entities by one year. As a result, public business entities will apply the new revenue standard to annual reporting periods beginning after December 15, 2017, and for interim reporting periods within annual reporting periods beginning after December 15, 2017. We intend to adopt this standard on January 1, 2018. We are currently evaluating our plan for adoption and its impact to our revenue recognition policies, procedures and control framework, and the resulting impact to our consolidated financial position, results of operations and cash flows.
Short-Duration Contracts. In May 2015, the FASB issued ASU 2015-09, Disclosures about Short-Duration Contracts, which will require additional disclosure on the liability for unpaid claims and claim adjustment expenses. We intend to adopt this standard effective for our annual report for the year ending December 31, 2016, and for interim periods thereafter. It requires additional disclosure only and will not have a significant impact to our consolidated financial statements.
Software Licenses. In April 2015, the FASB issued ASU 2015-05, Customer's Accounting for Fees Paid in a Cloud Computing Arrangement, which will require customers to determine whether a cloud computing arrangement includes the license of software by applying the same guidance cloud service providers use to make this determination. The ASU also eliminates the existing requirement for customers to account for software licenses they acquire by analogizing to the guidance on leases. This ASU will be effective for us in the first quarter of 2016, and is applied either prospectively or retrospectively. We are evaluating the potential effects of adoption to our financial statements.
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC did not have, or are not believed by management to have, a material impact on our present or future consolidated financial statements.
Recent Accounting Pronouncements Adopted
Income Taxes. In the fourth quarter of 2015, we early adopted ASU 2015-17, Balance Sheet Classification of Deferred Taxes, which requires deferred tax assets and liabilities to be classified as non-current, in a classified statement of financial position. We have applied the guidance retrospectively to all periods presented. Such retrospective adoption had an insignificant impact to our consolidated balance sheets, and had no impact to our consolidated statements of income, stockholders’ equity, and cash flows.
Business Combinations. In the fourth quarter of 2015, we early adopted ASU 2015-16, Simplifying the Accounting for Measurement-Period Adjustments, which requires acquirers to recognize adjustments to provisional amounts identified during the measurement period (a reasonable time period after the acquisition date) in the reporting period in which such adjustment amounts are determined. For the year ended December 31, 2015, there was no impact to our consolidated financial statements.
Debt Issuance Costs. In the fourth quarter of 2015, we early adopted ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, which requires that debt issuance costs related to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of such debt liability, consistent with debt discounts. In a subsequent Staff Announcement, the SEC announced that it would not object to the deferral and presentation of debt issuance costs relating to line-of-credit arrangements as an asset. We have applied the guidance retrospectively to all periods presented. Such retrospective adoption had an insignificant impact to our consolidated balance sheets, and had no impact to our consolidated statements of income, stockholders’ equity, and cash flows.

20

Table of Contents

3. Net Income per Share
The following table sets forth the calculation of the denominators used to compute basic and diluted net income per share:
 
December 31,
 
2015
 
2014
 
2013
 
(In millions)
Shares outstanding at the beginning of the period
49

 
46

 
47

Weighted-average number of shares:
 
 
 
 
 
Issued:
 
 
 
 
 
Common stock offering
3

 

 

Convertible senior notes

 
1

 

Repurchased

 

 
(1
)
Denominator for basic net income per share
52

 
47

 
46

Effect of dilutive securities:
 
 
 
 
 
Share-based compensation
1

 

 
1

Convertible senior notes (1)
1

 
1

 

1.125% Warrants (1)
2

 

 

Denominator for diluted net income per share
56

 
48

 
47

 
 
 
 
 
 
Potentially dilutive common shares excluded from calculations (2):
 
 
 
 
 
1.125% Warrants

 
13

 
12

_______________________________ 
(1)
For more information regarding the convertible senior notes, including the 1.625% Notes, 3.75% Notes, and 3.75% Exchange, refer to Note 12, "Debt." For more information regarding the 1.125% Warrants, refer to Note 13, "Derivatives."
(2)
The dilutive effect of all potentially dilutive common shares is calculated using the treasury-stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would be anti-dilutive. For the years ended December 31, 2014 and 2013, the 1.125% Warrants were excluded from diluted shares outstanding because the exercise price exceeded the average market price of our common stock.
4. Business Combinations
During 2015, we closed on business combinations in both the Health Plans and Other segments. For all of these transactions we applied the acquisition method of accounting, where the total purchase price was allocated, or preliminarily allocated, to tangible and intangible assets acquired, and liabilities assumed based on their respective fair values. For Health Plans acquisitions, in general, only intangible assets are acquired. All of the 2015 acquisitions were funded using available cash.
Health Plans
Consistent with our strategy to grow in our existing markets, we closed the following Health Plans acquisitions in 2015:
Florida. On November 1, 2015, our Florida health plan closed on its acquisition of the Medicaid contracts, and certain assets related to operation of the Medicaid business, of Integral Health Plan, Inc. The final purchase price was $67 million, and the Florida health plan added approximately 101,000 members in the Northwest and Southwest regions of Florida as a result of this transaction. On the closing date, we withheld 10%, or approximately $7 million, of the purchase price to establish an indemnification amount held as security for the seller's indemnification obligations under the purchase agreement. We have recorded the indemnification amount to restricted assets, which will be settled in November 2016. If we do not have any claims against the seller on or before the settlement date, we will pay the full withhold amount to the seller. As of December 31, 2015, we had not made any claims against the withhold amount.
On August 1, 2015, our Florida health plan closed on its acquisition of the Medicaid contracts, and certain assets related to the operation of the Medicaid business, of Preferred Medical Plan, Inc. The final purchase price was $8 million, and the Florida health plan added approximately 23,000 members as a result of this transaction.

21

Table of Contents

Michigan. On September 1, 2015, our Michigan health plan closed on its acquisition of the Medicaid and MIChild contracts, and certain provider agreements, of HealthPlus of Michigan and its subsidiary, HealthPlus Partners, Inc. The purchase price was $47 million, and the Michigan health plan added approximately 68,000 members as a result of this transaction.
For the Health Plans acquisitions closed in 2015, we recorded goodwill amounting to $90 million in the aggregate, which relates to future economic benefits arising from expected synergies to be achieved. Such synergies include use of our existing infrastructure to support the added membership. The amount recorded as goodwill represents intangible assets that do not qualify for separate recognition as identifiable intangible assets. The entire amount recorded as goodwill is deductible for income tax purposes. Refer to the table below for a summary of the intangible assets identified, and their economic lives.
Announced Acquisitions. As described in Note 1, "Basis of Presentation," we announced several Health Plans acquisitions in 2015 that did not close until January 1, 2016. Because the closing dates for these acquisitions fell on January 1, 2016, a holiday, approximately $101 million was recorded to prepaid expenses and other assets as of December 31, 2015, for purchase price amounts funded in December 2015. Such amounts are reported in investing activities in the accompanying consolidated statements of cash flows. The total aggregate purchase price for these acquisitions amounted to approximately $115 million, which will be allocated among goodwill and intangible assets. The initial accounting for these transactions is incomplete.
Transaction costs associated with the Health Plans acquisitions were insignificant.
Other
Pathways. Consistent with our strategy to acquire and develop new products and capabilities, on November 1, 2015, we acquired all of the outstanding ownership interests in Pathways Health and Community Support LLC (Pathways), formerly known as Providence Human Services, LLC. Pathways is one of the largest national providers of accessible, outcome-based behavioral/mental health and social services with operations in 23 states and the District of Columbia.
The following table summarizes the preliminary values of the assets acquired and liabilities assumed at the date of acquisition.
 
November 1, 2015
 
(In millions)
Assets:
 
Cash and cash equivalents
$
20

Receivables
52

Prepaid expenses and other current assets
4

Property and equipment
14

Intangible assets
19

Goodwill
155

Other assets
1

Liabilities:
 
Medical claims and benefits payable
(2
)
Accounts payable and accrued liabilities
(23
)
Deferred revenue
(2
)
Other long-term liabilities
(7
)
Total purchase price
$
231

As of December 31, 2015, the purchase price allocation for the acquisition was preliminary and subject to completion. Adjustments to the current fair value estimates in the above table may occur as the process conducted for various valuations and assessments is finalized, including tax assets and liabilities. Goodwill is calculated as the excess of the consideration transferred over the net assets recognized and represents the estimated future economic benefits arising from other assets acquired that could not be individually identified and separately recognized, including expected medical cost synergies to be achieved, and the workforce acquired. Such synergies include the achievement of better outcomes for our members through more effective care coordination and integration, and our retention of the net profit margin captured by the mental health provider. The workforce acquired is a significant component of goodwill because it represents primarily the patient-facing employees, now employed by us, who provide the behavioral/mental health and social services. Approximately 10% of the goodwill recorded at December 31, 2015, is deductible for income tax purposes. This percentage may increase if certain tax elections are completed in 2016.

22

Table of Contents

The gross contractual amount of receivables, at the acquisition date, was approximately $61 million. At the acquisition date, the best estimate of contractual cash flows not expected to be collected was approximately $9 million.
In connection with this acquisition, we incurred approximately $3 million in transaction costs, which are recorded in general and administrative expenses.
The following table presents the intangible assets identified, by segment. The weighted-average amortization period for the Health Plans identified intangible assets, in the aggregate, is 6.4 years. The weighted-average amortization period for the Other identified intangible assets, in the aggregate, is 4.2 years.
 
Fair Value
 
Useful Life
 
(In millions)
 
(years)
Intangible asset type
 
 
 
Health Plans:
 
 
 
Contract rights - member list
$
23

 
5
Provider network
9

 
10
Other:
 
 
 
Contract licenses
5

 
2
Contract rights - member list
14

 
5
 
$
51

 
 
5. Fair Value Measurements
We consider the carrying amounts of cash and cash equivalents and other current assets and current liabilities (not including derivatives and current portion of long-term debt) to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:
Level 1 — Observable Inputs
Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices on one or more securities exchanges.
Level 2 — Directly or Indirectly Observable Inputs
Level 2 financial instruments are traded frequently though not necessarily daily. Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets.
Level 3 — Unobservable Inputs
Level 3 financial instruments are valued using unobservable inputs that represent management's best estimate of what market participants would use in pricing the financial instrument at the measurement date. Our Level 3 financial instruments include the following:
Derivative financial instruments. Derivative financial instruments include the 1.125% Call Option derivative asset and the 1.125% Conversion Option derivative liability. These derivatives are not actively traded and are valued based on an option pricing model that uses observable and unobservable market data for inputs. Significant market data inputs used to determine fair value as of December 31, 2015 included the price of our common stock, the time to maturity of the derivative instruments, the risk-free interest rate, and the implied volatility of our common stock. As described further in Note 13, "Derivatives," the 1.125% Call Option asset and the 1.125% Conversion Option liability were designed such that changes in their fair values would offset, with minimal impact to the consolidated statements of income. Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated. The changes in Level 3 instruments for the year ended December 31, 2015 were insignificant.

23

Table of Contents

Our financial instruments measured at fair value on a recurring basis at December 31, 2015, were as follows:
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In millions)
Corporate debt securities
$
1,184

 
$

 
$
1,184

 
$

Government-sponsored enterprise securities (GSEs)
211

 
211

 

 

Municipal securities
185

 

 
185

 

Certificates of deposit
80

 

 
80

 

U.S. treasury notes
78

 
78

 

 

Asset-backed securities
63

 

 
63

 

Subtotal - current investments
1,801

 
289

 
1,512

 

1.125% Call Option derivative asset
374

 

 

 
374

Total assets measured at fair value on a recurring basis
$
2,175

 
$
289

 
$
1,512

 
$
374

 
 
 
 
 
 
 
 
1.125% Conversion Option derivative liability
$
374

 
$

 
$

 
$
374

Total liabilities measured at fair value on a recurring basis
$
374

 
$

 
$

 
$
374

Our financial instruments measured at fair value on a recurring basis at December 31, 2014, were as follows:
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In millions)
Corporate debt securities
$
641

 
$

 
$
641

 
$

GSEs
122

 
122

 

 

Municipal securities
127

 

 
127

 

Certificates of deposit
69

 

 
69

 

U.S. treasury notes
60

 
60

 

 

Subtotal - current investments
1,019

 
182

 
837

 

1.125% Call Option derivative asset
329

 

 

 
329

Total assets measured at fair value on a recurring basis
$
1,348

 
$
182

 
$
837

 
$
329

 
 
 
 
 
 
 
 
1.125% Conversion Option derivative liability
$
329

 
$

 
$

 
$
329

Total liabilities measured at fair value on a recurring basis
$
329

 
$

 
$

 
$
329

Fair Value Measurements – Disclosure Only
The carrying amounts and estimated fair values of our senior notes, which are classified as Level 2 financial instruments, are indicated in the following table. Fair value for these securities is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets. As described in Note 2, "Significant Accounting Policies," the carrying amount of debt has been reduced by deferred issuance costs for all periods presented.
 
December 31, 2015
 
December 31, 2014
 
Carrying
 
Total Fair Value
 
Carrying
 
Total Fair Value
 
Amount
 
 
Amount
 
 
(In millions)
5.375% Notes
$
689

 
$
700

 
$

 
$

1.125% Convertible Notes
448

 
865

 
426

 
767

1.625% Convertible Notes
273

 
365

 
264

 
337

 
$
1,410

 
$
1,930

 
$
690

 
$
1,104


24

Table of Contents

6. Investments
The following tables summarize our investments as of the dates indicated:
 
December 31, 2015
 
Amortized
 
Gross
Unrealized
 
Estimated
 
Cost
 
Gains
 
Losses
 
Fair Value
 
(In millions)
Corporate debt securities
$
1,189

 
$

 
$
5

 
$
1,184

GSEs
212

 

 
1

 
211

Municipal securities
186

 

 
1

 
185

Certificates of deposit
80

 

 

 
80

U.S. treasury notes
78

 

 

 
78

Asset-backed securities
63

 

 

 
63

 
$
1,808

 
$

 
$
7

 
$
1,801

 
December 31, 2014
 
Amortized
 
Gross
Unrealized
 
Estimated
 
Cost
 
Gains
 
Losses
 
Fair Value
 
(In millions)
Corporate debt securities
$
643

 
$

 
$
2

 
$
641

GSEs
122

 

 

 
122

Municipal securities
127

 

 

 
127

Certificates of deposit
69

 

 

 
69

U.S. treasury notes
60

 

 

 
60

 
$
1,021

 
$

 
$
2

 
$
1,019

The contractual maturities of our investments as of December 31, 2015 are summarized below:
 
Amortized
Cost
 
Estimated
Fair Value
 
(In millions)
Due in one year or less
$
830

 
$
829

Due after one year through five years
967

 
962

Due after five years through ten years
11

 
10

 
$
1,808

 
$
1,801

Gross realized gains and losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Gross realized investment gains and losses for the years ended December 31, 2015, 2014 and 2013 were insignificant.
We have determined that unrealized gains and losses at December 31, 2015 and 2014 are temporary in nature, because the change in market value for these securities has resulted from fluctuating interest rates, rather than a deterioration of the credit worthiness of the issuers. So long as we hold these securities to maturity, we are unlikely to experience gains or losses. In the event that we dispose of these securities before maturity, we expect that realized gains or losses, if any, will be immaterial.

25

Table of Contents

The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2015.
 
In a Continuous Loss Position
for Less than 12 Months
 
In a Continuous Loss Position
for 12 Months or More
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total Number of Positions
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total Number of Positions
 
(Dollars in millions)
Corporate debt securities
$
825

 
$
4

 
588

 
$
119

 
$
1

 
87

GSEs
182

 
1

 
77

 

 

 

Municipal securities
128

 
1

 
181

 
5

 

 
12

Certificates of deposit
53

 

 
218

 

 

 

U.S. treasury notes
53

 

 
32

 

 

 

Asset-backed securities
55

 

 
47

 

 

 

 
$
1,296

 
$
6

 
1,143

 
$
124

 
$
1

 
99

The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2014.
 
In a Continuous Loss Position
for Less than 12 Months
 
In a Continuous Loss Position
for 12 Months or More
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total Number of Positions
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total Number of Positions
 
(Dollars in millions)
Corporate debt securities
$
379

 
$
1

 
265

 
$
29

 
$
1

 
10

GSEs
75

 

 
22

 
3

 

 
3

Municipal securities
54

 

 
64

 
11

 

 
13

Certificates of deposit
13

 

 
52

 

 

 

U.S. treasury notes
19

 

 
13

 

 

 

 
$
540

 
$
1

 
416

 
$
43

 
$
1

 
26



26

Table of Contents

7. Receivables
Receivables consist primarily of amounts due from government Medicaid agencies, which may be subject to potential retroactive adjustments. Because all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is immaterial. The information below is presented by segment.
 
December 31,
 
2015
 
2014
 
(In millions)
California
$
104

 
$
311

Florida
22

 
2

Illinois
35

 
32

Michigan
39

 
20

New Mexico
51

 
50

Ohio
66

 
45

Puerto Rico
33

 

South Carolina
6

 
4

Texas
56

 
29

Utah
18

 
6

Washington
53

 
43

Wisconsin
22

 
8

Direct delivery and other
6

 
11

Total Health Plans segment
511

 
561

Molina Medicaid Solutions segment
37

 
35

Other segment
49

 

 
$
597

 
$
596

8Property, Equipment, and Capitalized Software
A summary of property, equipment, and capitalized software is as follows:
 
December 31,
 
2015
 
2014
 
(In millions)
Land
$
16

 
$
15

Building and improvements
153

 
195

Furniture and equipment
250

 
141

Capitalized software
336

 
267

 
755

 
618

Less: accumulated depreciation and amortization on building and improvements, furniture and equipment
(167
)
 
(129
)
Less: accumulated amortization for capitalized software
(195
)
 
(148
)
 
(362
)
 
(277
)
Property, equipment, and capitalized software, net
$
393

 
$
341

Depreciation recognized for building and improvements, and furniture and equipment was $49 million, $35 million, and $27 million for the years ended December 31, 2015, 2014 and 2013, respectively. Amortization of capitalized software was $52 million, $59 million, and $46 million for the years ended December 31, 2015, 2014 and 2013, respectively.
Molina Center. We acquired the Molina Center in December 2011. Subsequently, in June 2013 we entered into a sale-leaseback transaction for the Molina Center. Due to our continuing involvement with the leased property, the sale did not qualify for sales recognition and we remain the "accounting owner" of the property. See Note 12, "Debt."

27

Table of Contents

Future minimum rental income on noncancelable leases from third party tenants of the Molina Center is sublease rental income, and is reported in other revenue in our consolidated statements of income. The future minimum rental income is as follows:
 
2016
 
2017
 
2018
 
2019
 
2020
 
Thereafter
 
Total
 
(In millions)
Future minimum rentals
$
4

 
4

 
4

 
2

 
2

 
1

 
$
17


9Goodwill and Intangible Assets
The following table provides the details of identified intangible assets, by major class, for the periods indicated:
 
Cost
 
Accumulated
Amortization
 
Net
Balance
 
(In millions)
Intangible assets:
 
 
 
 
 
Contract rights and licenses
$
224

 
$
120

 
$
104

Customer relationships
25

 
23

 
2

Contract backlog
24

 
24

 

Provider networks
27

 
11

 
16

Balance at December 31, 2015
$
300

 
$
178

 
$
122

Intangible assets:
 
 
 
 
 
Contract rights and licenses
$
182

 
$
105

 
$
77

Customer relationships
25

 
23

 
2

Contract backlog
24

 
23

 
1

Provider networks
18

 
9

 
9

Balance at December 31, 2014
$
249

 
$
160

 
$
89

Based on the balances of our identifiable intangible assets as of December 31, 2015, we estimate that our intangible asset amortization will be $25 million in 2016, $25 million in 2017, $22 million in 2018, $18 million in 2019, and $13 million in 2020. For a presentation of our goodwill and intangible assets by reportable segment, refer to Note 20, "Segment Information."
The following table presents the balances of goodwill as of December 31, 2015 and 2014:
 
December 31, 2014
 
Acquisitions by Segment
 
December 31, 2015
 
 
Health Plans
 
Other
 
 
(In millions)
Goodwill, gross
$
330

 
$
90

 
$
157

 
$
577

Accumulated impairment losses
(58
)
 

 

 
(58
)
Goodwill, net
$
272

 
$
90

 
$
157

 
$
519

The changes in the carrying amounts of goodwill and intangible assets, at cost, in 2015 were due to the acquisitions described in Note 4, "Business Combinations."

28

Table of Contents

10. Restricted Investments
Pursuant to the regulations governing our Health Plans segment subsidiaries, we maintain statutory deposits and deposits required by government authorities in certificates of deposit and U.S. treasury securities. We also maintain restricted investments as protection against the insolvency of certain capitated providers. In connection with a Molina Medicaid Solutions segment state contract, we maintained restricted investments as collateral for a letter of credit as of December 31, 2014. The following table presents the balances of restricted investments:
 
December 31,
 
2015
 
2014
 
(In millions)
Florida
$
34

 
$
29

Michigan
1

 
1

New Mexico
43

 
35

Ohio
12

 
13

Puerto Rico
10

 
5

South Carolina

 
6

Texas
4

 
3

Utah
4

 
4

Wisconsin
1

 

Other

 
1

Total Health Plans segment
109

 
97

Molina Medicaid Solutions segment

 
5

 
$
109

 
$
102

The contractual maturities of our held-to-maturity restricted investments as of December 31, 2015 are summarized below.
 
Amortized
Cost
 
Estimated
Fair Value
 
(In millions)
Due in one year or less
$
100

 
$
100

Due one year through five years
9

 
9

 
$
109

 
$
109

11Medical Claims and Benefits Payable
The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.
 
December 31,
 
2015
 
2014
 
2013
 
(In millions)
Fee-for-service claims incurred but not paid (IBNP)
$
1,191

 
$
871

 
$
424

Pharmacy payable
88

 
71

 
45

Capitation payable
140

 
28

 
20

Other
266

 
231

 
181

 
$
1,685

 
$
1,201

 
$
670

"Other" medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various government agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. Non-risk provider payables amounted to $167 million, $119 million and $151 million, as of December 31, 2015, 2014 and 2013, respectively.
The following table presents the components of the change in our medical claims and benefits payable from continuing and discontinued operations combined for the periods indicated. The amounts presented for "Components of medical care costs

29

Table of Contents

related to: Prior periods" represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the period were more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(Dollars in millions)
Balances at beginning of period
$
1,201

 
$
670

 
$
495

Components of medical care costs related to:
 
 
 
 
 
Current period
11,935

 
8,123

 
5,434

Prior periods
(141
)
 
(46
)
 
(53
)
Total medical care costs
11,794

 
8,077

 
5,381

 
 
 
 
 
 
Change in non-risk provider payables
48

 
(32
)
 
111

 
 
 
 
 
 
Payments for medical care costs related to:
 
 
 
 
 
Current period
10,448

 
7,064

 
4,932

Prior periods
910

 
450

 
385

Total paid
11,358

 
7,514

 
5,317

Balances at end of period
$
1,685

 
$
1,201

 
$
670


That portion of our total medical claims and benefits payable liability that is most subject to variability in the estimate is fee-for-service claims incurred but not paid (IBNP). Our IBNP, as included in medical claims and benefits payable, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors.
Assuming that our initial estimate of IBNP is accurate, we believe that amounts ultimately paid would generally be between 8% and 10% less than the IBNP liability recorded at the end of the period as a result of the inclusion in that liability of the provision for adverse claims deviation and the accrued cost of settling those claims. Because the amount of our initial liability is merely an estimate (and therefore not perfectly accurate), we will always experience variability in that estimate as new information becomes available with the passage of time. Therefore, there can be no assurance that amounts ultimately paid out will fall within the range of 8% to 10% lower than the liability that was initially recorded. Furthermore, because our initial estimate of IBNP is derived from many factors, some of which are qualitative in nature rather than quantitative, we are seldom able to assign specific values to the reasons for a change in estimate—we only know when the circumstances for any one or more factors are out of the ordinary.
The use of a consistent methodology in estimating our liability for medical claims and benefits payable minimizes the degree to which the under– or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. In particular, the use of a consistent methodology should result in the replenishment of reserves during any given period in a manner that generally offsets the benefit of favorable prior period development in that period. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate.
As indicated above, the amounts ultimately paid out on our medical claims and benefits payable liabilities in fiscal years 2015, 2014, and 2013 were less than what we had expected when we had established those liabilities. The differences between our original estimates and the amounts ultimately paid out (or now expected to be ultimately paid out) for the most part related to IBNP. While many related factors working in conjunction with one another determine the accuracy of our estimates, we are seldom able to quantify the impact that any single factor has on a change in estimate. In addition, given the variability inherent in the reserving process, we will only be able to identify specific factors if they represent a significant departure from expectations. As a result, we do not expect to be able to fully quantify the impact of individual factors on changes in estimates.
2015
We believe that the most significant factors that will determine the accuracy of our IBNP estimates at December 31, 2015 are:
A new version of diagnosis codes was required for all claims with dates of service October 1, 2015 and later. As a result, payment was delayed for a significant number of claims due to the use of diagnosis codes that were no longer valid. Due to the resulting variability in the ratio of paid to billed amounts, the reserves are subject to more than the usual amount of uncertainty.

30

Table of Contents

At our Illinois, Puerto Rico and Wisconsin health plans, we overpaid certain provider and outpatient facility claims due to a system configuration error. For this reason, the reserves are subject to more than the usual amount of uncertainty.
Our Michigan health plan added approximately 68,000 new members under an acquisition in the third quarter of 2015. Because these new members may have different utilization patterns than our legacy members, the reserves are subject to more than the usual amount of uncertainty.
Our Puerto Rico health plan started operations on April 1, 2015. Because we lack sufficient historical claims data, our reserves as of December 31, 2015 are based on a combination of claims payment experience and the expected claims in the pricing assumptions. For this reason, the reserves are subject to more than the usual amount of uncertainty.
We recognized favorable prior period claims development in the amount of $141 million for the year ended December 31, 2015. This amount represents our estimate as of December 31, 2015, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2014 was more than the amount that will ultimately be paid out in satisfaction of that liability. We believe the overestimation was due primarily to the following factors:
At our Ohio and California health plans, approximately 61,000 and 100,000 members, respectively, were enrolled in the new Medicaid expansion program during 2014. Also in Ohio, approximately 17,000 members were enrolled in the new MMP program in 2014. Because we lacked sufficient historical claims data, we initially estimated the reserves for these new members based upon a number of factors that included pricing assumptions provided by the state; our expectations regarding pent up demand; our beliefs about the speed at which new members would utilize health care services; and other factors. Our actual costs were ultimately less than expected.
At our New Mexico health plan, the state implemented a retroactive increase to the provider fee schedules in mid-2014. As a result, many claims that were previously settled were reopened, and subject to, additional payment. Because our reserving methodology is most accurate when claims payment patterns are consistent and predictable, the payment of additional amounts on claims that in some cases had been settled more than six months before added a substantial degree of complexity to our liability estimation process. Due to the difficulties in addressing that added complexity, liabilities recorded as of December 31, 2014, were in excess of amounts ultimately paid.
At our Washington health plan, in 2015 we collected amounts related to certain claims paid in 2013. Such collections were not anticipated in our reserves as of December 31, 2014.
2014
We recognized favorable prior period claims development in the amount of $46 million for the year ended December 31, 2014. This amount represented our estimate as of December 31, 2014, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2013 was more than the amount that was ultimately paid out in satisfaction of that liability. We believe the overestimation was due primarily to the following factors:
At our Ohio health plan, we entered new regions in the state, and a new product, ABD Kids, in July 2013. Because we lacked sufficient historical claims data, we initially estimated the reserves for these new members based upon a number of factors that included pricing assumptions provided by the state; our expectations regarding pent up demand; our beliefs about the speed at which new members would utilize health care services; and other factors. Our actual costs were ultimately less than expected.
At our Michigan health plan, we overestimated the impact of certain unpaid potentially high-dollar claims. In addition, we overestimated the impact of the flu season on the outpatient claims for November and December 2013, which caused an overestimation in our outpatient reserve liability as of December 31, 2013.
2013
We recognized favorable prior period claims development in the amount of $53 million for the year ended December 31, 2013. This amount represented our estimate as of December 31, 2013, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2012 was more than the amount that was ultimately paid out in satisfaction of that liability. We believe the overestimation was due primarily to the following factors:
At our Washington health plan certain high-cost newborns, as well as other high-cost disabled members, were covered by the health plan effective July 1, 2012. Because we lacked sufficient historical claims data, we initially estimated the reserves for these new members based upon a number of factors. Our actual costs were ultimately less than expected.
At our New Mexico health plan, we overestimated the impact of certain high-dollar outstanding claim payments as of December 31, 2012.

31

Table of Contents

At our Ohio health plan, we overestimated the impact of several potential high-dollar claims relating to our ABD members.     
12. Debt
As of December 31, 2015, contractual maturities of debt for the years ending December 31 are as follows (in millions):
 
Total
 
2016
 
2017
 
2018
 
2019
 
2020
 
Thereafter
5.375% Notes
$
700

 
$

 
$

 
$

 
$

 
$

 
$
700

1.125% Convertible Notes
550

 

 

 

 

 
550

 

1.625% Convertible Notes (1)
302

 

 

 

 

 

 
302

Other
1

 
1

 

 

 

 

 

 
$
1,553

 
$
1

 
$

 
$

 
$

 
$
550

 
$
1,002

(1)
The 1.625% Notes have a contractual maturity date in 2044; however, on specified dates beginning in 2018 as described below, holders of the 1.625% Notes may require us to repurchase some or all of the 1.625% Notes, or we may redeem any or all of the 1.625% Notes.
Substantially all of our debt is held at the parent, which is reported in the Other segment. The principal amounts, unamortized discount (net of premium related to 1.625% Notes), unamortized issuance costs, and net carrying amounts of debt were as follows:
 
Principal Balance
 
Unamortized Discount
 
Unamortized Issuance Costs
 
Net Carrying Amount
 
(In millions)
December 31, 2015:
 
 
 
 
 
 
 
5.375% Notes
$
700

 
$

 
$
11

 
$
689

1.125% Convertible Notes
550

 
95

 
7

 
448

1.625% Convertible Notes
302

 
25

 
4

 
273

Other
1

 

 

 
1

 
$
1,553

 
$
120

 
$
22

 
$
1,411

December 31, 2014:
 
 
 
 
 
 
 
1.125% Convertible Notes
$
550

 
$
115

 
$
9

 
$
426

1.625% Convertible Notes
302

 
33

 
5

 
264

 
$
852

 
$
148

 
$
14

 
$
690

 
Years Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Interest cost recognized for the period relating to:
 
 
 
 
 
Contractual interest coupon rate
$
17

 
$
13

 
$
13

Amortization of the discount
29

 
26

 
22

 
$
46

 
$
39

 
$
35

5.375% Senior Notes due 2022. On November 10, 2015, we completed the private offering of $700 million aggregate principal amount of senior notes (5.375% Notes) due November 15, 2022, unless earlier redeemed. Interest is payable semiannually in arrears on May 15 and November 15, beginning on May 15, 2016. The 5.375% Notes are not convertible into our common stock or any other securities.
The 5.375% Notes are guaranteed by certain of our wholly owned subsidiaries. The 5.375% Notes and the guarantees are effectively subordinated to all existing and future secured debt of us and our guarantors to the extent of the assets securing such debt. In addition, the 5.375% Notes and the guarantees are structurally subordinated to all indebtedness and other liabilities and preferred stock of our subsidiaries that do not guarantee the 5.375% Notes.
We may redeem some or all of the 5.375% Notes at any time, and prior to August 15, 2022, at a price equal to 100% of the principal amount redeemed plus accrued and unpaid interest thereon, plus a "make-whole" premium. Thereafter, we may redeem some or all of the 5.375% Notes at a price equal to 100% of the principal amount redeemed plus accrued and unpaid

32

Table of Contents

interest thereon. The 5.375% Notes contain customary non-financial covenants and change of control provisions.
In connection with the issuance and sale of the 5.375% Notes, we entered into a registration rights agreement. Under this agreement, we will use commercially reasonable efforts to register substantially identical notes (the Exchange Notes) with the SEC in 2016. We will then offer such freely tradable Exchange Notes in exchange for the 5.375% Notes. We will pay additional interest on the 5.375% Notes if the Exchange Notes offering is not completed timely.
Credit Facility. In June 2015, we entered into an unsecured $250 million revolving credit facility (Credit Facility). The Credit Facility has a term of five years and all amounts outstanding will be due and payable on June 12, 2020. Subject to obtaining commitments from existing or new lenders and satisfaction of other specified conditions, we may increase the Credit Facility to up to $350 million. As of December 31, 2015, outstanding letters of credit amounting to $6 million reduced the borrowing capacity to $244 million, and no amounts were outstanding under the Credit Facility.
Borrowings under the Credit Facility bear interest based, at our election, on a base rate or an adjusted London Interbank Offered Rate (LIBOR), plus in each case the applicable margin. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Facility, we are required to pay a quarterly commitment fee.
Although the Credit Facility is not secured by any of our assets, certain of our wholly owned subsidiaries have jointly and severally guaranteed our obligations under the Credit Facility.
The Credit Facility contains customary non-financial and financial covenants, including a minimum fixed charge coverage ratio, a maximum debt-to-EBITDA ratio and minimum statutory net worth. At December 31, 2015, we were in compliance with all financial covenants under the Credit Facility.
1.125% Cash Convertible Senior Notes due 2020. In February 2013, we issued $550 million aggregate principal amount of 1.125% cash convertible senior notes (1.125% Notes) due January 15, 2020, unless earlier repurchased or converted. Interest is payable semiannually in arrears on January 15 and July 15.
The 1.125% Notes are senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.125% Notes; equal in right of payment to any of our unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities of our subsidiaries.
The 1.125% Notes are convertible only into cash, and not into shares of our common stock or any other securities. The initial conversion rate for the 1.125% Notes is 24.5277 shares of our common stock per $1,000 principal amount of the 1.125% Notes. This represents an initial conversion price of approximately $40.77 per share of our common stock. Upon conversion, in lieu of receiving shares of our common stock, a holder will receive an amount in cash, per $1,000 principal amount of 1.125% Notes, equal to the settlement amount, determined in the manner set forth in the indenture. We may not redeem the 1.125% Notes prior to the maturity date. Holders may convert their 1.125% Notes only under the following circumstances:
during any calendar quarter commencing after the calendar quarter ending on June 30, 2013 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period immediately after any five consecutive trading day period (the measurement period) in which the trading price per $1,000 principal amount of 1.125% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
upon the occurrence of specified corporate events; or
at any time on or after July 15, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date.
The 1.125% Notes met the stock price trigger in the quarter ended December 31, 2015, and are convertible into cash through at least March 31, 2016. Because the 1.125% Notes may be converted to cash within 12 months, the $448 million carrying amount is reported in current portion of long-term debt as of December 31, 2015.
The 1.125% Notes contain an embedded cash conversion option (the 1.125% Conversion Option), which was separated from the 1.125% Notes and accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the 1.125% Conversion Option settles or expires. The initial fair value liability of the 1.125% Conversion Option simultaneously reduced the carrying value of the 1.125% Notes (effectively an original issuance discount).

33

Table of Contents

This discount is amortized to the 1.125% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 1.125% Notes at an effective rate of approximately 6%. As of December 31, 2015, the 1.125% Notes have a remaining amortization period of 4.0 years. The 1.125% Notes' if-converted value exceeded their principal amount by approximately $332 million and $93 million as of December 31, 2015 and December 31, 2014, respectively.
1.625% Convertible Senior Notes due 2044. In September 2014, we issued $125 million principal amount of 1.625% convertible senior notes (1.625% Notes) due August 15, 2044, unless earlier repurchased, redeemed or converted. Combined with the 1.625% Notes issued in connection with the 3.75% Exchange described below, the aggregate principal amount issued under the 1.625% Notes was $302 million.
Interest is payable semiannually in arrears on February 15 and August 15. In addition, beginning with the semiannual interest period commencing immediately following the interest payment date on August 15, 2018, contingent interest will accrue on the 1.625% Notes during any semiannual interest period in which certain conditions or events occur, or under certain events of default. For example, additional interest of 0.25% per year will be payable on the 1.625% Notes for any semiannual interest period for which the principal amount of 1.625% Notes outstanding is less than $100 million.
The 1.625% Notes are senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.625% Notes; equal in right of payment to any of our unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities of our subsidiaries.
The initial conversion rate for the 1.625% Notes is 17.2157 shares of our common stock per $1,000 principal amount of the 1.625% Notes. This represents an initial conversion price of approximately $58.09 per share of our common stock. Upon conversion, we will pay cash and, if applicable, deliver shares of our common stock to the converting holder in an amount per $1,000 principal amount of 1.625% Notes equal to the settlement amount (as defined in the related indenture).
Holders may convert their 1.625% Notes only under the following circumstances:
during any calendar quarter commencing after the calendar quarter ending on September 30, 2014 (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period after any five consecutive trading day period (the measurement period) in which the trading price per $1,000 principal amount of 1.625% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
upon the occurrence of specified corporate events;
if we call any 1.625% Notes for redemption, at any time until the close of business on the business day immediately preceding the redemption date;
during the period from, and including, May 15, 2018 to the close of business on the business day immediately preceding August 19, 2018; or
at any time on or after February 15, 2044 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 1.625% Notes, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.
As of December 31, 2015, the 1.625% Notes were not convertible.
We may not redeem the 1.625% Notes prior to August 19, 2018. On or after August 19, 2018, we may redeem for cash all or part of the 1.625% Notes, except for the 1.625% Notes we are required to repurchase in connection with a fundamental change or on any specified repurchase date. The redemption price for the 1.625% Notes will equal 100% of the principal amount of the 1.625% Notes being redeemed, plus accrued and unpaid interest. In addition, holders of the 1.625% Notes may require us to repurchase some or all of the 1.625% Notes for cash on August 19, 2018, August 19, 2024, August 19, 2029, August 19, 2034 and August 19, 2039, in each case, at a specified price equal to 100% of the principal amount of the 1.625% Notes to be repurchased, plus accrued and unpaid interest.
Because the 1.625% Notes are net share settled and have cash settlement features, we have allocated the principal amount between a liability component and an equity component. The reduced carrying value on the 1.625% Notes resulted in a debt discount that is amortized back to the 1.625% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. The expected life of the debt is approximately four years, beginning on the issuance date and

34

Table of Contents

ending on the first date we may redeem the notes in August 2018. As of December 31, 2015, the 1.625% Notes have a remaining amortization period of 2.6 years. This has resulted in our recognition of interest expense on the 1.625% Notes at an effective rate approximating what we would have incurred had nonconvertible debt with otherwise similar terms been issued, or approximately 5%. The outstanding 1.625% Notes’ if-converted value exceeded their principal amount by approximately $10 million as of December 31, 2015, and did not exceed their principal amount as of December 31, 2014. At December 31, 2015 and December 31, 2014, the equity component of the 1.625% Notes, including the impact of deferred taxes, was $23 million.
3.75% Exchange. In August 2014, we entered into separate, privately negotiated, exchange agreements (the 3.75% Exchange) with certain holders of our outstanding 3.75% convertible senior notes due 2014 (the 3.75% Notes). In this transaction, we exchanged $177 million aggregate principal amount of the 3.75% Notes for $177 million principal amount of 1.625% convertible senior notes due 2044, approximately 2 million shares of our common stock, and payment of accrued interest on the exchanged 3.75% Notes; additionally, we issued approximately 81,000 shares of common stock for services rendered in connection with the 3.75% Exchange. We did not receive any proceeds from the 3.75% Exchange.
3.75% Notes. As described above, we entered into the 3.75% Exchange transaction in August 2014, under which we exchanged $177 million of the outstanding principal amount of the 3.75% Notes for the 1.625% Notes. The remaining $10 million principal amount was repaid in full in October 2014.
Lease Financing Obligations. In 2013, we entered into a sale-leaseback transaction for the Molina Center located in Long Beach, California, and our Ohio health plan office building located in Columbus, Ohio. Due to our continuing involvement with these leased properties, the sale did not qualify for sales recognition and we remain the "accounting owner" of the properties. These assets continue to be included in our consolidated balance sheets, and also continue to be depreciated over their remaining useful lives. The lease financing obligation is amortized over the 25-year lease term such that there will be no gain or loss recorded if the lease is not extended at the end of its term. Rent will increase 3% per year through the initial term. Payments under the lease adjust the lease financing obligation, and the imputed interest is recorded to interest expense in our consolidated statements of income. Such interest amounted to $13 million for both years ended December 31, 2015 and 2014.
As described and defined in further detail in Note 17, "Related Party Transactions," we entered into a lease for office space in February 2013 consisting of two office buildings. We have concluded that we are the accounting owner of the buildings due to our continuing involvement with the properties. We have recorded $36 million to property, equipment and capitalized software, net, in the accompanying consolidated balance sheet as of December 31, 2015, which represents the total cost incurred by the Landlord for the construction of the buildings, net of accumulated depreciation. As of December 31, 2015 and December 31, 2014, the aggregate amount recorded to lease financing obligations, including the current portion, amounted to $40 million and $41 million, respectively. Payments under the lease adjust the lease financing obligation, and the imputed interest is recorded to interest expense in our consolidated statements of income. Such interest expense was $4 million and $3 million for the year ended December 31, 2015 and 2014, respectively. In addition to the capitalization of the costs incurred by the Landlord, we impute and record rent expense relating to the ground leases for the property sites. Such rent expense is computed based on the fair value of the land and our incremental borrowing rate, and was $1 million for both years ended December 31, 2015 and 2014. For information regarding the future minimum lease obligation, refer to Note 19, "Commitments and Contingencies."
13. Derivatives
The following table summarizes the fair values and the presentation of our derivative financial instruments (defined and discussed individually below) in the consolidated balance sheets:
 
 
 
December 31,
 
Balance Sheet Location
 
2015
 
2014
 
 
 
(In millions)
Derivative asset:
 
 
 
 
 
1.125% Call Option
Current assets: Derivative asset
 
$
374

 
$

 
Non-current assets: Derivative asset
 
$

 
$
329

 
 
 
 
 
 
Derivative liability:
 
 
 
 
 
1.125% Conversion Option
Current liabilities: Derivative liability
 
$
374

 
$

 
Non-current liabilities: Derivative liability
 
$

 
$
329

Our derivative financial instruments do not qualify for hedge treatment, therefore the change in fair value of these instruments is recognized immediately in our consolidated statements of income, and reported in other expense, net. Gains and losses for our derivative financial instruments are presented individually in the consolidated statements of cash flows, supplemental cash flow information.

35

Table of Contents

1.125% Notes Call Spread Overlay. Concurrent with the issuance of the 1.125% Notes in 2013, we entered into privately negotiated hedge transactions (collectively, the 1.125% Call Option) and warrant transactions (collectively, the 1.125% Warrants), with certain of the initial purchasers of the 1.125% Notes (the Counterparties). We refer to these transactions collectively as the Call Spread Overlay. Under the Call Spread Overlay, the cost of the 1.125% Call Option we purchased to cover the cash outlay upon conversion of the 1.125% Notes was reduced by proceeds from the sale of the 1.125% Warrants. Assuming full performance by the Counterparties (and 1.125% Warrants strike prices in excess of the conversion price of the 1.125% Notes), these transactions are intended to offset cash payments in excess of the principal amount of the notes due upon any conversion of the 1.125% Notes.
1.125% Call Option. The 1.125% Call Option, which is indexed to our common stock, is a derivative asset that requires mark-to-market accounting treatment due to cash settlement features until the 1.125% Call Option settles or expires. For further discussion of the inputs used to determine the fair value of the 1.125% Call Option, refer to Note 5, "Fair Value Measurements."
1.125% Conversion Option. The embedded cash conversion option within the 1.125% Notes is accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the cash conversion option settles or expires. For further discussion of the inputs used to determine the fair value of the 1.125% Conversion Option, refer to Note 5, "Fair Value Measurements."
As of December 31, 2015, the 1.125% Call Option and the 1.125% Conversion Option were classified as a current asset and current liability, respectively, because the 1.125% Notes may be converted within 12 months of December 31, 2015, as described in Note 12, "Debt."
14Income Taxes
The provision for income taxes for continuing operations consisted of the following:
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Current:
 
 
 
 
 
Federal
$
172

 
$
72

 
$
67

State
8

 
3

 

Foreign
6

 

 

Total current
186

 
75

 
67

Deferred:
 
 
 
 
 
Federal
(10
)
 

 
(25
)
State
4

 
(2
)
 
(6
)
Foreign
(1
)
 

 

Total deferred
(7
)
 
(2
)
 
(31
)
 
$
179

 
$
73

 
$
36

A reconciliation of the U.S. federal statutory income tax rate to the combined effective income tax rate for continuing operations is as follows:
 
Year Ended December 31,
 
2015
 
2014
 
2013
Statutory federal tax rate
35.0
 %
 
35.0
 %
 
35.0
 %
State income taxes, net of federal benefit
2.4

 
0.4

 
(0.5
)
Change in unrecognized tax benefits
0.9

 
(0.1
)
 
(3.7
)
Nondeductible health insurer fee (HIF)
17.0

 
22.9

 

Nondeductible compensation
0.6

 
(4.1
)
 
9.6

Nondeductible fair value of 1.125% Warrants

 

 
2.4

Other
(0.4
)
 
(0.3
)
 
2.0

Effective tax rate
55.5
 %
 
53.8
 %
 
44.8
 %
Our effective tax rate is based on expected income, statutory tax rates, and tax planning opportunities available to us in the various jurisdictions in which we operate. Significant management estimates and judgments are required in determining our

36

Table of Contents

effective tax rate. We are routinely under audit by federal, state, or local authorities regarding the timing and amount of deductions, nexus of income among various tax jurisdictions, and compliance with federal, state, foreign, and local tax laws.
During 2014, the Internal Revenue Service (IRS) issued final regulations related to compensation deduction limitations applicable to certain health insurance issuers. Pursuant to these final regulations, we reversed amounts treated as nondeductible in 2013 and recognized a tax benefit during 2014.
During 2015, 2014, and 2013, excess tax benefits from share-based compensation amounted to $8 million, $3 million, and $2 million, respectively. These amounts were recorded as a decrease to income taxes payable and an increase to additional paid-in capital.
Deferred tax assets and liabilities are classified as non-current. Significant components of our deferred tax assets and liabilities as of December 31, 2015 and 2014 were as follows:
 
December 31,
 
2015
 
2014
 
(In millions)
Accrued expenses
$
37

 
$
13

Reserve liabilities
14

 
4

Other accrued medical costs
5

 
4

Net operating losses
7

 
3

Unrealized losses
2

 
1

Unearned premiums
21

 
22

Lease financing obligation
35

 
34

Deferred compensation
8

 
10

Tax credit carryover
8

 
8

Valuation allowance
(9
)
 
(6
)
Total deferred income tax assets, net of valuation allowance
128

 
93

Prepaid expenses
(9
)
 
(6
)
Depreciation and amortization
(83
)
 
(57
)
Basis in debt
(18
)
 
(15
)
Total deferred income tax liabilities
(110
)
 
(78
)
Net deferred income tax asset - long term
$
18

 
$
15

At December 31, 2015, we had state net operating loss carryforwards of $180 million, which begin expiring in 2016.
At December 31, 2015, we had California enterprise zone tax credit carryovers of $11 million, which will begin to expire in 2024, and foreign tax credit carryovers of $1 million, which expire in 2025.
We evaluate the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. We have determined that as of December 31, 2015, $9 million of deferred tax assets did not satisfy the recognition criteria due to uncertainty regarding the realization of some of our state tax operating loss and foreign tax credit carryforwards. Therefore, we increased our valuation allowance by $3 million, from $6 million at December 31, 2014, to $9 million as of December 31, 2015.
We recognize tax benefits only if the tax position is more likely than not to be sustained. We are subject to income taxes in the United States, Puerto Rico, and numerous state jurisdictions. Significant judgment is required in evaluating our tax positions and determining our provision for income taxes. During the ordinary course of business, there are many transactions and calculations for which the ultimate tax determination is uncertain. We establish reserves for tax-related uncertainties based on estimates of whether, and the extent to which, additional taxes will be due. These reserves are established when we believe that certain positions might be challenged despite our belief that our tax return positions are fully supportable. We adjust these reserves in light of changing facts and circumstances, such as the outcome of tax audits. The provision for income taxes includes the impact of reserve provisions and changes to reserves that are considered appropriate.

37

Table of Contents

The roll forward of our unrecognized tax benefits is as follows:
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Gross unrecognized tax benefits at beginning of period
$
(3
)
 
$
(8
)
 
$
(11
)
Increases in tax positions for current year
(1
)
 

 

Increases in tax positions for prior years
(5
)
 
(1
)
 
(2
)
Decreases in tax positions for prior years

 

 
5

Settlements

 
6

 

Gross unrecognized tax benefits at end of period
$
(9
)
 
$
(3
)
 
$
(8
)
The total amount of unrecognized tax benefits at December 31, 2015, 2014 and 2013 that, if recognized, would affect the effective tax rates is $7 million, $2 million and $6 million, respectively. We expect that during the next 12 months it is reasonably possible that unrecognized tax benefit liabilities may decrease by as much as $1 million due to the normal expiration of statutes of limitation.
Our continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits in income tax expense. Amounts accrued for the payment of interest and penalties as of December 31, 2015, and 2014 were insignificant.
We are under examination by the IRS for calendar year 2011 and may be subject to examination for calendar years 2012 through 2014. We are under examination, or may be subject to examination, in Puerto Rico and certain state and local jurisdictions, with the major state jurisdictions being California, Utah, and Michigan, for the years 2010 through 2014.
15. Stockholders' Equity
Stockholders' equity increased $547 million during the year ended December 31, 2015. The increase was primarily due to the common stock offering described below, net income of $143 million, and $34 million related to share-based compensation transactions.
Common Stock Offering. In June 2015, we completed an underwritten public offering of 5,750,000 shares of our common stock, including the over-allotment option. Net of issuance costs, proceeds from the offering amounted to $373 million, or $64.90 per share, resulting in an increase to additional paid-in capital. We are using the proceeds to finance working capital needs, acquisitions, capital expenditures, and other general corporate activities.
1.125% Warrants. In connection with the 1.125% Notes Call Spread Overlay transaction described in Note 13, "Derivatives," in 2013, we issued 13,490,236 warrants with a strike price of $53.8475 per share. The number of warrants and the strike price are subject to adjustment under certain circumstances. If the market value per share of our common stock exceeds the strike price of the 1.125% Warrants on any trading day during the 160 trading day measurement period (beginning on April 15, 2020) under the 1.125% Warrants, we will be obligated to issue to the Counterparties a number of shares equal in value to the product of the amount by which such market value exceeds such strike price and 1/160th of the aggregate number of shares of our common stock underlying the 1.125% Warrants, subject to a share delivery cap. The 1.125% Warrants could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the applicable strike price of the 1.125% Warrants. Refer to Note 3, "Net Income per Share," for dilution information for the periods presented. We will not receive any additional proceeds if the 1.125% Warrants are exercised.
Securities Repurchase Programs. Effective as of December 16, 2015, our board of directors authorized the repurchase of up to $50 million in aggregate of our common stock or senior notes. This newly authorized repurchase program extends through December 31, 2016.
In February 2015, our board of directors authorized the repurchase of up to $50 million in aggregate of our common stock. We did not repurchase any shares under this program, which expired December 31, 2015.
Stock Incentive Plans. At December 31, 2015, we had employee equity incentives outstanding under two plans: (1) the 2011 Equity Incentive Plan (2011 Plan); and (2) the 2002 Equity Incentive Plan (from which equity incentives are no longer awarded).
The 2011 Plan provides for the award of restricted shares and units, performance shares and units, stock options and stock bonuses to the company’s officers, employees, directors, consultants, advisers, and other service providers. The 2011 Plan provides for the issuance of up to 4.5 million shares of common stock.
Restricted share awards are granted with a fair value equal to the market price of our common stock on the date of grant, and generally vest in equal annual installments over periods up to four years from the date of grant. Stock option awards have an

38

Table of Contents

exercise price equal to the fair market value of our common stock on the date of grant, generally vest in equal annual installments over periods up to four years from the date of grant, and have a maximum term of ten years from the date of grant.
In connection with our stock plans, we issued approximately 830,000 shares of common stock, net of shares used to settle employees’ income tax obligations, in the year ended December 31, 2015.
The following table illustrates the components of our share-based compensation expense that are reported in general and administrative expenses in the consolidated statements of income: 
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
 
Pretax
Charges
 
Net-of-Tax
Amount
 
Pretax
Charges
 
Net-of-Tax
Amount
 
Pretax
Charges
 
Net-of-Tax
Amount
Restricted stock and performance awards
$
19

 
$
13

 
$
19

 
$
12

 
$
26

 
$
23

Employee stock purchase plan and stock options
4

 
3

 
3

 
2

 
3

 
2

 
$
23

 
$
16

 
$
22

 
$
14

 
$
29

 
$
25

As of December 31, 2015, there was $25 million of total unrecognized compensation expense related to unvested restricted share awards, including those with performance conditions, which we expect to recognize over a remaining weighted-average period of 1.6 years. This unrecognized compensation cost assumes an estimated forfeiture rate of 6.5% for non-executive employees as of December 31, 2015. As of December 31, 2015, the unrecognized compensation expense related to unvested stock options was insignificant.
Restricted stock. Restricted and performance stock activity for the year ended December 31, 2015 is summarized below:
 
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested balance as of December 31, 2014
1,282,072

 
$
33.55

Granted - restricted shares
273,710

 
64.56

Granted - performance shares
162,827

 
63.90

Vested - restricted shares
(371,489
)
 
34.58

Vested - performance shares
(264,604
)
 
30.80

Forfeited
(47,759
)
 
37.51

Unvested balance as of December 31, 2015
1,034,757

 
46.68

The total fair value of restricted and performance share awards granted during the years ended December 31, 2015, 2014, and 2013 was $28 million, $25 million, and $33 million, respectively. The total fair value of restricted share awards, including those with performance or market conditions which vested during the years ended December 31, 2015, 2014, and 2013 was $39 million, $24 million, and $22 million, respectively.
In 2015, our named executive officers were granted approximately 163,000 restricted shares with performance and market conditions. The grant date fair value for the awards with market conditions were determined based on a Monte Carlo Simulation which projected Total Stockholder Return (TSR) over the performance period using correlations and volatilities of our ISS peer groups. The weighted-average grant date fair value per share of the 2015 performance awards based on three-year TSR was $49.43, determined using additional inputs as follows: risk-free interest rate of 0.8%, dividend yield of 0%, and expected life of 2.8 years.
As of December 31, 2015, there were approximately 377,000 unvested restricted shares outstanding which contained one or more performance measures. In the event the vesting conditions are not achieved, the awards will lapse. Based on our assessment as of December 31, 2015, we expect the performance conditions relating to approximately 199,000 of these outstanding restricted share awards to be met in full.
In 2015, we reversed approximately $3 million in share-based compensation expense recognized from grant date through March 31, 2015, related to 178,000 of the awards granted in 2014, due to management's determination in the second quarter of 2015 that the achievement of the underlying performance conditions was not probable.

39

Table of Contents

In December 2015, approximately 229,000 restricted stock awards with performance conditions, granted in 2013, vested due to achievement of the total revenue metric as defined in the terms of the grant.
Employee Stock Purchase Plan. Under our employee stock purchase plan (ESPP), eligible employees may purchase common shares at 85% of the lower of the fair market value of our common stock on either the first or last trading day of each six-month offering period. Each participant is limited to a maximum purchase of $25,000 (as measured by the fair value of the stock acquired) per year through payroll deductions. We estimate the fair value of the stock issued using the Black-Scholes option pricing model. For the years ended December 31, 2015, 2014, and 2013, the inputs to this model were as follows: risk-free interest rates of approximately 0.1%; expected volatilities ranging from approximately 30% to 50%, dividend yields of 0%, and an average expected life of 0.5 years. We issued approximately 301,900, 327,200 and 299,600 shares of our common stock under the ESPP during the years ended December 31, 2015, 2014, and 2013, respectively. The 2011 ESPP provides for the issuance of up to three million shares of common stock.
Stock Options. No stock options were granted in 2015 and 2014, and stock options outstanding as of December 31, 2015 were insignificant. The grant date fair value per share of the stock options awarded to the new members of our board of directors during 2013 was $14.67. We estimated the fair value of each stock option award using the Black-Scholes option pricing model, with the following inputs: risk-free interest rate of 1.4%, expected volatility of 41.3%, dividend yield of 0%, and expected life of 7 years. The total intrinsic value of options exercised during the years ended December 31, 2015, 2014, and 2013 was $6 million, $2 million, and $1 million, respectively.
16Employee Benefits
We sponsor defined contribution 401(k) plans that cover substantially all full-time salaried and hourly employees of our company and its subsidiaries. Eligible employees are permitted to contribute up to the maximum amount allowed by law. We match up to the first 4% of compensation contributed by employees. Expense recognized in connection with our contributions to the 401(k) plans totaled $27 million, $21 million and $13 million in the years ended December 31, 2015, 2014, and 2013, respectively.
We also have a nonqualified deferred compensation plan for certain key employees. Under this plan, eligible participants may defer up to 100% of their base salary and 100% of their bonus to provide tax-deferred growth for retirement. The funds deferred are invested in corporate-owned life insurance, under a rabbi trust.
17. Related Party Transactions
Prior to December 22, 2015, we were the lessee under a lease with 6th & Pine Development, LLC (the Landlord) for two office buildings. The principal members of the Landlord were John C. Molina, our chief financial officer and a director of Molina Healthcare, Inc., and his wife. In addition, in connection with the development of the buildings being leased, John C. Molina pledged certain of his common stock holdings in Molina Healthcare, Inc. Dr. J. Mario Molina, our chief executive officer, president and chairman of the board of directors, holds a partial interest in such shares as trust beneficiary. On December 22, 2015, the Landlord assigned the lease to an unrelated third party. There were no significant changes to the lease other than the assignment to the new owner. As a result of the assignment, as of December 31, 2015, amounts previously reported as lease financing obligations - related party were reported in lease financing obligations on the accompanying consolidated balance sheets. For information regarding the lease financing obligation associated with this lease, refer to Note 12, "Debt."
Our California health plan has entered into a provider agreement with Pacific Healthcare IPA (Pacific), which is 50% owned by the brother-in-law of Dr. J. Mario Molina and John C. Molina. Under the terms of this provider agreement, the California health plan paid Pacific approximately $1 million in each of 2015 and 2014 for medical care provided to health plan members. Payments in 2013 were insignificant.
Refer to Note 18, "Variable Interest Entities (VIEs)," for a discussion of the Joseph M. Molina, M.D. Professional Corporations.

40

Table of Contents

18Variable Interest Entities (VIEs)
Joseph M. Molina M.D., Professional Corporations
The Joseph M. Molina, M.D. Professional Corporations (JMMPC) were created in 2012 to further advance our direct delivery business. JMMPC's primary shareholder is Dr. J. Mario Molina, our chief executive officer, president, and chairman of the board of directors. Dr. Molina is paid no salary and receives no dividends in connection with his work for, or ownership of, JMMPC. JMMPC provides primary care medical services through its employed physicians and other medical professionals. Beginning in 2014, JMMPC also provided certain specialty referral services to our California health plan members through a contracted provider network. Substantially all of the individuals served by JMMPC are members of our health plans. JMMPC does not have agreements to provide professional medical services with any other entities.
Our wholly owned subsidiary, Molina Medical Management, Inc. (MMM), has entered into services agreements with JMMPC to provide clinic facilities, clinic administrative support staff, patient scheduling services and medical supplies to JMMPC. The services agreements were designed such that JMMPC will operate at break even, ensuring the availability of quality care and access for our health plan members. The services agreements provide that the administrative fees charged to JMMPC by MMM are reviewed annually to assure the achievement of this goal.
Separately, our California, Florida, New Mexico, Utah and Washington health plans have entered into primary care services agreements with JMMPC. These agreements direct our health plans to perform a monthly reconciliation, to either fund JMMPC's operating deficits, or receive JMMPC's operating surpluses, such that JMMPC will derive no profit or loss. Because the MMM services agreements described above mitigate the likelihood of significant operating deficits or surpluses, such monthly reconciliation amounts are generally insignificant.
We have determined that JMMPC is a VIE, and that we are its primary beneficiary. We have reached this conclusion under the power and benefits criterion model according to GAAP. Specifically, we have the power to direct the activities that most significantly affect JMMPC's economic performance, and the obligation to absorb losses or right to receive benefits that are potentially significant to the VIE, under the agreements described above. Because we are its primary beneficiary, we have consolidated JMMPC. JMMPC's assets may be used to settle only JMMPC's obligations, and JMMPC's creditors have no recourse to the general credit of Molina Healthcare, Inc. As of December 31, 2015, JMMPC had total assets of $17 million, and total liabilities of $17 million. As of December 31, 2014, JMMPC had total assets of $31 million, and total liabilities of $31 million.
Our maximum exposure to loss as a result of our involvement with JMMPC is generally limited to the amounts needed to fund JMMPC's ongoing payroll, employee benefits and medical care costs associated with JMMPC's specialty referral activities. We believe that such loss exposures will be immaterial to our consolidated operating results and cash flows for the foreseeable future.
New Markets Tax Credit
In 2011, our New Mexico data center subsidiary entered into a financing transaction with Wells Fargo Community Investment Holdings, LLC (Wells Fargo), its wholly owned subsidiary New Mexico Healthcare Data Center Investment Fund, LLC (Investment Fund), and certain of Wells Fargo's affiliated Community Development Entities (CDEs), in connection with our participation in the federal government's New Markets Tax Credit Program (NMTC). The NMTC was established by Congress to facilitate new or increased investments in businesses and real estate projects in low-income communities. The NMTC attracts investment capital to low-income communities by permitting investors to receive a tax credit against their federal income tax return in exchange for equity investments in specialized financial institutions, called CDEs, which provide financing to qualified active businesses operating in low-income communities. The credit amounts to 39% of the original investment amount and is claimed over a period of seven years (five percent for each of the first three years, and six percent for each of the remaining four years). The investment in the CDE cannot be redeemed before the end of the seven-year period.
In 2011, as a result of a series of simultaneous financing transactions, Wells Fargo contributed capital of $6 million to the Investment Fund, and Molina Healthcare, Inc. loaned the principal amount of $16 million to the Investment Fund. The Investment Fund then contributed the proceeds to certain CDEs, which, in turn, loaned the proceeds of $21 million to our New Mexico data center subsidiary. Wells Fargo will be entitled to claim the NMTC while we effectively received net loan proceeds equal to Wells Fargo's contribution to the Investment Fund, or approximately $6 million. Additionally, financing costs incurred in structuring the arrangement amounting to $1 million were deferred and will be recognized as expense over the term of the loans. This transaction also includes a put/call feature that becomes enforceable at the end of the seven-year compliance period. Wells Fargo may exercise its put option or we can exercise the call, both of which will serve to transfer the debt obligation to us. Incremental costs to maintain the structure during the compliance period will be recognized as incurred.
We have determined that the financing arrangement with Investment Fund and CDEs is a VIE, and that we are the primary beneficiary of the VIE. We reached this conclusion based on the following:

41

Table of Contents

The ongoing activities of the VIE—collecting and remitting interest and fees and NMTC compliance—were all considered in the initial design and are not expected to significantly affect economic performance throughout the life of the VIE;
Contractual arrangements obligate us to comply with NMTC rules and regulations and provide various other guarantees to Investment Fund and CDEs;
Wells Fargo lacks a material interest in the underling economics of the project; and
We are obligated to absorb losses of the VIE.
Because we are the primary beneficiary of the VIE, we have included it in our consolidated financial statements. Wells Fargo's contribution of $6 million is included in cash at December 31, 2015 and December 31, 2014 and the offsetting Wells Fargo's interest in the financing arrangement is included in other liabilities in the accompanying consolidated balance sheets.
As described above, this transaction also includes a put/call provision whereby we may be obligated or entitled to repurchase Wells Fargo's interest in the Investment Fund. The value attributed to the put/call is nominal. The NMTC is subject to 100% recapture for a period of seven years as provided in the Internal Revenue Code and applicable U.S. Treasury regulations. We are required to be in compliance with various regulations and contractual provisions that apply to the NMTC arrangement. Non-compliance with applicable requirements could result in Wells Fargo's projected tax benefits not being realized and, therefore, require us to indemnify Wells Fargo for any loss or recapture of NMTCs related to the financing until such time as the recapture provisions have expired under the applicable statute of limitations. We do not anticipate any credit recaptures will be required in connection with this arrangement.
19Commitments and Contingencies
Certain Leasing Transactions. As described in Note 12, "Debt," we entered into certain leasing transactions that have been classified as lease financing obligations. Such leases have initial terms that range from 16.5 years to 25 years. Additionally, the leases provide for renewal options ranging from 10 years to 25 years in aggregate.
Operating Leases. We lease administrative and clinic facilities and certain equipment under non-cancelable operating leases expiring at various dates through 2025. Facility lease terms generally range from five to 10 years with one to two renewal options for extended terms. In most cases, we are required to make additional payments under facility operating leases for taxes, insurance and other operating expenses incurred during the lease period. Certain of our leases contain rent escalation clauses or lease incentives, including rent abatements and tenant improvement allowances. Rent escalation clauses and lease incentives are taken into account in determining total rent expense to be recognized during the lease term.
Future minimum lease payments by year and in the aggregate under all operating leases and lease financing obligations consist of the following approximate amounts:
 
Lease Financing Obligations
 
Operating Leases
 
Total
 
(In millions)
2016
$
15

 
$
49

 
$
64

2017
16

 
47

 
63

2018
16

 
41

 
57

2019
16

 
32

 
48

2020
17

 
24

 
41

Thereafter
323

 
39

 
362

 
$
403

 
$
232

 
$
635

Rental expense related to operating leases amounted to $44 million, $32 million, and $25 million for the years ended December 31, 2015, 2014, and 2013, respectively. The amounts reported in "Lease Financing Obligations" above represent our contractual lease commitments for the properties described in Note 12, "Debt" under the subheading "Lease Financing Obligations." Payments under these leases adjust the lease financing obligation, and the imputed interest is recorded to interest expense in our consolidated statements of income.

42

Table of Contents

Employment Agreements. In 2002 we entered into employment agreements with our Chief Executive Officer and Chief Financial Officer, which were amended and restated in 2009. These employment agreements had initial terms of one to three years and are subject to automatic one-year extensions thereafter. Should the executives be terminated without cause or resign for good reason before a change of control, as defined, we will pay one year’s base salary and termination bonus, as defined, in addition to full vesting of equity compensation, and a cash payment for health and welfare benefits.
In 2013 we entered into employment agreements with our Chief Operating Officer, Chief Accounting Officer, and Chief Legal Officer. These agreements continue until terminated by us, or the executive resigns. If the executive’s employment is terminated by us without cause or the executive resigns for good reason, the executive will be entitled to receive one year’s base salary and termination bonus, as defined, full vesting of time-based equity compensation, and a cash payment for health and welfare benefits.
Payment of the severance benefits described above is contingent upon the executive’s signing a release agreement waiving claims against us. If the executives are terminated for cause, no further payments are due under the contracts.
Legal Proceedings. The health care and business process outsourcing industries are subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.
We are involved in legal actions in the ordinary course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. We have accrued liabilities for certain matters for which we deem the loss to be both probable and estimable. Although we believe that our estimates of such losses are reasonable, these estimates could change as a result of further developments of these matters. The outcome of legal actions is inherently uncertain and such pending matters for which accruals have not been established have not progressed sufficiently through discovery and/or development of important factual information and legal issues to enable us to estimate a range of possible loss, if any. While it is not possible to accurately predict or determine the eventual outcomes of these items, an adverse determination in one or more of these pending matters could have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
State of Louisiana. On June 26, 2014, the state of Louisiana filed a Petition for Damages against Molina Medicaid Solutions, Molina Healthcare, Inc., Unisys Corporation, and Paramax Systems Corporation, a subsidiary of Unisys, in the Parish of Baton Rouge, 19th Judicial District, versus number 631612. The Petition alleges that between 1989 and 2012, the defendants utilized an incorrect reimbursement formula for the payment of pharmaceutical claims. We believe we have several meritorious defenses to the claims of the state, and any liability for the alleged claims is not currently probable or reasonably estimable.
United States of America, ex rel., Anita Silingo v. Mobile Medical Examination Services, Inc., et al. On or around October 14, 2014, Molina Healthcare of California, Molina Healthcare of California Partner Plan, Inc., Mobile Medical Examination Services, Inc. (MedXM), and other health plan defendants were served with a Complaint previously filed under seal in the Central District Court of California by Relator, Anita Silingo, Case No. SACV13-1348-FMO(SHx). The Complaint alleges that MedXM improperly modified medical records and otherwise took inappropriate steps to increase members’ risk adjustment scores, and that the defendants, including Molina Healthcare of California and Molina Healthcare of California Partner Plan, Inc., purportedly turned a “blind eye” to these unlawful practices. The Department of Justice has declined to intervene. The District Court dismissed this action as to Molina without leave to amend as to some allegations and with leave to amend as to other allegations. On October 22, 2015, the Relator filed a third amended complaint. We believe that we have several meritorious defenses to the claims of the Relator, and any liability for the alleged claims is not currently probable or reasonably estimable.
Hospital Management Contract. During the fourth quarter of 2015, we recorded a contract settlement charge of approximately $15 million as a result of our termination of a hospital management agreement.
Professional Liability Insurance. We carry medical professional liability insurance for health care services rendered in the primary care institutions that we manage. In addition, we also carry errors and omissions insurance for all Molina entities.
Provider Claims. Many of our medical contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations have led certain medical providers to pursue us for additional compensation. The claims made by providers in such circumstances often involve issues of contract compliance, interpretation, payment methodology, and intent. These claims often extend to services provided by the providers over a number of years.
Various providers have contacted us seeking additional compensation for claims that we believe to have been settled. These matters, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows.

43

Table of Contents

States' Budgets. From time to time the states in which our health plans operate may delay premium payments. For example, the state of Illinois is currently operating without a budget for its fiscal year ending June 30, 2016. As of December 31, 2015, our Illinois health plan served approximately 98,000 members, and recognized premium revenue of approximately $397 million for the year ended December 31, 2015. As of February 23, 2016, Illinois is current with its premium payments.
In another example, the Commonwealth of Puerto Rico has reported that it may lack sufficient resources to fund all necessary governmental programs including health care-related programs, as well as meet its debt obligations for its fiscal year ending June 30, 2016. Our Puerto Rico health plan became operational on April 1, 2015. As of December 31, 2015, the plan served approximately 348,000 members and recognized premium revenue of approximately $192 million in the fourth quarter of 2015, or approximately $64 million per month. As of February 23, 2016, the Commonwealth continues to pay us weekly for current membership.
It is the practice of the Commonwealth to pay us for eligible members only after those members have been assigned to us, and our plan has sent electronic confirmation of the receipt of eligibility. Particularly in the early stages of our contract with Puerto Rico, the plan's confirmation of eligibility of certain members was not accepted by the Commonwealth as a result of various technical issues. The plan has continued to pay for medical services for all members in question, but the Commonwealth is withholding payment of approximately $12 million of premium revenue related to those members. We believe we have a valid claim to all of the premiums withheld and we are in discussions with the Commonwealth regarding this matter.
It has been our practice in the past, and will remain so in the future, to continue to serve our members and pay health care providers for services rendered in circumstances where state (or Commonwealth) governments are temporarily unable to pay us, so long as we continue to believe that such state (or Commonwealth) governments will ultimately pay us.
Regulatory Capital and Dividend Restrictions. Our health plans, which are operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. Regulators in some states may also attempt to enforce capital requirements upon us that require the retention of net worth in excess of amounts formally required by statute or regulation. Such statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us. Based upon current statutes and regulations, the net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was approximately $1,229 million at December 31, 2015, and $859 million at December 31, 2014. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company – Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $612 million and $203 million as of December 31, 2015, and 2014, respectively.
The National Association of Insurance Commissioners (NAIC), adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules which may vary from state to state. All of the states in which our health plans operate, except California and Florida, have adopted these rules. California and Florida have not adopted NAIC risk-based capital requirements for HMOs, and have not formally given notice of their intention to do so. Such requirements, if adopted by California and Florida, may increase the minimum capital required for those states.
As of December 31, 2015, our health plans had aggregate statutory capital and surplus of approximately $1,350 million compared with the required minimum aggregate statutory capital and surplus of approximately $776 million. All of our health plans were in compliance with the minimum capital requirements at December 31, 2015. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.
20. Segment Information
We have three reportable segments. These segments include our Health Plans and Molina Medicaid Solutions segments, which comprise the vast majority of our operations, and our Other segment. As of December 31, 2015, we changed our reporting structure as a result of the Pathways acquisition in November 2015, which is reported in Other.
Our reportable segments are consistent with how we currently manage the business and view the markets we serve. The Health Plans segment consists of our health plans and our direct delivery business. Our health plans represent operating segments that have been aggregated for reporting purposes because they share similar economic characteristics. The Molina Medicaid Solutions segment provides MMIS design, development, implementation; business process outsourcing solutions; hosting services; and information technology support services to state Medicaid agencies. Our Other segment includes other businesses, such as our Pathways behavioral health and social services provider, that do not meet the quantitative thresholds for a

44

Table of Contents

reportable segment as defined by U.S. generally accepted accounting principles (GAAP), as well as corporate amounts not allocated to other reportable segments.
The following table presents gross margin as the appropriate earnings measure for our reportable segments, based on how our chief operating decision maker currently reviews results, assesses performance, and allocates resources.
Gross margin for our Health Plans segment is referred to as "Medical margin," and for our Molina Medicaid Solutions and Other segments, as "Service margin." Medical margin represents the actual dollars earned by the Health Plans segment after medical costs are deducted from premium revenue. The medical care ratio represents the amount of medical care costs as a percentage of premium revenue. One of the key metrics used to assess the performance of the Health Plans segment is the medical care ratio; therefore, the underlying medical margin is the most important measure of earnings reviewed by the chief operating decision maker. The service margin is equal to service revenue minus cost of service revenue. We previously reported our segment results to the operating income level, where we reported the cost of all centralized services within our most significant segment, the Health Plans segment.
The accounting policies of the segments are the same as those described in Note 2, "Significant Accounting Policies."
 
 
Health Plans
 
Molina Medicaid Solutions
 
Other
 
Consolidated
 
 
 
 
 
 
 
(In millions)
2015
 
 
 
 
 
 
 
 
Total revenue (1)
 
$
13,917

 
$
195

 
$
66

 
$
14,178

Gross margin
 
1,447

 
55

 
5

 
1,507

Depreciation and amortization (2)
 
95

 
25

 
6

 
126

Goodwill, and intangible assets, net
 
393

 
73

 
175

 
641

Total assets
 
4,707

 
213

 
1,656

 
6,576

 
 
 
 
 
 
 
 
 
2014
 
 
 
 
 
 
 
 
Total revenue (1)
 
9,449

 
210

 
8

 
9,667

Gross margin
 
947

 
53

 

 
1,000

Depreciation and amortization (2)
 
83

 
46

 
5

 
134

Goodwill, and intangible assets, net
 
286

 
75

 

 
361

Total assets
 
3,355

 
185

 
895

 
4,435

 
 
 
 
 
 
 
 
 
2013
 
 
 
 
 
 
 
 
Total revenue (1)
 
6,376

 
205

 
8

 
6,589

Gross margin
 
799

 
44

 

 
843

Depreciation and amortization (2)
 
60

 
28

 
6

 
94

Goodwill, and intangible assets, net
 
249

 
81

 

 
330

Total assets
 
1,921

 
176

 
891

 
2,988

______________________
(1)
Total revenues consists primarily of premium revenue for the Health Plans segment, and service revenue for the Molina Medicaid Solutions and Other segments.
(2)
Depreciation and amortization reported in accompanying consolidated statements of cash flows.


45

Table of Contents

The following table reconciles gross margin by segment to consolidated income from continuing operations before income tax expense:
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Gross margin:
 
 
 
 
 
Health Plans
$
1,447

 
$
947

 
$
799

Molina Medicaid Solutions
55

 
53

 
44

Other
5

 

 

Other operating revenues (1)
684

 
434

 
205

Other operating expenses (2)
1,804

 
1,241

 
911

Operating income
387

 
193

 
137

Other expenses, net
65

 
58

 
56

Income from continuing operations before income tax expense
$
322

 
$
135

 
$
81

______________________
(1)
Other operating revenues include premium tax revenue, health insurer fee revenue, investment income and other revenue.
(2)
Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fee expenses and depreciation and amortization.

21Quarterly Results of Operations (Unaudited)
The following table summarizes quarterly unaudited results of operations for the years ended December 31, 2015 and 2014.
 
For The Quarter Ended
 
March 31,
2015
 
June 30,
2015
 
September 30, 2015
 
December 31,
2015
 
(In millions, except per-share data)
Premium revenue
$
2,971

 
$
3,304

 
$
3,377

 
$
3,589

Service revenue
52

 
47

 
47

 
107

Operating income
82

 
116

 
113

 
76

Income from continuing operations
28

 
39

 
46

 
30

Net income
28

 
39

 
46

 
30

Net income per share (1):
 
 
 
 
 
 
 
Basic
$
0.58

 
$
0.78

 
$
0.84

 
$
0.54

Diluted
$
0.56

 
$
0.72

 
$
0.77

 
$
0.52

 
For The Quarter Ended
 
March 31,
2014
 
June 30,
2014
 
September 30, 2014
 
December 31,
2014
 
(In millions, except per-share data)
Premium revenue
$
1,940

 
$
2,167

 
$
2,317

 
$
2,599

Service revenue
54

 
50

 
52

 
54

Operating income
24

 
32

 
40

 
97

Income from continuing operations
4

 
8

 
16

 
34

Net income
4

 
8

 
16

 
34

Net income per share (1):
 
 
 
 
 
 
 
Basic
$
0.10

 
$
0.17

 
$
0.34

 
$
0.70

Diluted
$
0.09

 
$
0.16

 
$
0.33

 
$
0.69

_______________________________

46

Table of Contents

(1)
The dilutive effect of all potentially dilutive common shares is calculated using the treasury-stock method. Certain potentially dilutive common shares issuable are not included in the computation of diluted net income per share because to do so would be anti-dilutive. For the year ended December 31, 2014, the 1.125% Warrants were excluded from diluted shares outstanding because the exercise price exceeded the average market price of our common stock.


47

Table of Contents

22Condensed Financial Information of Registrant
The condensed balance sheets as of December 31, 2015 and 2014, and the related condensed statements of income, comprehensive income and cash flows for each of the three years in the period ended December 31, 2015 for our parent company Molina Healthcare, Inc. (the Registrant), are presented below.
Condensed Balance Sheets
 
December 31,
 
2015
 
2014
 
(Amounts in millions, except per-share data)
ASSETS
Current assets:
 

 
 
Cash and cash equivalents
$
360

 
$
75

Investments
252

 
126

Income taxes refundable
7

 
13

Due from affiliates
86

 
18

Prepaid expenses and other current assets
46

 
33

Derivative asset
374

 

Total current assets
1,125

 
265

Property, equipment, and capitalized software, net
267

 
265

Goodwill and intangible assets, net
61

 
65

Investments in subsidiaries
2,205

 
1,377

Deferred income taxes
23

 
11

Derivative asset

 
329

Advances to related parties and other assets
36

 
43

 
$
3,717

 
$
2,355

 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 
 
Accounts payable and accrued liabilities
$
157

 
$
107

Current portion of long-term debt
449

 

Derivative liability
374

 

Total current liabilities
980

 
107

Senior notes
962

 
690

Lease financing obligations
198

 
157

Lease financing obligations - related party

 
40

Derivative liability

 
329

Other long-term liabilities
20

 
22

Total liabilities
2,160

 
1,345

Stockholders' equity:
 
 
 
Common stock, $0.001 par value; 150 shares authorized; outstanding:
 
 


56 shares at December 31, 2015 and 50 shares at December 31, 2014

 

Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding

 

Additional paid-in capital
803

 
396

Accumulated other comprehensive loss
(4
)
 
(1
)
Retained earnings
758

 
615

Total stockholders' equity
1,557

 
1,010

 
$
3,717

 
$
2,355


48

Table of Contents

Condensed Statements of Income
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Revenue:
 
 
 
 
 
Management fees and other operating revenue
$
928

 
$
704

 
$
599

Investment income
3

 
2

 
3

Total revenue
931

 
706

 
602

Expenses:
 
 
 
 
 

Medical care costs
55

 
46

 
38

General and administrative expenses
797

 
583

 
504

Depreciation and amortization
82

 
73

 
51

Total operating expenses
934

 
702

 
593

Operating (loss) income
(3
)
 
4

 
9

Interest expense
66

 
57

 
51

Other expense

 
1

 
4

Loss before income taxes and equity in net income of subsidiaries
(69
)
 
(54
)
 
(46
)
Income tax benefit
(21
)
 
(27
)
 
(16
)
Net loss before equity in net income of subsidiaries
(48
)
 
(27
)
 
(30
)
Equity in net income of subsidiaries
191

 
89

 
83

Net income
$
143

 
$
62

 
$
53


Condensed Statements of Comprehensive Income
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Net income
$
143

 
$
62

 
$
53

Other comprehensive income (loss):
 
 
 
 
 
Unrealized investment loss
(5
)
 

 
(1
)
Effect of income tax benefit
2

 

 

Other comprehensive loss, net of tax
(3
)
 

 
(1
)
Comprehensive income
$
140

 
$
62

 
$
52


49

Table of Contents


Condensed Statements of Cash Flows
 
Year Ended December 31,
 
2015
 
2014
 
2013
 
(In millions)
Operating activities:
 
 
 
 
 
Net cash provided by operating activities
$
113

 
$
74

 
$
63

Investing activities:
 
 
 
 
 

Capital contributions to subsidiaries
(770
)
 
(292
)
 
(166
)
Dividends received from subsidiaries
142

 

 
24

Purchases of investments
(244
)
 
(129
)
 
(363
)
Proceeds from sales and maturities of investments
118

 
263

 
98

Purchases of equipment
(91
)
 
(94
)
 
(77
)
Change in amounts due to/from affiliates
(68
)
 
16

 
(6
)
Other, net

 
8

 
(6
)
Net cash used in investing activities
(913
)
 
(228
)
 
(496
)
Financing activities:
 
 
 
 
 

Proceeds from senior notes offerings, net of issuance costs
689

 
123

 
538

Proceeds from common stock offering, net of issuance costs
373

 

 

Proceeds from sale-leaseback transactions

 

 
159

Purchase of call option

 

 
(149
)
Proceeds from issuance of warrants

 

 
75

Treasury stock repurchases

 

 
(53
)
Principal payment on term loan of subsidiary

 

 
(47
)
Repayment of amount borrowed under credit facility

 

 
(40
)
Proceeds from employee stock plans
18

 
14

 
9

Principal payments on convertible senior notes

 
(10
)
 

Other, net
5

 
2

 
2

Net cash provided by financing activities
1,085

 
129

 
494

Net increase (decrease) in cash and cash equivalents
285

 
(25
)
 
61

Cash and cash equivalents at beginning of year
75

 
100

 
39

Cash and cash equivalents at end of year
$
360

 
$
75

 
$
100

Notes to Condensed Financial Information of Registrant
Note A - Basis of Presentation
The Registrant was incorporated in 2002. Prior to that date, Molina Healthcare of California (formerly known as Molina Medical Centers) operated as a California health plan and as the parent company for three other state health plans. In June 2003, the employees and operations of the corporate entity were transferred from Molina Healthcare of California to the Registrant.
The Registrant's investment in subsidiaries is stated at cost plus equity in undistributed earnings of subsidiaries since the date of acquisition. The accompanying condensed financial information of the Registrant should be read in conjunction with the consolidated financial statements and accompanying notes.
Note B - Transactions with Subsidiaries
The Registrant provides certain centralized medical and administrative services to its subsidiaries pursuant to administrative services agreements, including medical affairs and quality management, health education, credentialing, management, financial, legal, information systems and human resources services. Fees are based on the fair market value of services rendered and are recorded as operating revenue. Payment is subordinated to the subsidiaries' ability to comply with minimum capital and other restrictive financial requirements of the states in which they operate. Charges in 2015, 2014, and 2013 for these services amounted to $914 million, $692 million, and $592 million, respectively, and are included in operating revenue.

50

Table of Contents

During 2013, the Registrant used a portion of the proceeds from the sale of the Molina Center, described in Note 12, "Debt," to repay the remaining principal balance of the related term loan, on behalf of a subsidiary of the Registrant.
The Registrant and its subsidiaries are included in the consolidated federal and state income tax returns filed by the Registrant. Income taxes are allocated to each subsidiary in accordance with an intercompany tax allocation agreement. The agreement allocates income taxes in an amount generally equivalent to the amount which would be expensed by the subsidiary if it filed a separate tax return. Net operating loss benefits are paid to the subsidiary by the Registrant to the extent such losses are utilized in the consolidated tax returns.
Note C - Dividends and Capital Contributions
When the Registrant receives dividends from its subsidiaries, such amounts are recorded as a reduction to the investments in the respective subsidiaries.
For all periods presented, the Registrant made capital contributions to certain subsidiaries primarily to comply with minimum net worth requirements and to fund contract acquisitions. Such amounts have been recorded as an increase in investment in the respective subsidiaries, net of insignificant returns of capital.
Note D - Related Party Transactions
The Registrant's related party transactions are described in Note 17, "Related Party Transactions."

51

Table of Contents

23. Supplemental Condensed Consolidating Financial Information

The 5.375% Notes are guaranteed by certain of our wholly owned subsidiaries. The 5.375% Notes and the guarantees are effectively subordinated to all existing and future secured debt of us and our guarantors to the extent of the assets securing such debt. In addition, the 5.375% Notes and the guarantees are structurally subordinated to all indebtedness and other liabilities and preferred stock of our subsidiaries that do not guarantee the 5.375% Notes. The 5.375% Notes are fully and unconditionally guaranteed on a joint and several basis, with exceptions considered customary for such guarantees, limited to the release of the guarantee when a subsidiary guarantor's capital stock is sold, or a sale of all of the subsidiary guarantor's assets used in its operations. The following condensed consolidating financial statements present Molina Healthcare, Inc. (as parent guarantor), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10, "Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered."


52

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
 
December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
360

 
$
42

 
$
1,927

 
$

 
$
2,329

Investments
252

 

 
1,549

 

 
1,801

Receivables

 
79

 
518

 

 
597

Income taxes refundable
7

 
3

 
3

 

 
13

Due from (to) affiliates
86

 
(4
)
 
(82
)
 

 

Prepaid expenses and other current assets
46

 
11

 
136

 
(1
)
 
192

Derivative asset
374

 

 

 

 
374

Total current assets
1,125

 
131

 
4,051

 
(1
)
 
5,306

Property, equipment, and capitalized software, net
267

 
52

 
74

 

 
393

Deferred contract costs

 
81

 

 

 
81

Goodwill and intangible assets, net
61

 
246

 
334

 

 
641

Restricted investments

 

 
109

 

 
109

Investment in subsidiaries
2,205

 
1

 

 
(2,206
)
 

Deferred income taxes
23

 
(35
)
 
30

 

 
18

Other assets
36

 
2

 
6

 
(16
)
 
28

 
$
3,717

 
$
478

 
$
4,604

 
$
(2,223
)
 
$
6,576

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$

 
$
3

 
$
1,682

 
$

 
$
1,685

Amounts due government agencies

 
1

 
728

 

 
729

Accounts payable and accrued liabilities
157

 
35

 
170

 

 
362

Deferred revenue

 
34

 
189

 

 
223

Current portion of long-term debt
449

 

 

 

 
449

Derivative liability
374

 

 

 

 
374

Total current liabilities
980

 
73

 
2,769

 

 
3,822

Long-term debt
1,160

 

 
16

 
(16
)
 
1,160

Other long-term liabilities
20

 
2

 
16

 
(1
)
 
37

Total liabilities
2,160

 
75

 
2,801

 
(17
)
 
5,019

Total stockholders’ equity
1,557

 
403

 
1,803

 
(2,206
)
 
1,557

 
$
3,717

 
$
478

 
$
4,604

 
$
(2,223
)
 
$
6,576


53

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEET

 
December 31, 2014
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
75

 
$
15

 
$
1,449

 
$

 
$
1,539

Investments
126

 

 
893

 

 
1,019

Receivables

 
35

 
561

 

 
596

Due from (to) affiliates
18

 
(1
)
 
(17
)
 

 

Prepaid expenses and other current assets
33

 
25

 
11

 
(20
)
 
49

Total current assets
252

 
74

 
2,897

 
(20
)
 
3,203

Property, equipment, and capitalized software, net
265

 
25

 
51

 

 
341

Deferred contract costs

 
54

 

 

 
54

Goodwill and intangible assets, net
65

 
75

 
221

 

 
361

Restricted investments

 
5

 
97

 

 
102

Investment in subsidiaries
1,377

 

 

 
(1,377
)
 

Derivative asset
11

 

 

 

 
329

Deferred income taxes
329

 
(17
)
 
21

 

 
15

Other assets
43

 

 
5

 
(18
)
 
30

 
$
2,342

 
$
216

 
$
3,292

 
$
(1,415
)
 
$
4,435

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$

 
$

 
$
1,201

 
$

 
$
1,201

Amounts due government agencies

 
2

 
525

 

 
527

Accounts payable and accrued liabilities
107

 
12

 
143

 
(20
)
 
242

Deferred revenue

 
31

 
165

 

 
196

Income taxes (refundable) payable
(13
)
 
7

 
15

 

 
9

Total current liabilities
94

 
52

 
2,049

 
(20
)
 
2,175

Long-term debt
887

 

 
16

 
(16
)
 
887

Derivative liability
329

 

 

 

 
329

Other long-term liabilities
22

 
1

 
13

 
(2
)
 
34

Total liabilities
1,332

 
53

 
2,078

 
(38
)
 
3,425

Total stockholders’ equity
1,010

 
163

 
1,214

 
(1,377
)
 
1,010

 
$
2,342

 
$
216

 
$
3,292

 
$
(1,415
)
 
$
4,435



54

Table of Contents


MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF INCOME

 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
931

 
$
293

 
$
13,931

 
$
(977
)
 
$
14,178

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
55

 
36

 
11,753

 
(50
)
 
11,794

Cost of service revenue

 
184

 
9

 

 
193

General and administrative expenses
797

 
41

 
1,235

 
(927
)
 
1,146

Premium tax expenses

 

 
397

 

 
397

Health insurer fee expenses

 

 
157

 

 
157

Depreciation and amortization
82

 
4

 
18

 

 
104

Total expenses
934

 
265

 
13,569

 
(977
)
 
13,791

Operating (loss) income
(3
)
 
28

 
362

 

 
387

Total other expenses (income), net
66

 

 
(1
)
 

 
65

(Loss) income before income taxes
(69
)
 
28

 
363

 

 
322

Income tax (benefit) expense
(21
)
 
9

 
191

 

 
179

Net (loss) income before equity in earnings of subsidiaries
(48
)
 
19

 
172

 

 
143

Equity in net earnings of subsidiaries
191

 
(1
)
 

 
(190
)
 

Net income (loss)
$
143

 
$
18

 
$
172

 
$
(190
)
 
$
143


 
Year Ended December 31, 2014
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
706

 
$
240

 
$
9,454

 
$
(733
)
 
$
9,667

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
46

 
27

 
8,034

 
(31
)
 
8,076

Cost of service revenue

 
157

 

 

 
157

General and administrative expenses
583

 
29

 
855

 
(702
)
 
765

Premium tax expenses

 

 
294

 

 
294

Health insurer fee expenses

 

 
89

 

 
89

Depreciation and amortization
73

 
5

 
15

 

 
93

Total expenses
702

 
218

 
9,287

 
(733
)
 
9,474

Operating income
4

 
22

 
167

 

 
193

Total other expenses, net
58

 

 

 

 
58

(Loss) income before income taxes
(54
)
 
22

 
167

 

 
135

Income tax (benefit) expense
(27
)
 
8

 
92

 

 
73

Net (loss) income before equity in earnings of subsidiaries
(27
)
 
14

 
75

 

 
62

Equity in net earnings of subsidiaries
89

 

 

 
(89
)
 

Net income (loss)
$
62

 
$
14

 
$
75

 
$
(89
)
 
$
62



55

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF INCOME
 
Year Ended December 31, 2013
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
602

 
$
211

 
$
6,385

 
$
(609
)
 
$
6,589

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
38

 
21

 
5,328

 
(7
)
 
5,380

Cost of service revenue

 
161

 

 

 
161

General and administrative expenses
504

 
26

 
738

 
(602
)
 
666

Premium tax expenses

 

 
172

 

 
172

Depreciation and amortization
51

 
7

 
15

 

 
73

Total expenses
593

 
215

 
6,253

 
(609
)
 
6,452

Operating income (loss)
9

 
(4
)
 
132

 

 
137

Total other expenses, net
55

 

 
1

 

 
56

(Loss) income before income taxes
(46
)
 
(4
)
 
131

 

 
81

Income tax (benefit) expense
(16
)
 
(1
)
 
53

 

 
36

Net (loss) income before equity in earnings of subsidiaries
(30
)
 
(3
)
 
78

 

 
45

Equity in net earnings of subsidiaries
83

 

 

 
(83
)
 

Income (loss) from continuing operations
53

 
(3
)
 
78

 
(83
)
 
45

Income from discontinued operations, net of tax

 

 
8

 

 
8

Net income (loss)
$
53

 
$
(3
)
 
$
86

 
$
(83
)
 
$
53


MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENTS OF COMPREHENSIVE INCOME

 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
143

 
$
18

 
$
172

 
$
(190
)
 
$
143

Other comprehensive (loss) income, net of tax
(3
)
 

 
(3
)
 
3

 
(3
)
Comprehensive income
$
140

 
$
18

 
$
169

 
$
(187
)
 
$
140


 
Year Ended December 31, 2014
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
62

 
$
14

 
$
75

 
$
(89
)
 
$
62

Other comprehensive income, net of tax

 

 

 

 

Comprehensive income
$
62

 
$
14

 
$
75

 
$
(89
)
 
$
62


 
Year Ended December 31, 2013
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income (loss)
$
53

 
$
(3
)
 
$
86

 
$
(83
)
 
$
53

Other comprehensive loss, net of tax
(1
)
 

 

 

 
(1
)
Comprehensive income (loss)
$
52

 
$
(3
)
 
$
86

 
$
(83
)
 
$
52


56

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
 
Year Ended December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
113

 
$
58

 
$
954

 
$

 
$
1,125

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(244
)
 

 
(1,679
)
 

 
(1,923
)
Proceeds from sales and maturities of investments
118

 

 
1,008

 

 
1,126

Purchases of equipment
(91
)
 
(23
)
 
(18
)
 

 
(132
)
Decrease (increase) in restricted investments

 
5

 
(11
)
 

 
(6
)
Net cash paid in business combinations

 
(214
)
 
(236
)
 

 
(450
)
Capital contributions to subsidiaries
(770
)
 
238

 
532

 

 

Dividends received from subsidiaries
142

 
(17
)
 
(125
)
 

 

Change in amounts due to/from affiliates
(68
)
 
15

 
53

 

 

Other, net

 
(35
)
 

 

 
(35
)
Net cash used in investing activities
(913
)
 
(31
)
 
(476
)
 

 
(1,420
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offering, net of issuance costs
689

 

 

 

 
689

Proceeds from common stock offering, net of issuance costs
373

 

 

 

 
373

Proceeds from employee stock plans
18

 

 

 

 
18

Other, net
5

 

 

 

 
5

Net cash provided by financing activities
1,085

 

 

 

 
1,085

Net increase in cash and cash equivalents
285

 
27

 
478

 

 
790

Cash and cash equivalents at beginning of period
75

 
15

 
1,449

 

 
1,539

Cash and cash equivalents at end of period
$
360

 
$
42

 
$
1,927

 
$

 
$
2,329


 
Year Ended December 31, 2014
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
74

 
$
29

 
$
957

 
$

 
$
1,060

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(129
)
 

 
(824
)
 

 
(953
)
Proceeds from sales and maturities of investments
263

 

 
370

 

 
633

Purchases of equipment
(94
)
 
(12
)
 
(9
)
 

 
(115
)
(Increase) decrease in restricted investments

 
5

 
(39
)
 

 
(34
)
Net cash paid in business combinations

 

 
(44
)
 

 
(44
)
Capital contributions to subsidiaries
(292
)
 
14

 
278

 

 

Change in amounts due to/from affiliates
16

 
(1
)
 
(15
)
 

 

Other, net
8

 
(29
)
 
(2
)
 

 
(23
)
Net cash used in investing activities
(228
)
 
(23
)
 
(285
)
 

 
(536
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offering, net of issuance costs
123

 

 

 

 
123

Contingent consideration liabilities settled

 

 
(50
)
 

 
(50
)
Principal payments on convertible senior notes
(10
)
 

 

 

 
(10
)
Proceeds from employee stock plans
14

 

 

 

 
14

Other, net
2

 

 

 

 
2

Net cash provided by (used in) financing activities
129

 

 
(50
)
 

 
79

Net (decrease) increase in cash and cash equivalents
(25
)
 
6

 
622

 

 
603

Cash and cash equivalents at beginning of period
100

 
9

 
827

 

 
936

Cash and cash equivalents at end of period
$
75

 
$
15

 
$
1,449

 
$

 
$
1,539


57

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
 
Year Ended December 31, 2013
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
63

 
$
(29
)
 
$
156

 
$

 
$
190

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(363
)
 

 
(407
)
 

 
(770
)
Proceeds from sales and maturities of investments
98

 

 
302

 

 
400

Purchases of equipment
(77
)
 
(8
)
 
(13
)
 

 
(98
)
Increase in restricted investments

 
(10
)
 
(9
)
 

 
(19
)
Net cash paid in business combinations

 

 
(62
)
 

 
(62
)
Capital contributions to subsidiaries
(166
)
 
10

 
156

 

 

Dividends received from subsidiaries
24

 

 
(24
)
 
 
 

Change in amounts due to/from affiliates
(6
)
 
(4
)
 
10

 

 

Other, net
(6
)
 
13

 
(1
)
 

 
6

Net cash (used in) provided by investing activities
(496
)
 
1

 
(48
)
 

 
(543
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from senior notes offering, net of issuance costs
538

 

 

 

 
538

Proceeds from sale-leaseback transactions
159

 

 

 

 
159

Purchase of call option
(149
)
 

 

 

 
(149
)
Proceeds from issuance of warrants
75

 

 

 

 
75

Treasury stock purchases
(53
)
 

 

 

 
(53
)
Principal payments on term loan
(47
)
 

 
(1
)
 

 
(48
)
Repayment of amount borrowed under credit facility
(40
)
 

 

 

 
(40
)
Proceeds from employee stock plans
9

 

 

 

 
9

Other, net
2

 

 

 

 
2

Net cash provided by (used in) financing activities
494

 

 
(1
)
 

 
493

Net increase (decrease) in cash and cash equivalents
61

 
(28
)
 
107

 

 
140

Cash and cash equivalents at beginning of period
39

 
37

 
720

 

 
796

Cash and cash equivalents at end of period
$
100

 
$
9

 
$
827

 
$

 
$
936



58

Exhibit
Table of Contents

PART I. FINANCIAL INFORMATION
Item 1.    Financial Statements
MOLINA HEALTHCARE, INC.
CONSOLIDATED BALANCE SHEETS
 
June 30,
2016
 
December 31,
2015
 
(Amounts in millions,
except per-share data)
 
(Unaudited)
 
 
ASSETS
Current assets:
 
 
 
Cash and cash equivalents
$
2,345

 
$
2,329

Investments
1,968

 
1,801

Receivables
1,012

 
597

Income taxes refundable
23

 
13

Prepaid expenses and other current assets
197

 
192

Derivative asset

 
374

Total current assets
5,545

 
5,306

Property, equipment, and capitalized software, net
448

 
393

Deferred contract costs
80

 
81

Intangible assets, net
146

 
122

Goodwill
611

 
519

Restricted investments
107

 
109

Deferred income taxes

 
18

Derivative asset
226

 

Other assets
39

 
28

 
$
7,202

 
$
6,576

 
 
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
 
 
 
Medical claims and benefits payable
$
1,766

 
$
1,685

Amounts due government agencies
1,238

 
729

Accounts payable and accrued liabilities
537

 
362

Deferred revenue
104

 
223

Current portion of long-term debt
1

 
449

Derivative liability

 
374

Total current liabilities
3,646

 
3,822

Senior notes
1,428

 
962

Lease financing obligations
198

 
198

Deferred income taxes
25

 

Derivative liability
226

 

Other long-term liabilities
38

 
37

Total liabilities
5,561

 
5,019

 
 
 
 
Stockholders’ equity:
 
 
 
Common stock, $0.001 par value; 150 shares authorized; outstanding: 57 shares at June 30, 2016 and 56 shares at December 31, 2015

 

Preferred stock, $0.001 par value; 20 shares authorized, no shares issued and outstanding

 

Additional paid-in capital
822

 
803

Accumulated other comprehensive gain (loss)
4

 
(4
)
Retained earnings
815

 
758

Total stockholders' equity
1,641

 
1,557

 
$
7,202

 
$
6,576

See accompanying notes.

1

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF INCOME
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions, except per-share data)
(Unaudited)
Revenue:
 
 
 
 
 
 
 
Premium revenue
$
4,029

 
$
3,304

 
$
8,024

 
$
6,275

Service revenue
135

 
47

 
275

 
99

Premium tax revenue
109

 
95

 
218

 
190

Health insurer fee revenue
76

 
74

 
166

 
122

Investment income
8

 
4

 
16

 
7

Other revenue
2

 
1

 
3

 
3

Total revenue
4,359

 
3,525

 
8,702

 
6,696

Operating expenses:
 
 
 
 
 
 
 
Medical care costs
3,594

 
2,929

 
7,182

 
5,565

Cost of service revenue
116

 
33

 
243

 
69

General and administrative expenses
351

 
287

 
691

 
543

Premium tax expenses
109

 
95

 
218

 
190

Health insurer fee expenses
50

 
40

 
108

 
81

Depreciation and amortization
34

 
25

 
66

 
50

Total operating expenses
4,254

 
3,409

 
8,508

 
6,498

Operating income
105

 
116

 
194

 
198

Interest expense
25

 
15

 
50

 
30

Income before income tax expense
80

 
101

 
144

 
168

Income tax expense
47

 
62

 
87

 
101

Net income
$
33

 
$
39

 
$
57

 
$
67

 
 
 
 
 
 
 

Net income per share:
 
 
 
 
 
 

Basic
$
0.58

 
$
0.78

 
$
1.02

 
$
1.36

Diluted
$
0.58

 
$
0.72

 
$
1.01

 
$
1.29

See accompanying notes.

2

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(Amounts in millions)
(Unaudited)
Net income
$
33

 
$
39

 
$
57

 
$
67

Other comprehensive income (loss):
 
 
 
 
 
 
 
Unrealized investment gain (loss)
4

 
(3
)
 
13

 
(1
)
Less: effect of income taxes
2

 
(1
)
 
5

 

Other comprehensive income (loss), net of tax
2

 
(2
)
 
8

 
(1
)
Comprehensive income
$
35

 
$
37

 
$
65

 
$
66


See accompanying notes.


3

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Six Months Ended June 30,
 
2016
 
2015
 
(Amounts in millions)
(Unaudited)
Operating activities:
 
 
 
Net income
$
57

 
$
67

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation and amortization
89

 
62

Deferred income taxes
39

 
7

Share-based compensation
16

 
9

Amortization of convertible senior notes and lease financing obligations
15

 
15

Other, net
11

 
9

Changes in operating assets and liabilities:
 
 
 
Receivables
(415
)
 
(35
)
Prepaid expenses and other assets
(143
)
 
(97
)
Medical claims and benefits payable
82

 
292

Amounts due government agencies
509

 
298

Accounts payable and accrued liabilities
147

 
158

Deferred revenue
(119
)
 
(138
)
Income taxes
(10
)
 
1

Net cash provided by operating activities
278

 
648

Investing activities:
 
 
 
Purchases of investments
(974
)
 
(993
)
Proceeds from sales and maturities of investments
812

 
541

Purchases of property, equipment and capitalized software
(102
)
 
(66
)
Change in restricted investments
5

 
(14
)
Net cash paid in business combinations
(8
)
 
(8
)
Other, net
(6
)
 
(17
)
Net cash used in investing activities
(273
)
 
(557
)
Financing activities:
 
 
 
Proceeds from common stock offering, net of issuance costs

 
373

Proceeds from employee stock plans
10

 
8

Other, net
1

 
3

Net cash provided by financing activities
11

 
384

Net increase in cash and cash equivalents
16

 
475

Cash and cash equivalents at beginning of period
2,329

 
1,539

Cash and cash equivalents at end of period
$
2,345

 
$
2,014


4

Table of Contents

MOLINA HEALTHCARE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(continued)
 
Six Months Ended June 30,
 
2016
 
2015
 
(Amounts in millions)
(Unaudited)
Supplemental cash flow information:
 
 
 
 
 
 
 
Schedule of non-cash investing and financing activities:
 
 
 
Common stock used for share-based compensation
$
(7
)
 
$
(9
)
 
 
 
 
Details of change in fair value of derivatives, net:
 
 
 
Loss on 1.125% Call Option
$
(148
)
 
$
(179
)
Gain on 1.125% Conversion Option
148

 
179

Change in fair value of derivatives, net
$

 
$

 
 
 
 
Details of business combinations:
 
 
 
Fair value of assets acquired
$
(131
)
 
$

Purchase price amounts accrued/received (paid)
21

 
(8
)
Reversal of amounts advanced to sellers in prior year
102

 

Net cash paid in business combinations
$
(8
)
 
$
(8
)

See accompanying notes.


5

Table of Contents

MOLINA HEALTHCARE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
June 30, 2016
1. Basis of Presentation
Organization and Operations
Molina Healthcare, Inc. provides quality health care to people receiving government assistance. We offer cost-effective Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist government agencies in their administration of the Medicaid program. We have three reportable segments. These segments include our Health Plans and Molina Medicaid Solutions segments, which comprise the vast majority of our operations, and our Other segment. As of December 31, 2015, we changed our reporting structure as a result of the Pathways acquisition in November 2015, which is reported in Other. All prior periods reported conform to this presentation.
Our Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico, and includes our direct delivery business. As of June 30, 2016, these health plans served 4.2 million members eligible for Medicaid, Medicare, and other government-sponsored health care programs for low-income families and individuals. Additionally, we serve Health Insurance Marketplace (Marketplace) members, most of whom receive government premium subsidies. The health plans are operated by our respective wholly owned subsidiaries in those states, each of which is licensed as a health maintenance organization (HMO). Our direct delivery business consists primarily of the operation of primary care clinics in several states in which we operate.
Our Molina Medicaid Solutions segment provides business processing and information technology development and administrative services to Medicaid agencies in Idaho, Louisiana, Maine, New Jersey, West Virginia, and the U.S. Virgin Islands, and drug rebate administration services in Florida.
Our Other segment includes businesses, such as our Pathways behavioral health and social services provider, that do not meet the quantitative thresholds for a reportable segment as defined by U.S. generally accepted accounting principles (GAAP), as well as corporate amounts not allocated to other reportable segments.
Market Updates - Health Plans
Illinois. On January 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business of, Accountable Care Chicago, LLC, also known as MyCare Chicago and Loyola Physician Partners, LLC. See Note 4, "Business Combinations," for further information.
On March 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business, of Better Health Network, LLC. See Note 4, "Business Combinations," for further information.
Michigan. On January 1, 2016, our Michigan health plan closed on its acquisition of the Medicaid and MIChild membership, and certain Medicaid and MIChild assets, of HAP Midwest Health Plan, Inc. See Note 4, "Business Combinations," for further information.
New York. On April 19, 2016, we entered into an agreement with Universal American Corp. to acquire all outstanding equity interests of Today's Options of New York, Inc., which operates the Total Care Medicaid plan. Subject to regulatory approvals and the satisfaction of other closing conditions, we expect the transaction to close in the second half of 2016.
Washington. On January 1, 2016, our Washington health plan closed on its acquisition of the Medicaid contracts, and certain assets related to the operation of the Medicaid business, of Columbia United Providers, Inc. See Note 4, "Business Combinations," for further information.
Consolidation and Interim Financial Information
The consolidated financial statements include the accounts of Molina Healthcare, Inc., its subsidiaries, and variable interest entities (VIEs) in which Molina Healthcare, Inc. is considered to be the primary beneficiary. Such VIEs are insignificant to our consolidated financial position and results of operations. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the interim periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions have been eliminated. The consolidated results of operations for the current interim period are not necessarily indicative of the results for the entire year ending December 31, 2016.
The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to our audited consolidated financial statements for the fiscal year ended

6

Table of Contents

December 31, 2015. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in the December 31, 2015 audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with our December 31, 2015 audited consolidated financial statements.
2. Significant Accounting Policies
Revenue Recognition – Health Plans Segment
Premium revenue is fixed in advance of the periods covered and except as described below, is not generally subject to significant accounting estimates. Premium revenues are recognized in the month that members are entitled to receive health care services, and premiums collected in advance are deferred. Certain components of premium revenue are subject to accounting estimates and fall into the following categories:
Contractual Provisions That May Adjust or Limit Revenue or Profit
Medicaid
Medical Cost Floors (Minimums), Medical Cost Corridors, and Administrative Cost Ceilings (Maximums): A portion of our premium revenue may be returned if certain minimum amounts are not spent on defined medical care costs. In the aggregate, we recorded a liability under the terms of such contract provisions of $326 million and $214 million at June 30, 2016 and December 31, 2015, respectively, to amounts due government agencies. Approximately $297 million and $208 million of the liability accrued at June 30, 2016 and December 31, 2015, respectively, relates to our participation in Medicaid Expansion programs.
In certain circumstances, the health plans may receive additional premiums if amounts spent on medical care costs exceed a defined maximum threshold. We recorded receivables of $1 million and $3 million at June 30, 2016 and December 31, 2015, respectively, relating to such provisions.
Profit Sharing and Profit Ceiling: Our contracts with certain states contain profit-sharing or profit ceiling provisions under which we refund amounts to the states if our health plans generate profit above a certain specified percentage. In some cases, we are limited in the amount of administrative costs that we may deduct in calculating the refund, if any. Under these provisions, we recorded a liability of $1 million and $10 million at June 30, 2016 and December 31, 2015, respectively, for profit in excess of the amount we are allowed to retain.
Retroactive Premium Adjustments: The state Medicaid programs periodically adjust premium rates on a retroactive basis. In these cases, we must adjust our premium revenue in the period in which we learn of the adjustment, rather than in the months of service to which the retroactive adjustment applies. In the first quarter of 2016 our Florida health plan recorded a retroactive increase to Medicaid premium revenue of approximately $18 million, relating to dates of service prior to 2016.
Cost Plus Retroactive Premium Adjustments: In New Mexico, when members are retroactively enrolled into our health plan, we earn revenue only to the extent of the actual medical costs incurred by us for services provided during those retroactive periods, plus a small percentage of that medical cost for administration and profit. This arrangement first became effective July 1, 2014 (retroactive to January 1, 2014). We are paid normal monthly capitation rates for the retroactive eligibility periods, and the difference between those capitation rates and the amounts due to us on a cost plus basis are periodically settled with the state. To date, no such settlement has been made. During the years ended December 31, 2014 and 2015, our New Mexico contract was not specific as to the definition of retroactive membership, and the amount we owe the state (or that the state owes us) for the difference between capitation received and amounts due to us under the cost plus arrangement during those periods varies widely depending upon the definition of retroactive membership. Although we believe that the amount we have recorded as a liability for this matter is consistent with the state’s expectations, we cannot be certain that the state will not seek to recover an amount in excess of our recorded liability.
Medicare
Risk Adjustment: Our Medicare premiums are subject to retroactive increase or decrease based on the health status of our Medicare members (as measured by member risk score). We estimate our members' risk scores and the related amount of Medicare revenue that will ultimately be realized for the periods presented based on our knowledge of our members’ health status, risk scores and federal Centers for Medicare and Medicaid Services (CMS) practices. Based on our estimates, we have recorded a net receivable of $19 million and a net payable of $4 million for anticipated Medicare risk adjustment premiums at June 30, 2016 and December 31, 2015, respectively.

7

Table of Contents

Marketplace
Premium Stabilization Programs: The Affordable Care Act (ACA) established Marketplace premium stabilization programs effective January 1, 2014. These programs, commonly referred to as the "3R's," include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. We record receivables or payables related to the 3R programs and the Minimum MLR when the amounts are reasonably estimable as described below, and, for receivables, collection is reasonably assured. Our receivables (payables) for each of these programs, as of the dates indicated, were as follows:
 
June 30, 2016
 
December 31,
2015
 
Current Benefit Year
 
Prior Benefit Years
 
Total
 
 
(In millions)
Risk adjustment
$
(220
)
 
$
(254
)
 
$
(474
)
 
$
(214
)
Reinsurance
57

 
24

 
81

 
36

Risk corridor
(9
)
 
(3
)
 
(12
)
 
(10
)
Minimum MLR
(17
)
 
(2
)
 
(19
)
 
(3
)
Risk adjustment: Under this permanent program, our health plans' composite risk scores are compared to the overall average risk score for the relevant state and market pool. Generally, our health plans will pay into the pool if their composite risk scores are below the average risk score, and will receive funds from the pool if their composite risk scores are above the average risk score. We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk adjustment program as an adjustment to premium revenue in our consolidated statements of income. On June 30, 2016, CMS released the final update on risk adjustment and reinsurance payments for the 2015 benefit year, and we adjusted our accruals accordingly.
Reinsurance: This program is designed to provide reimbursement to insurers for high cost members. Our health plans pay an annual contribution on a per-member basis, and are eligible for recoveries if claims for individual members exceed a specified threshold, up to a maximum amount. This three-year program will end on December 31, 2016. We recognize the assessments to fund the transitional reinsurance program as a reduction to premium revenue in our consolidated statements of income. We recognize recoveries under the reinsurance program as a reduction to medical care costs in our consolidated statements of income.
Risk corridor: This program is intended to limit gains and losses of insurers by comparing allowable costs to a target amount as defined by the CMS. Variances from the target amount exceeding certain thresholds may result in amounts due to or receivables due from CMS. This three-year program will end on December 31, 2016. Due to uncertainties as to the amount of federal funding available to support the risk corridor program, we do not recognize amounts receivable under this program. All liabilities are recognized as incurred. We estimate our ultimate premium based on insurance policy year-to-date experience, and recognize estimated premiums relating to the risk corridor program as an adjustment to premium revenue in our consolidated statements of income.
Additionally, the ACA established a minimum annual medical loss ratio (Minimum MLR) of 80% for the Marketplace. The medical loss ratio represents medical costs as a percentage of premium revenue. What constitutes medical costs and premium revenue are specifically defined by federal regulations. If the Minimum MLR is not met, we may be required to pay rebates to our Marketplace policyholders. Each of the 3R programs is taken into consideration when computing the Minimum MLR. We recognize estimated rebates under the Minimum MLR as an adjustment to premium revenue in our consolidated statements of income.
Quality Incentives
At several of our health plans, revenue ranging from approximately 1% to 3% of certain health plan premiums is earned only if certain performance measures are met.
During the second quarter, we were informed by the Texas Department of Health and Human Services that it will not recoup any quality revenue for calendar years 2014, 2015, and 2016. Therefore, we recognized previously deferred quality revenue amounting to approximately $51 million in the second quarter of 2016. Of the $51 million adjustment, $44 million related to 2015 and 2014 dates of service, and $7 million related to the first quarter of 2016.
The following table quantifies the quality incentive premium revenue recognized for the periods presented, including the amounts earned in the periods presented and prior periods. Although the reasonably possible effects of a change in estimate related to quality incentive premium revenue as of June 30, 2016 are not known, we have no reason to believe that the

8

Table of Contents

adjustments to prior years noted below are not indicative of the potential future changes in our estimates as of June 30, 2016, other than the Texas quality revenue recognized in the second quarter of 2016 described above.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions)
Maximum available quality incentive premium - current period
$
41

 
$
28

 
$
81

 
$
58

Amount of quality incentive premium revenue recognized in current period:
 
 
 
 
 
 
 
Earned current period
$
36

 
$
11

 
$
54

 
$
21

Earned prior periods
49

 
11

 
54

 
11

Total
$
85

 
$
22

 
$
108

 
32

 
 
 
 
 
 
 
 
Quality incentive premium revenue recognized as a percentage of total premium revenue
2.1
%
 
0.7
%
 
1.3
%
 
0.5
%
Income Taxes
The provision for income taxes is determined using an estimated annual effective tax rate, which is generally greater than the U.S. federal statutory rate primarily because of state taxes, nondeductible expenses such as the Health Insurer Fee (HIF), certain compensation, and other general and administrative expenses. The effective tax rate may be subject to fluctuations during the year, particularly as a result of the level of pretax earnings, and also as new information is obtained. Such information may affect the assumptions used to estimate the annual effective tax rate, including factors such as the mix of pretax earnings in the various tax jurisdictions in which we operate, valuation allowances against deferred tax assets, the recognition or the reversal of the recognition of tax benefits related to uncertain tax positions, and changes in or the interpretation of tax laws in jurisdictions where we conduct business. We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities, along with net operating loss and tax credit carryovers.
Recent Accounting Pronouncements
Revenue Recognition. In May 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2016-12, Revenue from Contracts with Customers (Topic 606). The amendments, which address transition, collectibility, non-cash consideration and the presentation of sales and other similar taxes, do not change the core principles of ASU 2014-09, but rather address implementation issues and are intended to result in more consistent application. We intend to adopt this standard on January 1, 2018. We are evaluating the potential effects of the adoption to our financial statements.
In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, which amends certain aspects of ASC 606, Revenue from Contracts with Customers. ASU 2016-10 amends step two of the new revenue standard’s five-step model to include guidance on immaterial promised goods or services, shipping and handling activities and identifying when promises represent performance obligations. ASU 2016-10 also provides guidance related to licensing such as, but not limited to, sales-based and usage-based royalties and renewals of license that provide a right to use intellectual property. We intend to adopt this standard on January 1, 2018. We are evaluating the potential effects of the adoption to our financial statements.
In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers - Principal vs. Agent Considerations, which amends the principal–versus–agent implementation guidance in ASC 606. ASU 2016-08 clarifies that an entity should evaluate whether it is the principal or agent for each specified good or service promised in a contract with a customer as defined in ASC 606. The entity must first identify each specified good or service to be provided to the customer and then assess whether it controls each specified good or service. The ASU also removed two of the five indicators used in evaluating control under the old guidance and reframes the remaining three indicators. We intend to adopt this standard on January 1, 2018. We are evaluating the potential effects of the adoption to our financial statements.
Credit Losses. In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments, which changes how companies measure credit losses on most financial instruments measured at amortized cost, such as loans, receivables and held-to-maturity debt securities. Rather than generally recognizing credit losses when it is probable that the loss has been incurred, the revised guidance requires companies to recognize an allowance for credit losses for the difference between the amortized cost basis of a financial instrument and the amount of amortized cost that the company expects to collect over the instrument's contractual life. ASU 2016-13 is effective for fiscal periods beginning after December 15, 2019 and must

9

Table of Contents

be adopted as a cumulative effect adjustment to retained earnings. Early adoption is permitted. We are evaluating the potential effects of the adoption to our financial statements.
Stock Compensation. In March 2016, the FASB issued ASU 2016-09, Compensation-Stock Compensation, which simplifies several aspects of accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, statutory tax and classification in the statement of cash flows. ASU 2016-09 is effective for fiscal periods beginning after December 15, 2016 and must be adopted using the modified retrospective approach except for classification in the statement of cash flows, which must be adopted using either the prospective or retrospective approach. Early adoption is permitted. We are evaluating the potential effects of the adoption to our financial statements.
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the Securities and Exchange Commission (SEC) did not have, or are not believed by management to have, a material impact on our present or future consolidated financial statements.
3. Net Income per Share
The following table sets forth the calculation of basic and diluted net income per share:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions, except net income per share)
Numerator:
 
 
 
 
 
 
 
Net income
$
33

 
$
39

 
$
57

 
$
67

Denominator:
 
 
 
 
 
 
 
Shares outstanding at the beginning of the period
55

 
49

 
55

 
49

Weighted-average number of shares:
 
 
 
 
 
 
 
Issued in common stock offering

 
1

 

 
1

Denominator for basic net income per share
55

 
50

 
55

 
50

Effect of dilutive securities:
 
 
 
 
 
 
 
Convertible senior notes (1)

 
1

 

 

1.125% Warrants (1)

 
3

 
1

 
2

Denominator for diluted net income per share
55

 
54

 
56

 
52

 
 
 
 
 
 
 
 
Net income per share (2):
 
 
 
 
 
 
 
Basic
$
0.58

 
$
0.78

 
$
1.02

 
$
1.36

Diluted
$
0.58

 
$
0.72

 
$
1.01

 
$
1.29

______________________________
(1)
For more information regarding the convertible senior notes, refer to Note 10, "Debt." For more information regarding the 1.125% Warrants, refer to Note 11, "Derivatives."
(2)
Source data for calculations in thousands.
4. Business Combinations
In the first quarter of 2016, we closed on several business combinations in the Health Plans segment. For all of these transactions, we applied the acquisition method of accounting, where the total purchase price was allocated, or preliminarily allocated, to tangible and intangible assets acquired, and liabilities assumed based on their respective fair values. For the Health Plans acquisitions, described below, only intangible assets were acquired. All of these acquisitions were funded using available cash and acquisition-related costs were insignificant.
Health Plans
Consistent with our strategy to grow in our existing markets, we closed the following Health Plans acquisitions in the first quarter of 2016:
Illinois. On January 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business of, Accountable Care Chicago, LLC, also known as MyCare Chicago. The initial purchase price was approximately $35 million, and the Illinois health plan added approximately 58,000 Medicaid members as a result of this transaction.

10

Table of Contents

On January 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business, of Loyola Physician Partners, LLC. The final purchase price was approximately $12 million, and the Illinois health plan added approximately 18,000 Medicaid members as a result of this transaction.
On March 1, 2016, our Illinois health plan closed on its acquisition of the Medicaid membership, and certain assets related to the Medicaid business, of Better Health Network, LLC. The initial purchase price was approximately $18 million, and the Illinois health plan added approximately 34,000 Medicaid members as a result of this transaction.
Michigan. On January 1, 2016, our Michigan health plan closed on its acquisition of the Medicaid and MIChild membership, and certain Medicaid and MIChild assets, of HAP Midwest Health Plan, Inc. The final purchase price was approximately $31 million, and the Michigan health plan added approximately 68,000 Medicaid and MIChild members as a result of this transaction.
Washington. On January 1, 2016, our Washington health plan closed on its acquisition of the Medicaid contracts, and certain assets related to the operation of the Medicaid business, of Columbia United Providers, Inc. The final purchase price was approximately $28 million, and the Washington health plan added approximately 57,000 Medicaid members as a result of this transaction.
For these acquisitions, we recorded goodwill to the Health Plans segment amounting to $90 million in the aggregate, which relates to future economic benefits arising from expected synergies to be achieved. Such synergies include use of our existing infrastructure to support the added membership. The amount recorded as goodwill is deductible for income tax purposes.
The following table presents the intangible assets identified in the transactions described above. The weighted-average amortization period, in the aggregate, is 5.9 years. For these acquisitions in the aggregate, we expect to record amortization of approximately $6 million per year in the years 2016 through 2020 and $1 million in 2021.
 
Fair Value
 
Life
 
(In millions)
 
(Years)
Intangible asset type:
 
 
 
Contract rights - member list
$
28

 
5
Provider network
6

 
10
 
$
34

 
 
5. Fair Value Measurements
We consider the carrying amounts of cash and cash equivalents and other current assets and current liabilities (not including current portion of long-term debt) to approximate their fair values because of the relatively short period of time between the origination of these instruments and their expected realization or payment. For our financial instruments measured at fair value on a recurring basis, we prioritize the inputs used in measuring fair value according to a three-tier fair value hierarchy as follows:
Level 1 — Observable Inputs. Level 1 financial instruments are actively traded and therefore the fair value for these securities is based on quoted market prices on one or more securities exchanges.
Level 2 — Directly or Indirectly Observable Inputs. Level 2 financial instruments are traded frequently though not necessarily daily. Fair value for these investments is determined using a market approach based on quoted prices for similar securities in active markets or quoted prices for identical securities in inactive markets.
Level 3 — Unobservable Inputs. Level 3 financial instruments are valued using unobservable inputs that represent management's best estimate of what market participants would use in pricing the financial instrument at the measurement date. Our Level 3 financial instruments include derivative financial instruments.
Derivative financial instruments include the 1.125% Call Option derivative asset and the 1.125% Conversion Option derivative liability. These derivatives are not actively traded and are valued based on an option pricing model that uses observable and unobservable market data for inputs. Significant market data inputs used to determine fair value as of June 30, 2016 included the price of our common stock, the time to maturity of the derivative instruments, the risk-free interest rate, and the implied volatility of our common stock. As described further in Note 11, “Derivatives,” the 1.125% Call Option asset and the 1.125% Conversion Option liability were designed such that changes in their fair values would offset, with minimal impact to the consolidated statements of income. Therefore, the sensitivity of changes in the unobservable inputs to the option pricing model for such instruments is mitigated.

11

Table of Contents

The changes in fair value of Level 3 financial instruments were insignificant to our results of operations for the six months ended June 30, 2016.
Our financial instruments measured at fair value on a recurring basis at June 30, 2016, were as follows:
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In millions)
Corporate debt securities
$
1,345

 
$

 
$
1,345

 
$

Government-sponsored enterprise securities (GSEs)
196

 
196

 

 

Municipal securities
180

 

 
180

 

U.S. treasury notes
108

 
108

 

 

Asset-backed securities
71

 

 
71

 

Certificates of deposit
68

 

 
68

 

Subtotal - current investments
1,968

 
304

 
1,664

 

1.125% Call Option derivative asset
226

 

 

 
226

Total assets measured at fair value on a recurring basis
$
2,194

 
$
304

 
$
1,664

 
$
226

 
 
 
 
 
 
 
 
1.125% Conversion Option derivative liability
$
226

 
$

 
$

 
$
226

Total liabilities measured at fair value on a recurring basis
$
226

 
$

 
$

 
$
226

Our financial instruments measured at fair value on a recurring basis at December 31, 2015, were as follows:
 
Total
 
Level 1
 
Level 2
 
Level 3
 
(In millions)
Corporate debt securities
$
1,184

 
$

 
$
1,184

 
$

GSEs
211

 
211

 

 

Municipal securities
185

 

 
185

 

U.S. treasury notes
78

 
78

 

 

Asset-backed securities
63

 

 
63

 

Certificates of deposit
80

 

 
80

 

Subtotal - current investments
1,801

 
289

 
1,512

 

1.125% Call Option derivative asset
374

 

 

 
374

Total assets measured at fair value on a recurring basis
$
2,175

 
$
289

 
$
1,512

 
$
374

 
 
 
 
 
 
 
 
1.125% Conversion Option derivative liability
$
374

 
$

 
$

 
$
374

Total liabilities measured at fair value on a recurring basis
$
374

 
$

 
$

 
$
374

Fair Value Measurements – Disclosure Only
The carrying amounts and estimated fair values of our senior notes, which are classified as Level 2 financial instruments, are indicated in the following table.
 
June 30, 2016
 
December 31, 2015
 
Carrying
Value
 

Fair Value
 
Carrying
Value
 

Fair Value
 
(In millions)
5.375% Notes
$
690

 
$
702

 
$
689

 
$
700

1.125% Convertible Notes
460

 
742

 
448

 
865

1.625% Convertible Notes
278

 
329

 
273

 
365

 
$
1,428

 
$
1,773

 
$
1,410

 
$
1,930


12

Table of Contents

6. Investments
The following tables summarize our investments as of the dates indicated:
 
June 30, 2016
 
Amortized
 
Gross
Unrealized
 
Estimated
Fair
 
Cost
 
Gains
 
Losses
 
Value
 
(In millions)
Corporate debt securities
$
1,340

 
$
5

 
$

 
$
1,345

GSEs
196

 

 

 
196

Municipal securities
178

 
2

 

 
180

U.S. treasury notes
108

 

 

 
108

Asset-backed securities
71

 

 

 
71

Certificates of deposit
68

 

 

 
68

 
$
1,961

 
$
7

 
$

 
$
1,968

 
December 31, 2015
 
Amortized
 
Gross
Unrealized
 
Estimated
Fair
 
Cost
 
Gains
 
Losses
 
Value
 
(In millions)
Corporate debt securities
$
1,189

 
$

 
$
5

 
$
1,184

GSEs
212

 

 
1

 
211

Municipal securities
186

 

 
1

 
185

U.S. treasury notes
78

 

 

 
78

Asset-backed securities
63

 

 

 
63

Certificates of deposit
80

 

 

 
80

 
$
1,808

 
$

 
$
7

 
$
1,801

The contractual maturities of our investments as of June 30, 2016 are summarized below:
 
Amortized Cost
 
Estimated
Fair Value
 
(In millions)
Due in one year or less
$
1,084

 
$
1,084

Due after one year through five years
844

 
850

Due after five years through ten years
33

 
34

 
$
1,961

 
$
1,968

Gross realized gains and losses from sales of available-for-sale securities are calculated under the specific identification method and are included in investment income. Gross realized investment gains and losses for the three and six months ended June 30, 2016 and 2015 were insignificant.
We have determined that unrealized gains and losses at June 30, 2016 and December 31, 2015, are temporary in nature, because the change in market value for these securities has resulted from fluctuating interest rates, rather than a deterioration of the creditworthiness of the issuers. So long as we maintain the intent and ability to hold these securities to maturity, we are unlikely to experience gains or losses. In the event that we dispose of these securities before maturity, we expect that realized gains or losses, if any, will be immaterial. 
There were no available-for-sale investments in a material continuous loss position as of June 30, 2016.

13

Table of Contents

The following table segregates those available-for-sale investments that have been in a continuous loss position for less than 12 months, and those that have been in a loss position for 12 months or more as of December 31, 2015:
 
In a Continuous Loss Position
for Less than 12 Months
 
In a Continuous Loss Position
for 12 Months or More
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Positions
 
Estimated
Fair
Value
 
Unrealized
Losses
 
Total
Number of
Positions
 
(Dollars in millions)
Corporate debt securities
$
825

 
$
4

 
588

 
$
119

 
$
1

 
87

GSEs
182

 
1

 
77

 

 

 

Municipal securities
128

 
1

 
181

 

 

 

 
$
1,135

 
$
6

 
846

 
$
119

 
$
1

 
87

7. Receivables
Receivables consist primarily of amounts due from government Medicaid agencies, which may be subject to potential retroactive adjustments. Because all of our receivable amounts are readily determinable and substantially all of our creditors are governmental authorities, our allowance for doubtful accounts is immaterial. The information below is presented by segment.  
 
June 30,
2016
 
December 31,
2015
 
(In millions)
California
$
180

 
$
104

Florida
103

 
22

Illinois
106

 
35

Michigan
62

 
39

New Mexico
64

 
51

Ohio
112

 
66

Puerto Rico
50

 
33

South Carolina
11

 
6

Texas
60

 
56

Utah
38

 
18

Washington
81

 
53

Wisconsin
46

 
22

Direct delivery and other
5

 
6

Total Health Plans segment
918

 
511

Molina Medicaid Solutions segment
41

 
37

Other segment
53

 
49

 
$
1,012

 
$
597

8. Restricted Investments
Pursuant to the regulations governing our Health Plans segment subsidiaries, we maintain statutory deposits and deposits required by government authorities in certificates of deposit and U.S. treasury securities. We also maintain restricted investments as protection against the insolvency of certain capitated providers. The following table presents the balances of

14

Table of Contents

restricted investments:
 
June 30,
2016
 
December 31,
2015
 
(In millions)
Florida
$
28

 
$
34

Illinois
3

 

Michigan
1

 
1

New Mexico
43

 
43

Ohio
12

 
12

Puerto Rico
10

 
10

Texas
4

 
4

Utah
4

 
4

Wisconsin
1

 
1

Other
1

 

Total Health Plans segment
$
107

 
$
109

The contractual maturities of our held-to-maturity restricted investments as of June 30, 2016 are summarized below:
 
Amortized
Cost
 
Estimated
Fair Value
 
(In millions)
Due in one year or less
$
106

 
$
106

Due after one year through five years
1

 
1

 
$
107

 
$
107

9. Medical Claims and Benefits Payable
The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.
 
June 30,
2016
 
December 31,
2015
 
(In millions)
Fee-for-service claims incurred but not paid (IBNP)
$
1,292

 
$
1,191

Pharmacy payable
103

 
88

Capitation payable
37

 
140

Other
334

 
266

 
$
1,766

 
$
1,685

"Other" medical claims and benefits payable include amounts payable to certain providers for which we act as an intermediary on behalf of various government agencies without assuming financial risk. Such receipts and payments do not impact our consolidated statements of income. Non-risk provider payables amounted to $191 million and $167 million as of June 30, 2016 and December 31, 2015, respectively.
The following table presents the components of the change in our medical claims and benefits payable for the periods indicated. The amounts presented for “Components of medical care costs related to: Prior periods” represent the amount by which our original estimate of medical claims and benefits payable at the beginning of the period were more than the actual amount of the liability based on information (principally the payment of claims) developed since that liability was first reported.

15

Table of Contents

 
Six Months Ended June 30, 2016
 
Year Ended
December 31, 2015
 
(Dollars in millions)
Medical claims and benefits payable, beginning balance
$
1,685

 
$
1,201

Components of medical care costs related to:
 
 
 
Current period
7,371

 
11,935

Prior periods
(189
)
 
(141
)
Total medical care costs
7,182

 
11,794

 
 
 
 
Change in non-risk provider payables
24

 
48

 
 
 
 
Payments for medical care costs related to:
 
 
 
Current period
5,885

 
10,448

Prior periods
1,240

 
910

Total paid
7,125

 
11,358

Medical claims and benefits payable, ending balance
$
1,766

 
$
1,685

Benefit from prior period as a percentage of:
 
 
 
Balance at beginning of period
11.3
%
 
11.8
%
Premium revenue, trailing twelve months
1.3
%
 
1.1
%
Medical care costs, trailing twelve months
1.4
%
 
1.2
%
The portion of our total medical claims and benefits payable liability that is most subject to variability in the estimate is fee-for-service claims incurred but not paid (IBNP). Our IBNP, included in medical claims and benefits payable, represents our best estimate of the total amount of claims we will ultimately pay with respect to claims that we have incurred as of the balance sheet date. We estimate our IBNP monthly using actuarial methods based on a number of factors.
Assuming that our initial estimate of IBNP is accurate, we believe that amounts ultimately paid would generally be between 8% and 10% less than the IBNP liability recorded at the end of the period as a result of the inclusion in that liability of the provision for adverse claims deviation and the accrued cost of settling those claims. Because the amount of our initial liability is merely an estimate (and therefore not perfectly accurate), we will always experience variability in that estimate as new information becomes available with the passage of time. Therefore, there can be no assurance that amounts ultimately paid out will fall within the range of 8% to 10% lower than the liability that was initially recorded. Furthermore, because our initial estimate of IBNP is derived from many factors, some of which are qualitative in nature rather than quantitative, we are seldom able to assign specific values to the reasons for a change in estimate – we only know when the circumstances for any one or more factors are out of the ordinary.
The use of a consistent methodology in estimating our liability for medical claims and benefits payable minimizes the degree to which the under– or overestimation of that liability at the close of one period may affect consolidated results of operations in subsequent periods. In particular, the use of a consistent methodology should result in the replenishment of reserves during any given period in a manner that generally offsets the benefit of favorable prior period development in that period. Facts and circumstances unique to the estimation process at any single date, however, may still lead to a material impact on consolidated results of operations in subsequent periods. Any absence of adverse claims development (as well as the expensing through general and administrative expense of the costs to settle claims held at the start of the period) will lead to the recognition of a benefit from prior period claims development in the period subsequent to the date of the original estimate.
As indicated above, the amounts ultimately paid out on our medical claims and benefits payable liabilities in fiscal years 2016 and 2015 were less than what we had expected when we had established those liabilities. The differences between our original estimates and the amounts ultimately paid out (or now expected to be ultimately paid out) for the most part related to IBNP. While many related factors working in conjunction with one another serve to determine the accuracy of our estimates, we are seldom able to quantify the impact that any single factor has on a change in estimate. In addition, given the variability inherent in the reserving process, we will only be able to identify specific factors if they represent a significant departure from expectations. As a result, we do not expect to be able to fully quantify the impact of individual factors on changes in estimates.
We believe that the most significant uncertainties surrounding our IBNP estimates at June 30, 2016 are as follows:
In the first half of 2016, our Marketplace enrollment across all health plans increased by approximately 392,000 members. Some of the states with significant increases included:
California: 57,000

16

Table of Contents

Florida: 94,000
Texas: 110,000
Utah: 48,000
Wisconsin: 38,000
Because these new Marketplace members may have different utilization patterns than our legacy members, our estimates of the liability we have incurred for services provided to these members are subject to more than the usual amount of uncertainty.
Our Illinois health plan added over 100,000 new members under acquisitions of three Medicaid contracts during the first half of 2016. Because these new members may have different utilization patterns than our legacy members, our estimates of the liability we have incurred for services provided to these members are subject to more than the usual amount of uncertainty.
At our New Mexico, Puerto Rico and Washington health plans, we overpaid certain inpatient and outpatient facility claims. We adjusted our claims payment history to reflect the claims payment pattern that would have occurred without these overpayments. For this reason, our liability estimates at these health plans are subject to more than the usual amount of uncertainty.
At our Washington health plan, the covered benefits in two counties were expanded to include behavioral health benefits under the state's new fully integrated managed care program, which impacted about 80,000 members. Because these are new benefits, our liability estimate at this health plan is subject to more than the usual amount of uncertainty.
We recognized favorable prior period claims development in the amount of $189 million for the six months ended June 30, 2016. This amount represents our estimate as of June 30, 2016, of the extent to which our initial estimate of medical claims and benefits payable at December 31, 2015 was more than the amount that will ultimately be paid out in satisfaction of that liability. We believe the overestimation was due primarily to the following factors:
A new version of diagnostic codes was required for all claims with dates of service on October 1, 2015, and later. As a result, payment was delayed or denied for a significant number of claims due to provider submission of claims with diagnostic codes that were no longer valid. Once providers were able to submit claims with the correct diagnostic codes, our actual costs were ultimately less than expected.
At our New Mexico health plan, we overestimated the impact of several pending high-dollar claims, and our actual costs were ultimately less than expected.
At our Washington health plan, we overpaid certain outpatient facility claims in 2015 when the state converted to a new payment methodology. We did not include an estimate in the reserves for this potential recovery as of December 31, 2015.
At our California health plan, approximately 55,000 new members were added to our Medicaid Expansion product in 2015. For these new members, our actual costs were ultimately less than expected.
10. Debt
As of June 30, 2016, contractual maturities of debt for the years ending December 31 are as follows:
 
Total
 
2016
 
2017
 
2018
 
2019
 
2020
 
Thereafter
 
(In millions)
5.375% Notes
$
700

 
$

 
$

 
$

 
$

 
$

 
$
700

1.125% Convertible Notes
550

 

 

 

 

 
550

 

1.625% Convertible Notes (1)
302

 

 

 

 

 

 
302

 
$
1,552

 
$

 
$

 
$

 
$

 
$
550

 
$
1,002

(1)
The 1.625% Notes have a contractual maturity date in 2044; however, on specified dates beginning in 2018 as described below, holders of the 1.625% Notes may require us to repurchase some or all of the 1.625% Notes, or we may redeem any or all of the 1.625% Notes.

17

Table of Contents

Substantially all of our debt is held at the parent, which is reported in the Other segment. The principal amounts, unamortized discount (net of premium related to the 1.625% Notes), unamortized issuance costs, and net carrying amounts of debt were as follows:
 
Principal Balance
 
Unamortized Discount
 
Unamortized Issuance Costs
 
Net Carrying Amount
 
(In millions)
June 30, 2016:
 
 
 
 
 
 
 
5.375% Notes
$
700

 
$

 
$
10

 
$
690

1.125% Convertible Notes
550

 
84

 
6

 
460

1.625% Convertible Notes
302

 
20

 
4

 
278

 
$
1,552

 
$
104

 
$
20

 
$
1,428

December 31, 2015:
 
 
 
 
 
 
 
5.375% Notes
$
700

 
$

 
$
11

 
$
689

1.125% Convertible Notes
550

 
95

 
7

 
448

1.625% Convertible Notes
302

 
25

 
4

 
273

Other
1

 

 

 
1

 
$
1,553

 
$
120

 
$
22

 
$
1,411

Interest cost recognized relating to our convertible senior notes for the periods presented was as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions)
Contractual interest coupon rate
$
3

 
$
3

 
$
6

 
$
6

Amortization of the discount
8

 
7

 
15

 
14

 
$
11

 
$
10

 
$
21

 
$
20

5.375% Senior Notes due 2022. On November 10, 2015, we completed the private offering of $700 million aggregate principal amount of senior notes (5.375% Notes) due November 15, 2022, unless earlier redeemed. Interest is payable semiannually in arrears on May 15 and November 15. The 5.375% Notes are not convertible into our common stock or any other securities.
The 5.375% Notes are guaranteed by certain of our wholly owned subsidiaries. The 5.375% Notes and the guarantees are effectively subordinated to all existing and future secured debt of us and our guarantors to the extent of the assets securing such debt. In addition, the 5.375% Notes and the guarantees are structurally subordinated to all indebtedness and other liabilities and preferred stock of our subsidiaries that do not guarantee the 5.375% Notes.
We may redeem some or all of the 5.375% Notes at any time, and prior to August 15, 2022, at a price equal to 100% of the principal amount redeemed plus accrued and unpaid interest thereon, plus a "make-whole" premium. Thereafter, we may redeem some or all of the 5.375% Notes at a price equal to 100% of the principal amount redeemed plus accrued and unpaid interest thereon. The 5.375% Notes contain customary non-financial covenants and change of control provisions.
In connection with the issuance and sale of the 5.375% Notes, we entered into a registration rights agreement. Under this agreement, we will use commercially reasonable efforts to register substantially identical notes (the Exchange Notes) with the SEC in 2016. We will then offer such freely tradable Exchange Notes in exchange for the 5.375% Notes. We will pay additional interest on the 5.375% Notes if the Exchange Notes offering is not completed timely.
Credit Facility. In June 2015, we entered into an unsecured $250 million revolving credit facility (Credit Facility). The Credit Facility has a term of five years and all amounts outstanding will be due and payable on June 12, 2020. Subject to obtaining commitments from existing or new lenders and satisfaction of other specified conditions, we may increase the Credit Facility to up to $350 million. As of June 30, 2016, outstanding letters of credit amounting to $6 million reduced the borrowing capacity to $244 million, and no amounts were outstanding under the Credit Facility.
Borrowings under the Credit Facility bear interest based, at our election, on a base rate or an adjusted London Interbank Offered Rate (LIBOR), plus in each case the applicable margin. In addition to interest payable on the principal amount of indebtedness outstanding from time to time under the Credit Facility, we are required to pay a quarterly commitment fee.
Although the Credit Facility is not secured by any of our assets, certain of our wholly owned subsidiaries have jointly and severally guaranteed our obligations under the Credit Facility.

18

Table of Contents

The Credit Facility contains customary non-financial and financial covenants, including a minimum fixed charge coverage ratio, a maximum debt-to-EBITDA ratio and minimum statutory net worth. At June 30, 2016, we were in compliance with all financial covenants under the Credit Facility.
1.125% Cash Convertible Senior Notes due 2020. In February 2013, we issued $550 million aggregate principal amount of 1.125% cash convertible senior notes (1.125% Notes) due January 15, 2020, unless earlier repurchased or converted. Interest is payable semiannually in arrears on January 15 and July 15.
The 1.125% Notes are senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.125% Notes; equal in right of payment to any of our unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities of our subsidiaries.
The 1.125% Notes are convertible only into cash, and not into shares of our common stock or any other securities. The initial conversion rate for the 1.125% Notes is 24.5277 shares of our common stock per $1,000 principal amount of the 1.125% Notes. This represents an initial conversion price of approximately $40.77 per share of our common stock. Upon conversion, in lieu of receiving shares of our common stock, a holder will receive an amount in cash, per $1,000 principal amount of 1.125% Notes, equal to the settlement amount, determined in the manner set forth in the indenture. We may not redeem the 1.125% Notes prior to the maturity date. Holders may convert their 1.125% Notes only under the following circumstances:
during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period immediately after any five consecutive trading day period (the measurement period) in which the trading price per $1,000 principal amount of 1.125% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
upon the occurrence of specified corporate events; or
at any time on or after July 15, 2019 until the close of business on the second scheduled trading day immediately preceding the maturity date.
The 1.125% Notes did not meet the stock price trigger in the quarter ended June 30, 2016; therefore the $460 million carrying amount was reclassified to long-term debt as of June 30, 2016.
The 1.125% Notes contain an embedded cash conversion option (the 1.125% Conversion Option), which was separated from the 1.125% Notes and accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the 1.125% Conversion Option settles or expires. The initial fair value liability of the 1.125% Conversion Option simultaneously reduced the carrying value of the 1.125% Notes (effectively an original issuance discount). This discount is amortized to the 1.125% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. This has resulted in our recognition of interest expense on the 1.125% Notes at an effective rate of approximately 6%. As of June 30, 2016, the 1.125% Notes have a remaining amortization period of 3.5 years. The 1.125% Notes' if-converted value exceeded their principal amount by approximately $180 million and $332 million as of June 30, 2016 and December 31, 2015, respectively.
1.625% Convertible Senior Notes due 2044. In September 2014, we issued $125 million principal amount of 1.625% convertible senior notes (1.625% Notes) due August 15, 2044, unless earlier repurchased, redeemed or converted. Combined with the 1.625% Notes issued in an exchange transaction in 2014, the aggregate principal amount of 1.625% Notes issued was $302 million.
Interest is payable semiannually in arrears on February 15 and August 15. In addition, beginning with the semiannual interest period commencing immediately following the interest payment date on August 15, 2018, contingent interest will accrue on the 1.625% Notes during any semiannual interest period in which certain conditions or events occur, or under certain events of default. For example, additional interest of 0.25% per year will be payable on the 1.625% Notes for any semiannual interest period for which the principal amount of 1.625% Notes outstanding is less than $100 million.
The 1.625% Notes are senior unsecured obligations and rank senior in right of payment to any of our indebtedness that is expressly subordinated in right of payment to the 1.625% Notes; equal in right of payment to any of our unsecured indebtedness that is not subordinated; effectively junior in right of payment to any of our secured indebtedness to the extent of

19

Table of Contents

the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities of our subsidiaries.
The initial conversion rate for the 1.625% Notes is 17.2157 shares of our common stock per $1,000 principal amount of the 1.625% Notes. This represents an initial conversion price of approximately $58.09 per share of our common stock. Upon conversion, we will pay cash and, if applicable, deliver shares of our common stock to the converting holder in an amount per $1,000 principal amount of 1.625% Notes equal to the settlement amount (as defined in the related indenture).
Holders may convert their 1.625% Notes only under the following circumstances:
during any calendar quarter (and only during such calendar quarter), if the last reported sale price of the common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day;
during the five business day period after any five consecutive trading day period (the measurement period) in which the trading price per $1,000 principal amount of 1.625% Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;
upon the occurrence of specified corporate events;
if we call any 1.625% Notes for redemption, at any time until the close of business on the business day immediately preceding the redemption date;
during the period from, and including, May 15, 2018 to the close of business on the business day immediately preceding August 19, 2018; or
at any time on or after February 15, 2044 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 1.625% Notes, in integral multiples of $1,000 principal amount, at the option of the holder regardless of the foregoing circumstances.
As of June 30, 2016, the 1.625% Notes were not convertible.
We may not redeem the 1.625% Notes prior to August 19, 2018. On or after August 19, 2018, we may redeem all or part of the 1.625% Notes for cash, except for the 1.625% Notes we are required to repurchase in connection with a fundamental change or on any specified repurchase date. The redemption price for the 1.625% Notes will equal 100% of the principal amount of the 1.625% Notes being redeemed, plus accrued and unpaid interest. In addition, holders of the 1.625% Notes may require us to repurchase some or all of the 1.625% Notes for cash on August 19, 2018, August 19, 2024, August 19, 2029, August 19, 2034 and August 19, 2039, in each case, at a specified price equal to 100% of the principal amount of the 1.625% Notes to be repurchased, plus accrued and unpaid interest.
Because the 1.625% Notes are net share settled and have cash settlement features, we have allocated the principal amount between a liability component and an equity component. The reduced carrying value on the 1.625% Notes resulted in a debt discount that is amortized back to the 1.625% Notes' principal amount through the recognition of non-cash interest expense over the expected life of the debt. The expected life of the debt is approximately four years, beginning on the issuance date and ending on the first date we may redeem the 1.625% Notes in August 2018. As of June 30, 2016, the 1.625% Notes have a remaining amortization period of 2.1 years. This has resulted in our recognition of interest expense on the 1.625% Notes at an effective rate approximating what we would have incurred had nonconvertible debt with otherwise similar terms been issued, or approximately 5%. The outstanding 1.625% Notes’ if-converted value did not exceed their principal amount at June 30, 2016 and exceeded their principal amount at December 31, 2015 by approximately $10 million. At June 30, 2016 and December 31, 2015, the equity component of the 1.625% Notes, including the impact of deferred taxes, was $23 million.

20

Table of Contents

11. Derivatives
The following table summarizes the fair values and the presentation of our derivative financial instruments (defined and discussed individually below) in the consolidated balance sheets:
 
Balance Sheet Location
 
June 30,
2016
 
December 31,
2015
 
 
 
(In millions)
Derivative asset:
 
 
 
 
 
1.125% Call Option
Current assets: Derivative asset
 
$

 
$
374

 
Non-current assets: Derivative asset
 
$
226

 
$

Derivative liability:
 
 
 
 
 
1.125% Conversion Option
Current liabilities: Derivative liability
 
$

 
$
374

 
Non-current liabilities: Derivative liability
 
$
226

 
$

Our derivative financial instruments do not qualify for hedge treatment; therefore the change in fair value of these instruments is recognized immediately in our consolidated statements of income, and reported in other expense, net. Gains and losses for our derivative financial instruments are presented individually in the consolidated statements of cash flows, supplemental cash flow information.
1.125% Notes Call Spread Overlay. Concurrent with the issuance of the 1.125% Notes in 2013, we entered into privately negotiated hedge transactions (collectively, the 1.125% Call Option) and warrant transactions (collectively, the 1.125% Warrants), with certain of the initial purchasers of the 1.125% Notes (the Counterparties). We refer to these transactions collectively as the Call Spread Overlay. Under the Call Spread Overlay, the cost of the 1.125% Call Option we purchased to cover the cash outlay upon conversion of the 1.125% Notes was reduced by proceeds from the sale of the 1.125% Warrants. Assuming full performance by the Counterparties (and 1.125% Warrants strike prices in excess of the conversion price of the 1.125% Notes), these transactions are intended to offset cash payments in excess of the principal amount of the 1.125% Notes due upon any conversion of the 1.125% Notes.
1.125% Call Option. The 1.125% Call Option, which is indexed to our common stock, is a derivative asset that requires mark-to-market accounting treatment due to cash settlement features until the 1.125% Call Option settles or expires. For further discussion of the inputs used to determine the fair value of the 1.125% Call Option, refer to Note 5, "Fair Value Measurements."
1.125% Conversion Option. The embedded cash conversion option within the 1.125% Notes is accounted for separately as a derivative liability, with changes in fair value reported in our consolidated statements of income until the cash conversion option settles or expires. For further discussion of the inputs used to determine the fair value of the 1.125% Conversion Option, refer to Note 5, "Fair Value Measurements."
As of June 30, 2016, the 1.125% Call Option and the 1.125% Conversion Option were classified as a non-current asset and non-current liability, respectively, because the 1.125% Notes may not be converted within 12 months of June 30, 2016, as described in Note 10, "Debt."
12. Stockholders' Equity
Stockholders' equity increased $84 million during the six months ended June 30, 2016 compared with stockholders' equity at December 31, 2015. The increase was primarily due to net income of $57 million, $8 million of other comprehensive income and $19 million related to employee stock transactions.
1.125% Warrants. In connection with the Call Spread Overlay transaction described in Note 11, "Derivatives," in 2013, we issued 13,490,236 warrants with a strike price of $53.8475 per share. The number of warrants and the strike price are subject to adjustment under certain circumstances. If the market value per share of our common stock exceeds the strike price of the 1.125% Warrants on any trading day during the 160 trading day measurement period (beginning on April 15, 2020) under the 1.125% Warrants, we will be obligated to issue to the Counterparties a number of shares equal in value to the product of the amount by which such market value exceeds such strike price and 1/160th of the aggregate number of shares of our common stock underlying the 1.125% Warrants, subject to a share delivery cap. The 1.125% Warrants could separately have a dilutive effect to the extent that the market value per share of our common stock exceeds the applicable strike price of the 1.125% Warrants. Refer to Note 3, "Net Income per Share," for dilution information for the periods presented. We will not receive any additional proceeds if the 1.125% Warrants are exercised.

21

Table of Contents

Securities Repurchase Program. Effective as of December 16, 2015, our board of directors authorized the repurchase of up to $50 million in aggregate of our common stock or senior notes. This repurchase program extends through December 31, 2016.
Stock Incentive Plans. In connection with our equity incentive plans and employee stock purchase plan, approximately 446,000 shares of common stock vested, net of shares used to settle employees’ income tax obligations, during the six months ended June 30, 2016.
Charged to general and administrative expenses, total share-based compensation expense was as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions)
Restricted stock and performance awards
$
8

 
$
2

 
$
13

 
$
7

Employee stock purchase plan and stock options
1

 
1

 
3

 
2

 
$
9

 
$
3

 
$
16

 
$
9

As of June 30, 2016, there was $45 million of total unrecognized compensation expense related to unvested restricted share awards, including those with performance conditions, which we expect to recognize over a remaining weighted-average period of 1.8 years. This unrecognized compensation cost assumes an estimated forfeiture rate of 4.3% for non-executive employees as of June 30, 2016.
Restricted stock. Restricted and performance stock activity for the six months ended June 30, 2016 is summarized below:
 
Shares
 
Weighted
Average
Grant Date
Fair Value
 
(In thousands)
 
 
Unvested balance as of December 31, 2015
1,035

 
$
46.68

Granted
505

 
64.22

Vested
(329
)
 
41.45

Forfeited
(19
)
 
52.01

Unvested balance as of June 30, 2016
1,192

 
55.47

The total fair value of restricted and performance awards granted during the six months ended June 30, 2016 and 2015 was $32 million and $27 million, respectively. The total fair value of restricted awards, including those with performance and market conditions, which vested during the six months ended June 30, 2016 and 2015 was $21 million and $24 million, respectively.
As of June 30, 2016, there were approximately 603,000 unvested restricted shares outstanding which contained one or more performance measures. In the event the vesting conditions are not achieved, the awards will lapse. Based on our assessment as of June 30, 2016, we expect the performance conditions for approximately 425,000 of these outstanding restricted share awards to be met in full.
13. Segment Information
We have three reportable segments. These segments include our Health Plans and Molina Medicaid Solutions segments, which comprise the vast majority of our operations, and our Other segment. As of December 31, 2015, we changed our reporting structure as a result of the Pathways acquisition in November 2015, which is reported in Other.
Our reportable segments are consistent with how we currently manage the business and view the markets we serve. The Health Plans segment consists of our health plans and our direct delivery business. Our health plans are operating segments that have been aggregated for reporting purposes because they share similar economic characteristics. The Molina Medicaid Solutions segment provides Medicaid management information system (MMIS) design, development, and implementation; business process outsourcing solutions; hosting services; and information technology support services to state Medicaid agencies. Our Other segment includes other businesses, such as our Pathways behavioral health and social services provider, that do not meet the quantitative thresholds for a reportable segment as defined by GAAP, as well as corporate amounts not allocated to other reportable segments.
Gross margin is the appropriate earnings measure for our reportable segments, based on how our chief operating decision maker currently reviews results, assesses performance, and allocates resources.

22

Table of Contents

Gross margin for our Health Plans segment is referred to as "Medical margin," and for our Molina Medicaid Solutions and Other segments, as "Service margin." Medical margin represents the amount earned by the Health Plans segment after medical costs are deducted from premium revenue. The medical care ratio represents the amount of medical care costs as a percentage of premium revenue, and is one of the key metrics used to assess the performance of the Health Plans segment. Therefore, the underlying medical margin is the most important measure of earnings reviewed by the chief operating decision maker. The service margin is equal to service revenue minus cost of service revenue.
 
 
Health Plans
 
Molina Medicaid Solutions
 
Other
 
Consolidated
 
 
 
 
 
 
 
(In millions)
Three Months Ended June 30, 2016
 
 
 
 
 
 
 
 
Total revenue (1)
 
$
4,223

 
$
46

 
$
90

 
$
4,359

Gross margin
 
435

 
5

 
14

 
454

 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2016
 
 
 
 
 
 
 
 
Total revenue (1)
 
$
8,424

 
$
98

 
$
180

 
$
8,702

Gross margin
 
842

 
11

 
21

 
874

 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2015
 
 
 
 
 
 
 
 
Total revenue (1)
 
$
3,477

 
$
47

 
$
1

 
$
3,525

Gross margin
 
375

 
14

 

 
389

 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2015
 
 
 
 
 
 
 
 
Total revenue (1)
 
$
6,593

 
$
99

 
$
4

 
$
6,696

Gross margin
 
710

 
30

 

 
740

 
 
 
 
 
 
 
 
 
Total Assets
 
 
 
 
 
 
 
 
June 30, 2016
 
$
5,521

 
$
252

 
$
1,429

 
$
7,202

December 31, 2015
 
4,707

 
213

 
1,656

 
6,576

______________________
(1)
Total revenue consists primarily of premium revenue for the Health Plans segment, and service revenue for the Molina Medicaid Solutions and Other segments.
The following table reconciles gross margin by segment to consolidated income before income tax expense:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
 
(In millions)
Gross margin:
 
 
 
 
 
 
 
Health Plans
$
435

 
$
375

 
$
842

 
$
710

Molina Medicaid Solutions
5

 
14

 
11

 
30

Other
14

 

 
21

 

Total gross margin
454

 
389

 
874

 
740

Add: other operating revenues (1)
195

 
174

 
403

 
322

Less: other operating expenses (2)
(544
)
 
(447
)
 
(1,083
)
 
(864
)
Operating income
105

 
116

 
194

 
198

Other expenses, net
(25
)
 
(15
)
 
(50
)
 
(30
)
Income before income tax expense
$
80

 
$
101

 
$
144

 
$
168


23

Table of Contents

______________________
(1)
Other operating revenues include premium tax revenue, health insurer fee revenue, investment income and other revenue.
(2)
Other operating expenses include general and administrative expenses, premium tax expenses, health insurer fee expenses and depreciation and amortization.
14. Commitments and Contingencies
Legal Proceedings. The health care and business process outsourcing industries are subject to numerous laws and regulations of federal, state, and local governments. Compliance with these laws and regulations can be subject to government review and interpretation, as well as regulatory actions unknown and unasserted at this time. Penalties associated with violations of these laws and regulations include significant fines and penalties, exclusion from participating in publicly funded programs, and the repayment of previously billed and collected revenues.
We are involved in legal actions in the ordinary course of business, some of which seek monetary damages, including claims for punitive damages, which are not covered by insurance. We have accrued liabilities for certain matters for which we deem the loss to be both probable and estimable. Although we believe that our estimates of such losses are reasonable, these estimates could change as a result of further developments of these matters. The outcome of legal actions is inherently uncertain and such pending matters for which accruals have not been established have not progressed sufficiently through discovery and/or development of important factual information and legal issues to enable us to estimate a range of possible loss, if any. While it is not possible to accurately predict or determine the eventual outcomes of these items, an adverse determination in one or more of these pending matters could have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
State of Louisiana. On June 26, 2014, the state of Louisiana filed a Petition for Damages against Molina Medicaid Solutions, Molina Healthcare, Inc., Unisys Corporation, and Paramax Systems Corporation, a subsidiary of Unisys, in the Parish of Baton Rouge, 19th Judicial District, versus number 631612. The Petition alleges that between 1989 and 2012, the defendants utilized an incorrect reimbursement formula for the payment of pharmaceutical claims. We believe we have several meritorious defenses to the claims of the state, and any liability for the alleged claims is not currently probable and is not reasonably estimable.
United States of America, ex rel., Anita Silingo v. Mobile Medical Examination Services, Inc., et al. On or around October 14, 2014, Molina Healthcare of California, Molina Healthcare of California Partner Plan, Inc., Mobile Medical Examination Services, Inc. (MedXM), and other health plan defendants were served with a Complaint previously filed under seal in the Central District Court of California by Relator, Anita Silingo, Case No. SACV13-1348-FMO(SHx). The Complaint alleges that MedXM improperly modified medical records and otherwise took inappropriate steps to increase members’ risk adjustment scores, and that the defendants, including Molina Healthcare of California and Molina Healthcare of California Partner Plan, Inc., purportedly turned a “blind eye” to these unlawful practices. On October 22, 2015, the Relator filed a third amended complaint. On July 11, 2016, the District Court dismissed with prejudice the third amended complaint, without leave to amend, thereby concluding this litigation.
Rodriguez v. Providence Community Corrections.  On October 1, 2015, seven individuals, on behalf of themselves and all others similarly situated, filed a complaint in the District Court for the Middle District of Tennessee, Nashville Division, Case No. 3:15-cv-01048 (the "Rodriquez Litigation"), against Providence Community Corrections, Inc. (now known as Pathways Community Corrections, Inc., or "PCC"). Rutherford County, Tennessee formerly contracted with PCC for the administration of misdemeanor probation, which involved the collection of court costs and fees from probationers. The complaint alleges, among other things, that PCC illegally assessed fees and surcharges against probationers and made improper threats of arrest and probation revocation if the probationers did not pay such amounts. The plaintiffs in the Rodriguez Litigation seek alleged compensatory, treble, and punitive damages, plus attorneys’ fees, for alleged federal and state constitutional violations, as well as alleged violations of the Racketeer Influenced and Corrupt Organization Act. PCC’s agreement with Rutherford County terminated effective December 29, 2015. On November 1, 2015, one month after the Rodriguez Litigation had been commenced, we acquired PCC from The Providence Service Corporation ("Providence") pursuant to a membership interest purchase agreement. We have notified Providence that, for its failure to disclose the Rodriguez Litigation, we intend to seek indemnification from Providence under the membership interest purchase agreement for any liability arising from the Rodriguez Litigation.
Provider Claims. Many of our medical contracts are complex in nature and may be subject to differing interpretations regarding amounts due for the provision of various services. Such differing interpretations have led certain medical providers to pursue us for additional compensation. The claims made by providers in such circumstances often involve issues of contract compliance, interpretation, payment methodology, and intent. These claims often extend to services provided by the providers over a number of years.

24

Table of Contents

Various providers have contacted us seeking additional compensation for claims that we believe to have been settled. These matters, when finally concluded and determined, will not, in our opinion, have a material adverse effect on our business, consolidated financial position, results of operations, or cash flows.
States' Budgets. From time to time, the states in which our health plans operate may experience financial difficulties, which could lead to delays in premium payments. It has been our practice in the past to continue to serve our members and pay health care providers for services rendered in circumstances where state (or Commonwealth) governments are temporarily unable to pay us, so long as we continue to believe that such state (or Commonwealth) governments will ultimately pay us.
Regulatory Capital and Dividend Restrictions. Our health plans, which are operated by our respective wholly owned subsidiaries in those states, are subject to state laws and regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state. Regulators in some states may also attempt to enforce capital requirements upon us that require the retention of net worth in excess of amounts formally required by statute or regulation. Such statutes, regulations and informal capital requirements also restrict the timing, payment, and amount of dividends and other distributions that may be paid to us as the sole stockholder. To the extent our subsidiaries must comply with these regulations, they may not have the financial flexibility to transfer funds to us.
Based on current statutes and regulations, the net assets in these subsidiaries (after intercompany eliminations) which may not be transferable to us in the form of loans, advances, or cash dividends was approximately $1,299 million at June 30, 2016, and $1,229 million at December 31, 2015. Because of the statutory restrictions that inhibit the ability of our health plans to transfer net assets to us, the amount of retained earnings readily available to pay dividends to our stockholders is generally limited to cash, cash equivalents and investments held by the parent company – Molina Healthcare, Inc. Such cash, cash equivalents and investments amounted to $466 million and $612 million as of June 30, 2016 and December 31, 2015, respectively.
The National Association of Insurance Commissioners (NAIC) adopted rules effective December 31, 1998, which, if implemented by the states, set minimum capitalization requirements for insurance companies, HMOs, and other entities bearing risk for health care coverage. The requirements take the form of risk-based capital (RBC) rules which may vary from state to state.
As of June 30, 2016, our health plans had aggregate statutory capital and surplus of approximately $1,384 million compared with the required minimum aggregate statutory capital and surplus of approximately $854 million. All of our health plans were in compliance with the minimum capital requirements at June 30, 2016. We have the ability and commitment to provide additional capital to each of our health plans when necessary to ensure that statutory capital and surplus continue to meet regulatory requirements.
15. Related Party Transactions
Our California health plan has entered into a provider agreement with Pacific Healthcare IPA (Pacific), which is 50% owned by the brother-in-law of Dr. J. Mario Molina, our Chief Executive Officer, and John C. Molina, our Chief Financial Officer. Under the terms of this provider agreement, the California health plan pays Pacific for medical care Pacific provides to health plan members. For the three and six months ended June 30, 2016 and 2015, the amounts paid to Pacific were insignificant.
Refer to Note 16, "Variable Interest Entities (VIEs)," for a discussion of the Joseph M. Molina, M.D. Professional Corporations.
16Variable Interest Entities (VIEs)
Joseph M. Molina M.D., Professional Corporations
The Joseph M. Molina, M.D. Professional Corporations (JMMPC) were created to further advance our direct delivery business. JMMPC's primary shareholder is Dr. J. Mario Molina, our chief executive officer, president, and chairman of the board of directors. Dr. Molina is paid no salary and receives no dividends in connection with his work for, or ownership of, JMMPC. JMMPC provides primary care medical services through its employed physicians and other medical professionals. JMMPC also provides certain specialty referral services to our California health plan members through a contracted provider network. Substantially all of the individuals served by JMMPC are members of our health plans. JMMPC does not have agreements to provide professional medical services with any other entities.
Our wholly owned subsidiary, Molina Medical Management, Inc. (MMM), has entered into services agreements with JMMPC to provide clinic facilities, clinic administrative support staff, patient scheduling services and medical supplies to JMMPC. The services agreements were designed such that JMMPC will operate at break even, ensuring the availability of quality care and access for our health plan members. The services agreements provide that the administrative fees charged to JMMPC by MMM are reviewed annually to assure the achievement of this goal.
Separately, our California, Florida, New Mexico, Utah and Washington health plans have entered into primary care services agreements with JMMPC. These agreements direct our health plans to perform a monthly reconciliation, to either fund

25

Table of Contents

JMMPC's operating deficits, or receive JMMPC's operating surpluses, such that JMMPC will derive no profit or loss. Because the MMM services agreements described above mitigate the likelihood of significant operating deficits or surpluses, such monthly reconciliation amounts are generally insignificant. For the three months ended June 30, 2016 and 2015, our health plans paid $31 million and $27 million, respectively, to JMMPC for health care services provided by JMMPC to the health plans' members. For the six months ended June 30, 2016 and 2015, our health plans paid $61 million and $52 million, respectively, to JMMPC for health care services provided by JMMPC to the health plans' members.
We have determined that JMMPC is a VIE, and that we are its primary beneficiary. We have reached this conclusion under the power and benefits criterion model according to GAAP. Specifically, we have the power to direct the activities that most significantly affect JMMPC's economic performance, and the obligation to absorb losses or right to receive benefits that are potentially significant to the VIE, under the agreements described above. Because we are its primary beneficiary, we have consolidated JMMPC. JMMPC's assets may be used to settle only JMMPC's obligations, and JMMPC's creditors have no recourse to the general credit of Molina Healthcare, Inc. As of June 30, 2016, JMMPC had total assets of $13 million, and total liabilities of $13 million. As of December 31, 2015, JMMPC had total assets of $17 million, and total liabilities of $17 million.
Our maximum exposure to loss as a result of our involvement with JMMPC is generally limited to the amounts needed to fund JMMPC's ongoing payroll, employee benefits and medical care costs associated with JMMPC's specialty referral activities. We believe that such loss exposures will be immaterial to our consolidated operating results and cash flows for the foreseeable future.
17. Supplemental Condensed Consolidating Financial Information

The 5.375% Notes are guaranteed by certain of our wholly owned subsidiaries. The 5.375% Notes and the guarantees are effectively subordinated to all existing and future secured debt of us and our guarantors to the extent of the assets securing such debt. In addition, the 5.375% Notes and the guarantees are structurally subordinated to all indebtedness and other liabilities and preferred stock of our subsidiaries that do not guarantee the 5.375% Notes. The 5.375% Notes are fully and unconditionally guaranteed on a joint and several basis, with exceptions considered customary for such guarantees, limited to the release of the guarantee when a subsidiary guarantor's capital stock is sold, or a sale of all of the subsidiary guarantor's assets used in its operations. The following condensed consolidating financial statements present Molina Healthcare, Inc. (as parent guarantor), the subsidiary guarantors, the subsidiary non-guarantors and eliminations. These condensed consolidating financial statements have been prepared and presented in accordance with SEC Regulation S-X Rule 3-10, "Financial Statements of Guarantors and Issuers of Guaranteed Securities Registered or Being Registered."



26

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
 
June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(in millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
214

 
$
29

 
$
2,102

 
$

 
$
2,345

Investments
252

 

 
1,716

 

 
1,968

Receivables
3

 
87

 
922

 

 
1,012

Income tax refundable
37

 
3

 
(17
)
 

 
23

Due from (to) affiliates
99

 
(9
)
 
(90
)
 

 

Prepaid expenses and other current assets
50

 
13

 
134

 

 
197

Total current assets
655

 
123

 
4,767

 

 
5,545

Property, equipment, and capitalized software, net
305

 
67

 
76

 

 
448

Deferred contract costs

 
80

 

 

 
80

Intangible assets, net
8

 
23

 
115

 

 
146

Goodwill
51

 
228

 
332

 

 
611

Restricted investments

 

 
107

 

 
107

Investment in subsidiaries
2,346

 
1

 

 
(2,347
)
 

Derivative asset
226

 

 

 

 
226

Other assets
47

 
3

 
5

 
(16
)
 
39

 
$
3,638

 
$
525

 
$
5,402

 
$
(2,363
)
 
$
7,202

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$

 
$

 
$
1,766

 
$

 
$
1,766

Amounts due government agencies

 

 
1,238

 

 
1,238

Accounts payable and accrued liabilities
128

 
31

 
378

 

 
537

Deferred revenue

 
38

 
66

 

 
104

Current portion of long-term debt
1

 

 

 

 
1

Total current liabilities
129

 
69

 
3,448

 

 
3,646

Long-term debt
1,626

 

 
16

 
(16
)
 
1,626

Deferred income taxes
(3
)
 
40

 
(12
)
 

 
25

Derivative liability
226

 

 

 

 
226

Other long-term liabilities
19

 
2

 
17

 

 
38

Total liabilities
1,997

 
111

 
3,469

 
(16
)
 
5,561

Total stockholders’ equity
1,641

 
414

 
1,933

 
(2,347
)
 
1,641

 
$
3,638

 
$
525

 
$
5,402

 
$
(2,363
)
 
$
7,202



27

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
 
December 31, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(in millions)
ASSETS
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
360

 
$
42

 
$
1,927

 
$

 
$
2,329

Investments
252

 

 
1,549

 

 
1,801

Receivables

 
79

 
518

 

 
597

Income tax refundable
7

 
3

 
3

 

 
13

Intercompany
86

 
(4
)
 
(82
)
 

 

Prepaid expenses and other current assets
46

 
11

 
136

 
(1
)
 
192

Derivative asset
374

 

 

 

 
374

Total current assets
1,125

 
131

 
4,051

 
(1
)
 
5,306

Property, equipment, and capitalized software, net
267

 
52

 
74

 

 
393

Deferred contract costs

 
81

 

 

 
81

Goodwill and intangible assets, net
61

 
246

 
334

 

 
641

Restricted investments

 

 
109

 

 
109

Investment in subsidiaries, net
2,205

 
1

 

 
(2,206
)
 

Deferred income taxes
23

 
(35
)
 
30

 

 
18

Other assets
36

 
2

 
6

 
(16
)
 
28

 
$
3,717

 
$
478

 
$
4,604

 
$
(2,223
)
 
$
6,576

 
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
 
 
 
 
 
 
 
 
 
Medical claims and benefits payable
$

 
$
3

 
$
1,682

 
$

 
$
1,685

Amounts due government agencies

 
1

 
728

 

 
729

Accounts payable and accrued liabilities
157

 
35

 
170

 

 
362

Deferred revenue

 
34

 
189

 

 
223

Current portion of long-term debt
449

 

 

 

 
449

Derivative liability
374

 

 

 

 
374

Total current liabilities
980

 
73

 
2,769

 

 
3,822

Long-term debt
1,160

 

 
16

 
(16
)
 
1,160

Other long-term liabilities
20

 
2

 
16

 
(1
)
 
37

Total liabilities
2,160

 
75

 
2,801

 
(17
)
 
5,019

Total stockholders’ equity
1,557

 
403

 
1,803

 
(2,206
)
 
1,557

 
$
3,717

 
$
478

 
$
4,604

 
$
(2,223
)
 
$
6,576



28

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF INCOME
 
Three Months Ended June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
261

 
$
137

 
$
4,235

 
$
(274
)
 
$
4,359

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
19

 
11

 
3,578

 
(14
)
 
3,594

Cost of service revenue

 
106

 
10

 

 
116

General and administrative expenses
219

 
16

 
376

 
(260
)
 
351

Premium tax expenses

 

 
109

 

 
109

Health insurer fee expenses

 

 
50

 

 
50

Depreciation and amortization
23

 
3

 
8

 

 
34

Total expenses
261

 
136

 
4,131

 
(274
)
 
4,254

Operating income

 
1

 
104

 

 
105

Interest expense
25

 

 

 

 
25

(Loss) income before income taxes
(25
)
 
1

 
104

 

 
80

Income tax (benefit) expense
(12
)
 

 
59

 

 
47

Net (loss) income before equity in earnings of subsidiaries
(13
)
 
1

 
45

 

 
33

Equity in net earnings of subsidiaries
46

 

 

 
(46
)
 

Net income
$
33

 
$
1

 
$
45

 
$
(46
)
 
$
33

 
Three Months Ended June 30, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
224

 
$
59

 
$
3,478

 
$
(236
)
 
$
3,525

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
14

 
9

 
2,920

 
(14
)
 
2,929

Cost of service revenue

 
33

 

 

 
33

General and administrative expenses
190

 
7

 
312

 
(222
)
 
287

Premium tax expenses

 

 
95

 

 
95

Health insurer fee expenses

 

 
40

 

 
40

Depreciation and amortization
21

 

 
4

 

 
25

Total expenses
225

 
49

 
3,371

 
(236
)
 
3,409

Operating (loss) income
(1
)
 
10

 
107

 

 
116

Interest expense
15

 

 

 

 
15

(Loss) income before income taxes
(16
)
 
10

 
107

 

 
101

Income tax (benefit) expense
(12
)
 
4

 
70

 

 
62

Net (loss) income before equity in earnings of subsidiaries
(4
)
 
6

 
37

 

 
39

Equity in net earnings of subsidiaries
43

 

 

 
(43
)
 

Net income
$
39

 
$
6

 
$
37

 
$
(43
)
 
$
39










29

Table of Contents


MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF INCOME

 
Six Months Ended June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
512

 
$
277

 
$
8,450

 
$
(537
)
 
$
8,702

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
31

 
22

 
7,157

 
(28
)
 
7,182

Cost of service revenue

 
221

 
22

 

 
243

General and administrative expenses
436

 
23

 
741

 
(509
)
 
691

Premium tax expenses

 

 
218

 

 
218

Health insurer fee expenses

 

 
108

 

 
108

Depreciation and amortization
45

 
6

 
15

 

 
66

Total expenses
512

 
272

 
8,261

 
(537
)
 
8,508

Operating income

 
5

 
189

 

 
194

Interest expense
50

 

 

 

 
50

(Loss) income before income taxes
(50
)
 
5

 
189

 

 
144

Income tax (benefit) expense
(28
)
 
2

 
113

 

 
87

Net (loss) income before equity in earnings of subsidiaries
(22
)
 
3

 
76

 

 
57

Equity in net earnings of subsidiaries
79

 

 

 
(79
)
 

Net income
$
57

 
$
3

 
$
76

 
$
(79
)
 
$
57

 
Six Months Ended June 30, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Revenue:
 
 
 
 
 
 
 
 
 
Total revenue
$
443

 
$
123

 
$
6,596

 
$
(466
)
 
$
6,696

Expenses:
 
 
 
 
 
 
 
 
 
Medical care costs
26

 
17

 
5,547

 
(25
)
 
5,565

Cost of service revenue

 
69

 

 

 
69

General and administrative expenses
377

 
15

 
592

 
(441
)
 
543

Premium tax expenses

 

 
190

 

 
190

Health insurer fee expenses

 

 
81

 

 
81

Depreciation and amortization
41

 
1

 
8

 

 
50

Total expenses
444

 
102

 
6,418

 
(466
)
 
6,498

Operating (loss) income
(1
)
 
21

 
178

 

 
198

Interest expense
30

 

 

 

 
30

(Loss) income before income taxes
(31
)
 
21

 
178

 

 
168

Income tax (benefit) expense
(7
)
 
8

 
100

 

 
101

Net (loss) income before equity in earnings of subsidiaries
(24
)
 
13

 
78

 

 
67

Equity in net earnings of subsidiaries
91

 

 

 
(91
)
 

Net income
$
67

 
$
13

 
$
78

 
$
(91
)
 
$
67



30

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME

 
Three Months Ended June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
33

 
$
1

 
$
45

 
$
(46
)
 
$
33

Other comprehensive income (loss), net of tax
2

 

 
2

 
(2
)
 
2

Comprehensive income
$
35

 
$
1

 
$
47

 
$
(48
)
 
$
35

 
Three Months Ended June 30, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
39

 
$
6

 
$
37

 
$
(43
)
 
$
39

Other comprehensive (loss) income, net of tax
(2
)
 

 
(2
)
 
2

 
(2
)
Comprehensive income
$
37

 
$
6

 
$
35

 
$
(41
)
 
$
37

 
Six Months Ended June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
57

 
$
3

 
$
76

 
$
(79
)
 
$
57

Other comprehensive income (loss), net of tax
8

 

 
7

 
(7
)
 
8

Comprehensive income
$
65

 
$
3

 
$
83

 
$
(86
)
 
$
65

 
Six Months Ended June 30, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Net income
$
67

 
$
13

 
$
78

 
$
(91
)
 
$
67

Other comprehensive (loss) income, net of tax
(1
)
 

 
(1
)
 
1

 
(1
)
Comprehensive income
$
66

 
$
13

 
$
77

 
$
(90
)
 
$
66



31

Table of Contents

MOLINA HEALTHCARE, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
 
Six Months Ended June 30, 2016
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(21
)
 
16

 
283

 

 
$
278

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(67
)
 

 
(907
)
 

 
(974
)
Proceeds from sales and maturities of investments
67

 

 
745

 

 
812

Purchases of property, equipment and capitalized software
(73
)
 
(22
)
 
(7
)
 

 
(102
)
Decrease in restricted investments

 

 
5

 

 
5

Net cash paid in business combinations

 
(7
)
 
(1
)
 

 
(8
)
Capital contributions to subsidiaries
(106
)
 
8

 
98

 

 

Dividends received from subsidiaries
50

 

 
(50
)
 

 

Change in amounts due to/from affiliates
(13
)
 
5

 
8

 

 

Other, net
5

 
(12
)
 
1

 

 
(6
)
Net cash used in investing activities
(137
)
 
(28
)
 
(108
)
 

 
(273
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from employee stock plans
10

 

 

 

 
10

Other, net
2

 
(1
)
 

 

 
1

Net cash provided by (used in) financing activities
12

 
(1
)
 

 

 
11

Net (decrease) increase in cash and cash equivalents
(146
)
 
(13
)
 
175

 

 
16

Cash and cash equivalents at beginning of period
360

 
42

 
1,927

 

 
2,329

Cash and cash equivalents at end of period
$
214

 
$
29

 
$
2,102

 
$

 
$
2,345

 
Six Months Ended June 30, 2015
 
Parent Guarantor
 
Other Guarantors
 
Non-Guarantors
 
Eliminations
 
Consolidated
 
(In millions)
Operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
$
48

 
51

 
549

 

 
$
648

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of investments
(10
)
 

 
(983
)
 

 
(993
)
Proceeds from sales and maturities of investments
65

 

 
476

 

 
541

Purchases of property, equipment and capitalized software
(46
)
 
(9
)
 
(11
)
 

 
(66
)
Decrease in restricted investments

 

 
(14
)
 

 
(14
)
Net cash paid in business combinations

 

 
(8
)
 

 
(8
)
Capital contributions to subsidiaries
(77
)
 
4

 
73

 

 

Dividends received from subsidiaries
42

 
(17
)
 
(25
)
 

 

Change in amounts due to/from affiliates
(15
)
 
3

 
12

 

 

Other, net
(1
)
 
(16
)
 

 

 
(17
)
Net cash used in investing activities
(42
)
 
(35
)
 
(480
)
 

 
(557
)
Financing activities:
 
 
 
 
 
 
 
 
 
Proceeds from commons stock offering, net of issuance costs
373

 

 

 

 
373

Proceeds from employee stock plans
8

 

 

 

 
8

Other, net
3

 

 

 

 
3

Net cash provided by financing activities
384

 

 

 

 
384

Net increase in cash and cash equivalents
390

 
16

 
69

 

 
475

Cash and cash equivalents at beginning of period
75

 
15

 
1,449

 

 
1,539

Cash and cash equivalents at end of period
$
465

 
$
31

 
$
1,518

 
$

 
$
2,014


32

Table of Contents



33

Exhibit





























CONSOLIDATED FINANCIAL STATEMENTS
PROVIDENCE HUMAN SERVICES, LLC
Year Ended December 31, 2014
With Report of Independent Registered Public Accounting Firm




PROVIDENCE HUMAN SERVICES, LLC

Consolidated Financial Statements

Contents
Report of Independent Registered Public Accounting Firm
1
 
 
Consolidated Financial Statements
 
 
 
Consolidated Balance Sheet
2
Consolidated Statement of Comprehensive Loss and Member's Equity
3
Consolidated Statement of Cash Flows
4
Notes to Consolidated Financial Statements
5




REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Stockholders of
Molina Healthcare, Inc.
We have audited the accompanying consolidated balance sheet of Providence Human Services, LLC (the Company) as of December 31, 2014, and the related consolidated statements of comprehensive loss and member's equity, and cash flows for the year ended December 31, 2014. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Company’s internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of Providence Human Services, LLC at December 31, 2014, and the consolidated results of its operations and its cash flows for the year ended December 31, 2014, in conformity with U.S. generally accepted accounting principles.


/s/ ERNST & YOUNG LLP
Los Angeles, California
July 28, 2016


1


PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED BALANCE SHEET
December 31, 2014
(In thousands)
ASSETS
Current assets:
 
Cash and cash equivalents
$
26,322

Accounts receivable, net of allowance of $4,756
42,389

Prepaid expenses and other current assets
2,969

Total current assets
71,680

Property and equipment, net
11,435

Goodwill
6,414

Intangible assets, net
2,276

Deferred income taxes
178

Other assets
990

 
$
92,973

LIABILITIES AND MEMBER'S EQUITY
Current liabilities:
 
Accrued expenses
$
19,584

Accounts payable
2,820

Deferred revenue
472

Income taxes payable
288

Total current liabilities
23,164

Note payable
600

Other long-term liabilities
1,669

Total liabilities
25,433

Member's equity
67,540

 
$
92,973

 

See accompanying notes.

2


PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS AND MEMBER'S EQUITY
Year Ended December 31, 2014
(In thousands)
 
Service revenue
$
361,670

Operating expenses:
 
Service expense
202,871

General and administrative expense
170,276

Provision for doubtful accounts
3,566

Depreciation and amortization
2,553

Asset impairment charge
2,815

Total operating expenses
382,081

Loss before income taxes
(20,411
)
Provision for income taxes
300

Comprehensive loss
$
(20,711
)
 
 
Member's equity, beginning
$
49,161

Comprehensive loss
(20,711
)
Capital contributions from The Providence Service Corporation parent
39,090

Member's equity, ending
$
67,540

 
See accompanying notes.

3


PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED STATEMENT OF CASH FLOWS
Year Ended December 31, 2014
(In thousands)
Operating activities:
 
Comprehensive loss
$
(20,711
)
Adjustments to reconcile comprehensive loss to net cash provided by operating activities:
 
Intercompany transactions forgiven by The Providence Service Corporation parent
29,339

Depreciation and amortization
2,553

Provision for doubtful accounts
3,566

Deferred income taxes
11

Asset impairment charge
2,815

Changes in operating assets and liabilities, net of effects from acquisitions:
 
Accounts receivable, net
(12,093
)
Prepaid expenses and other current assets
(48
)
Accrued expenses
4,401

Accounts payable
(145
)
Deferred revenue
(1,133
)
Income taxes
288

Net cash provided by operating activities
8,843

Investing activities:
 
Purchases of equipment
(2,417
)
Other, net
(244
)
Net cash used in investing activities
(2,661
)
Net increase in cash and cash equivalents
6,182

Cash and cash equivalents at beginning of period
20,140

Cash and cash equivalents at end of period
$
26,322


Supplemental cash flow information:
Details of business combinations:
 
Fair value of:
 
Assets acquired
$
10,553

Note payable to seller
(600
)
Contingent consideration liability incurred
(202
)
Net cash contributed by The Providence Service Corporation parent for the Company's business combinations
$
9,751







See accompanying notes.


4



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)




1. Basis of Presentation
Organization and Operations
Providence Human Services, LLC is a Delaware limited liability company (the Company, or PHS), in which The Providence Service Corporation (the PSC Parent) is the sole member. The Company provides accessible, outcome-based behavioral/mental health and social services with operations in 23 states and the District of Columbia. The Company's counselors, social workers and behavioral health professionals work with clients, primarily in the client's home or community, who are eligible for government assistance due to income level, disabilities or court order.
On November 1, 2015, 100% of the Company's member interest was acquired from the PSC Parent by Molina Healthcare, Inc. (Molina), and on November 10, 2015, Molina completed the private offering of $700,000 aggregate principal amount of 5.375% senior notes due November 15, 2022 (the 5.375% Notes). The 5.375% Notes are guaranteed by the Company and certain of its wholly owned subsidiaries. See Note 10, "Supplemental Condensed Consolidating Financial Information," for more information.
Segment Information
The Company's subsidiaries share similar characteristics with regard to the clients they serve, the nature of services provided, and the method by which services are delivered. The Company's subsidiaries are also subject to similar regulatory environments and long-term economic prospects; as such, the Company presents one reportable segment.
Consolidation
The consolidated financial statements include the accounts of Providence Human Services, LLC and its subsidiaries. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition.
Seasonality
The Company experiences lower client demand for its home and community based services during the holiday and summer seasons which generally results in lower revenue during those periods. However, operating expenses do not vary significantly with these changes. As a result, the Company typically experiences lower operating margins during the holiday and summer seasons.
Use of Estimates
The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:
Revenue recognition;
Accounts receivable and allowance for doubtful accounts;
Accounting for business combinations, including goodwill and other intangible assets;
The determination of valuation allowances for deferred tax assets; and

5



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



The determination of unrecognized tax benefits.  
Evaluation of Subsequent Events
The Company has evaluated subsequent events through the date these financial statements were available to be issued.

2. Significant Accounting Policies
Cash and Cash Equivalents
Cash and cash equivalents consist of cash and short-term, highly liquid investments that are both readily convertible into known amounts of cash and have a maturity of three months or less on the date of purchase.
Fair Value of Financial Instruments
The carrying amounts of current assets, current liabilities and the note payable approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment.
Accounts Receivable and Allowance for Doubtful Accounts
The Company records all accounts receivable amounts at their contracted amount, less an allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts at an amount it estimates to be sufficient to cover the risk that an account will not be collected. The Company regularly evaluates its accounts receivable, especially receivables that are past due, and reassesses its allowance for doubtful accounts based on specific client collection issues. In circumstances where the Company is aware of a specific payer’s inability to meet its financial obligation, the Company records a specific allowance for doubtful accounts to reduce the net recognized receivable to the amount the Company reasonably expects to collect.
Goodwill
Goodwill represents the amount of the purchase price in excess of the fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is not amortized, but is subject to an annual impairment test performed in the first quarter following each fiscal year. To determine whether goodwill is impaired, the Company measures the fair values of its reporting units and compares such fair values with the carrying values of the respective units, including goodwill. If the fair value is less than the carrying value of the reporting unit, then the implied value of goodwill is calculated and compared with the carrying amount of goodwill to determine whether goodwill is impaired. In connection with the year-end asset impairment test, the Company also reconciles the aggregate fair value of its reporting units to its market capitalization including a reasonable control premium.
Similarly conducted interim impairment tests may also be required in advance of the annual impairment test if events occur or circumstances change that would more likely than not reduce the fair value, including goodwill, of one or more of the reporting units below the reporting unit’s carrying value. Such circumstances could include but are not limited to: (1) loss of significant contracts, (2) a significant adverse change in regulations applicable to the Company's business or in the climate of its business, (3) unanticipated competition, (4) an adverse action or assessment by a regulator, or (5) a significant decline in the Company's stock price.
For the year ended December 31, 2014, the Company considered both a market-based valuation approach and an income-based valuation approach when estimating the fair values of its reporting units with goodwill balances as of

6



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



that date. The valuation methodology applied in 2014 was consistent with prior methodology. Under the market approach, the fair value of the reporting unit is determined using one or more methods based on current values in the market for similar businesses. Under the income approach, the fair value of the reporting unit is based on the cash flow streams expected to be generated by the reporting unit over an appropriate period and then discounting the cash flows to present value using an appropriate discount rate. The income approach is dependent on a number of significant management assumptions, including estimates of future revenue and expenses, growth rates and discount rates. Inherent in such fair value determinations are certain judgments and estimates relating to future cash flows, including the Company's interpretation of current economic indicators and market valuations, and assumptions about strategic plans with regard to operations. To the extent additional information arises, or market conditions or strategies change, it is possible that the conclusion regarding whether existing goodwill is impaired could change and result in a material adverse effect on the Company's consolidated financial position or results of operations. See Note 5, "Goodwill and Intangible Assets, Net," for further information regarding goodwill impairment in 2014.
Long-Lived Assets, including Intangible Assets
Long-lived assets consist primarily of property, equipment, capitalized software and intangible assets. Finite-lived, separately-identified intangible assets acquired in business combinations are assets that represent future expected benefits but lack physical substance (such as purchased contract rights and provider contracts).
In connection with acquisitions, the Company calculates the fair value of any intangible assets acquired, and assesses whether any relevant factors limit the period over which acquired assets are expected to contribute directly or indirectly to future cash flows for amortization purposes. For customer relationship intangibles, for example, an appropriate useful life is then determined based on the expected period of time services will be provided to the payer. While discounted cash flows are used to value intangible assets, the Company applies the straight-line method of amortization to determine amortization expense.
Intangible assets are subject to impairment tests when events or circumstances indicate that a finite-lived intangible asset’s (or asset group’s) carrying value may not be recoverable. If applicable, the recoverability of the unamortized balance of long-lived assets is assessed based on undiscounted expected future cash flows. If the review indicates that the carrying value is not fully recoverable, the excess of the carrying value over the fair value of any long-lived asset is recognized as an impairment loss.
For the year ended December 31, 2014, there was no impairment of identified intangible assets.
Deferred Revenue
At times the Company may receive funding for certain services in advance of services to be rendered. These amounts are reflected in the consolidated balance sheet as deferred revenue until the services are rendered.
Revenue Recognition
The majority of the Company's contracts are negotiated fee-for-service arrangements with payers. The Company has generally been successful in retaining its payer contracts. However, a significant number of the Company's payer contracts allow the payer to terminate the contract immediately for cause, such as for the Company's failure to meet the contract obligations. Additionally, these contracts typically permit the payer to terminate the contract at any time prior to the stated expiration date without cause, at will and without penalty to the payer, either upon expiration of a short notice period, typically 30 days, or immediately, in the event of federal or state appropriations supporting the programs serviced by the contract are reduced or eliminated.

7



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



Fee-For-Service (FFS) contracts. Revenue related to services provided under FFS contracts is recognized at the time services are rendered and collection is determined to be probable. Such services are provided at established billing rates. As services are rendered, contract-specific documentation is prepared describing each service, time spent, and billing code to determine and support the value of each service provided and billed. The timing and amount of collection are dependent upon compliance with the billing requirements specified by each payer. Failure to comply with these requirements could delay the collection of amounts due to the Company under a contract or result in adjustments to amounts billed.
The performance of the Company’s contracts is subject to the condition that sufficient funds are appropriated, authorized and allocated by each state, city or other local government. If sufficient appropriations, authorizations and allocations are not provided by the respective state, city or other local government, the Company is at risk for uncollectible amounts or immediate termination or renegotiation of the financial terms of the Company’s contracts.
Cost-based service contracts. Revenues from the Company’s cost-based service contracts are recorded based on a combination of allowable direct costs, indirect overhead allocations, and stated allowable margins on those incurred costs. These revenues are compared to annual contract budget limits and, depending on reporting requirements, reductions of revenue may be recorded for certain contingencies. The Company annually submits projected costs for the coming year, which assist the contracting payers in establishing the annual contract amount to be paid for services provided under the contracts. The Company submits monthly cost reports which are used by the payers to determine the need for any payment adjustments. Completion of the cost report review process may range from one month to several years. In cases where funds paid to the Company exceed the allowable costs to provide services under contract, the Company may be required to repay amounts previously received.
The Company’s cost reports are generally audited by payers annually. The Company periodically reviews its provisional billing rates and allocation of costs and provides for estimated payment adjustments. The Company believes that adequate provisions have been made in its consolidated financial statements for any material adjustments that might result from the outcome of any cost report audits. Differences between the amounts provided and the settlement amounts are recorded in the Company’s consolidated statement of income in the year of settlement. Such settlements have historically not been material.
Annual block purchase contract. The Company’s annual block purchase contract requires the Company to provide or arrange for behavioral health services to eligible populations of beneficiaries as defined in the contract. The Company must provide a complete range of behavioral health clinical, case management, therapeutic and administrative services. The Company is obligated to provide services only to those clients with a demonstrated medical necessity. The Company’s annual funding allocation amount may be increased when its patient service encounters exceed the contract amount; however, such increases are subject to government appropriation. There is no contractual limit to the number of eligible beneficiaries that may be assigned to the Company, or a specified limit to the level of services that may be provided to these beneficiaries if the services are deemed to be medically necessary. Therefore, the Company is at-risk if the costs of providing necessary services exceed the associated reimbursement.
The terms of the contract may be reviewed prospectively and amended as necessary to ensure adequate funding of the Company’s contractual obligations; however, there is no assurance that amendments will be approved or that funding will be adequate.

8



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



Income Taxes
The Company and its subsidiaries are included in the consolidated federal income tax returns of the PSC Parent. Federal income taxes are allocated to the Company in an amount generally equivalent to the amount that would be expensed by the Company as if it filed a consolidated federal return separate from the PSC Parent.
Deferred tax assets and liabilities are determined based on differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance which includes amounts for net operating loss and tax credit carryforwards, as more fully described in Note 6, "Income Taxes," for which the Company has concluded that it is more likely than not that these net operating loss and tax credit carryforwards will not be realized in the ordinary course of operations.
Concentrations of Credit Risk
Contracts with governmental agencies and other entities that contract with governmental agencies accounted for approximately 93% of the Company's service revenue for the year ended December 31, 2014. These contracts are subject to possible statutory and regulatory changes, rate adjustments, administrative rulings, rate freezes and funding reductions. Reductions in amounts paid under these contracts for the Company's services or changes in methods or regulations governing payments for the Company's services could have a material adverse effect on the Company's financial position, results of operations, or cash flows.
Recent Accounting Pronouncements
Income Taxes. The Company has early adopted Accounting Standards Update (ASU) 2015-17, Balance Sheet Classification of Deferred Taxes, which requires deferred tax assets and liabilities to be classified as non-current in a classified statement of financial position. The adoption had no significant impact to the Company's consolidated balance sheet, and no impact to the statements of comprehensive loss and member's equity, and cash flows.
Revenue Recognition. In May 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09 - Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. 
In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which amends certain aspects of ASU 2014-09, Revenue from Contracts with Customers (Topic 606) Section A - Summary and Amendments That Create Revenue From Contracts With Customers (Topic 606) and Other Assets and Deferred Costs - Contracts With Customers (Subtopic 340-40). The amendments, which address transition, collectibility, non-cash consideration and the presentation of sales and other similar taxes, do not change the core principles of ASU 2014-09, but rather address implementation issues and are intended to result in more consistent application.
In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, which amends certain aspects of ASC 606, Revenue from Contracts with Customers. ASU 2016-10 amends step two of the new revenue standard’s five-step model to include guidance on immaterial promised goods or services, shipping and handling activities and identifying when promises represent performance obligations. ASU 2016-10 also provided

9



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



guidance related to licensing such as, but not limited to, sales-based and usage-based royalties and renewals of license that provide a right to use intellectual property.
In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers - Principal vs. Agent Considerations, which amends the principal–versus–agent implementation guidance in ASC 606. ASU 2016-08 clarifies that an entity should evaluate whether it is the principal or agent for each specified good or service promised in a contract with a customer as defined in ASC 606. The entity must first identify each specified good or service to be provided to the customer and then assess whether it controls each specified good or service. The ASU also removed two of the five indicators used in evaluating control under the old guidance and re-frames the remaining three indicators.
In July 2015, the FASB affirmed its proposal to defer the effective date of ASU 2014-09 for all entities by one year. As a result, non-public business entities will apply the new revenue standard to annual reporting periods beginning after December 15, 2018. The Company intends to adopt this standard on January 1, 2018, however, because it is a wholly owned subsidiary of a public business entity. The Company is currently evaluating its plan for adoption and the impact to its revenue recognition policies, procedures and control framework, and the resulting impact to its financial position, results of operations and cash flows.
Leases. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets. ASU 2016-02 is effective for non-public entities for annual reporting periods beginning after December 15, 2019, and requires a modified retrospective transition approach. The Company intends to adopt this standard on January 1, 2019, however, because it is a wholly owned subsidiary of a public business entity. Early adoption is permitted; the Company is currently evaluating the potential effects of the adoption to its financial statements.
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), and the American Institute of Certified Public Accountants, did not have, or are not believed by management to have, a material impact on the Company's present or future consolidated financial statements.

3. Business Combinations
Consistent with the Company's strategy to pursue acquisition opportunities in adjacent markets and complementary service lines to leverage its core competencies and relationships with national, state and county governmental agencies, the following transactions were completed in 2014. For these transactions, the Company applied the acquisition method of accounting, under which the total purchase price is allocated to tangible and intangible assets acquired, and liabilities assumed, based on their respective fair values. For these acquisitions, substantially all of the assets acquired were intangible assets and acquisition-related costs were insignificant.
Providence Idaho. In the second quarter of 2014, the Company's wholly owned subsidiary, Providence of Idaho, LLC (Providence Idaho), acquired substantially all of the assets in Alternative Community Enrichment Services, Inc. d/b/a ACES Community Services, and ACES, Inc. d/b/a Pioneer Health Resources, together a psychosocial rehabilitation agency, mental health clinic and substance abuse disorder treatment program for Idaho, for a purchase price of $5,178. See Note 5, "Goodwill and Intangible Assets, Net," for further information regarding the Providence Idaho goodwill impairment in 2014.
A portion of the purchase price amounting to $600 represented an indemnification "hold-back" in the form of an unsecured, subordinated promissory note from Providence Idaho in favor of the seller. The promissory note, which bore interest at the annual rate of 2%, was established to secure the seller's indemnification obligations under the

10



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



asset purchase agreement. The note and related accrued interest were outstanding until repaid by the Company in the second quarter of 2016, as required under the terms of the asset purchase agreement.
In addition, a portion of the purchase price represented an "earn-out" amount, contingent upon Providence Idaho's achievement of certain financial metrics in each of 2014 and 2015. As of December 31, 2014, the Company determined that such financial metrics were not met in 2014, and were not expected to be met for 2015; therefore, the Company reversed the recorded contingent consideration liability, resulting in a gain of $202 in the year ended December 31, 2014.
Providence Massachusetts. In the fourth quarter of 2014, the Company's wholly owned subsidiary, Providence Human Services of Massachusetts, LLC (Providence Massachusetts), acquired substantially all of the assets of Valley Psychiatric Service, Inc., an outpatient behavioral health services provider in Massachusetts, for a purchase price of $5,375. On the closing date, $500 of the purchase price was transferred to a third party escrow agent to establish an indemnification account held as security for the seller's indemnification obligations under the purchase agreement, to be settled 15 months after the closing date. Because there were no claims during the settlement period, the indemnification funds were released to the seller in early 2016.
The following table summarizes the values of the assets acquired at the dates of acquisition.
 
 
Providence Idaho
 
Providence Massachusetts
 
Total
Assets:
 
 
 
 
 
 
Property and equipment
 
$
66

 
$
366

 
$
432

Goodwill
 
4,212

 
4,482

 
8,694

Intangible assets
 
900

 
527

 
1,427

Total purchase price
 
$
5,178

 
$
5,375

 
$
10,553

The Company recorded goodwill amounting to $8,694 in the aggregate for these acquisitions, which relates to future economic benefits arising from expected synergies to be achieved. Such synergies include use of the Company's existing infrastructure to support the additional clients served. The amount recorded as goodwill represents intangible assets that do not qualify for separate recognition as identifiable intangible assets. The entire amount recorded as goodwill is deductible for income tax purposes.
The Company recorded intangibles amounting to $1,427 in the aggregate for these acquisitions, which relates to the fair value of the customer relationships acquired. The useful life and weighted-average amortization period for these intangible assets, in the aggregate, is 5 years.

4. Property and Equipment, Net
Property and equipment are stated at historical cost, net of accumulated depreciation, or at fair value if the assets were initially recorded as the result of a business combination. Depreciation is calculated using the straight-line method over the estimated useful life of the asset. Maintenance and repairs are expensed as incurred. Gains and losses resulting from the disposition of property and equipment are reflected in operating expense.

11



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



 
December 31,
2014
 
 
Land
$
729

Building and improvements
8,134

Furniture and equipment
11,250

Capitalized software
2,134

 
22,247

Less: accumulated depreciation and amortization
(10,812
)
Property, equipment, and capitalized software, net
$
11,435

Depreciation amounted to $1,916 for the year ended December 31, 2014.

5. Goodwill and Intangible Assets, Net
Goodwill
In conjunction with its annual review of goodwill as of December 31, 2014, the Company determined that goodwill was impaired for its Providence Idaho reporting unit, attributable to lower than expected performance during 2014, as well as lower than expected projections in future years. As such, the Company recorded an impairment charge of $2,815 in the year ended December 31, 2014.
The following table summarizes the changes in goodwill during 2014:
 
December 31, 2013
 
Acquisitions
 
Impairment Charge
 
December 31, 2014
Goodwill, gross
$
535

 
$
8,694

 
$

 
$
9,229

Accumulated impairment losses

 

 
(2,815
)
 
(2,815
)
Goodwill, net
$
535

 
$
8,694

 
$
(2,815
)
 
$
6,414

Intangible Assets, Net
Intangible assets are initially recorded at fair value and are amortized on a straight-line basis over their expected useful lives. Amortization of intangible assets amounted to $637 for the year ended December 31, 2014. Based on the balances of identifiable intangible assets as of December 31, 2014, the Company estimates that intangible asset amortization will be approximately $800 in 2015, $762 in 2016, $312 in 2017, $312 in 2018, and $170 in 2019. As of December 31, 2014, intangible assets consisted of the following:
 
Expected Useful Life
 
Cost
 
Accumulated Amortization
 
Net
Customer relationships
3-15 years
 
$
3,948

 
$
1,672

 
$
2,276



12



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



6. Income Taxes
For the year ended December 31, 2014, the provision for income taxes consisted of the following:
Current—state
$
289

Deferred—state
11

Total provision for income taxes
$
300

A reconciliation of the U.S. federal statutory income tax rate the consolidated effective income tax rate is as follows:
Taxes on income at statutory federal rate
35.0
 %
Other
(2.4
)
Valuation allowance
(34.1
)
Effective tax rate
(1.5
)%
The components of the Company's deferred income tax assets and liabilities as of December 31, 2014, were as follows:
Depreciation and amortization
$
9,987

Net operating losses
7,382

Reserve liabilities
3,486

Other, net
658

Valuation allowance
(21,335
)
Total deferred income tax asset, net of valuation allowance
$
178

At December 31, 2014, the Company had federal and state net operating loss carryforwards of $16,903 and $32,533, respectively. The federal net operating loss begins expiring in 2029 and state net operating losses begin expiring in 2016.
The Company evaluates the need for a valuation allowance taking into consideration the ability to carry back and carry forward tax credits and losses, available tax planning strategies and future income, including reversal of temporary differences. The Company has determined that as of December 31, 2014, $21,335 of deferred tax assets did not satisfy the recognition criteria due to uncertainty regarding realization.
The Company is subject to taxation in the United States and numerous state and local jurisdictions, with major jurisdictions being Arizona, California, Georgia, Maine, Pennsylvania, Tennessee and Virginia. The Company is currently under exam by the Internal Revenue Service for tax year 2012. With few exceptions, the Company is no longer subject to U.S. federal, state and local income tax examinations before 2010. 
The Company’s continuing practice is to recognize interest and/or penalties related to unrecognized tax benefits, if any, in income tax expense. There were no unrecognized tax benefits as of December 31, 2014.

7. Defined Contribution Plan
The Company participated in a defined contribution 401(k) plan sponsored by the PSC Parent, which covers all employees. Eligible employees are permitted to contribute up to the maximum allowed by law. The Company, at its

13



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



discretion, may make a matching contribution to the plan. The Company's contribution to the plan amounted to $422 for the year ended December 31, 2014.
In the second quarter of 2016, the Company's employees became eligible to participate in Molina's 401(k) plan, which covers substantially all full-time salaried and hourly employees of Molina. Under Molina's plan, eligible employees are permitted to contribute up to the maximum allowed by law, and Molina matches up to the first 4% of compensation contributed by employees.

8. Related Party Transactions
When the Company acquired Maple Services, LLC in August 2005, the PSC Parent’s former Chief Executive Officer, former Chief Financial Officer, and Chief Executive Officer of Human Services, became members of the board of directors of the not-for-profit organization (Maple Star Colorado, Inc.) formerly managed by Maple Services, LLC. Prior to Molina's acquisition of the Company on November 1, 2015, the members of Maple Star Colorado, Inc.’s board of directors included the PSC Parent’s Chief Executive Officer and Chief Financial Officer, and the Company's Chief Executive Officer. Maple Star Colorado, Inc. is a non-profit member organization governed by its board of directors and the state laws of Colorado in which it is incorporated. Maple Star Colorado, Inc. is not a federally tax exempt organization and neither the Internal Revenue Service rules governing IRC Section 501(c)(3) exempt organizations, nor any other IRC sections applicable to tax exempt organizations, apply to this organization. The Company provided management services to Maple Star Colorado, Inc. under a management agreement for consideration in the amount of approximately $311 for the year ended December 31, 2014. Amounts due to the Company from Maple Star Colorado, Inc. for reimbursable expenses and management services provided to it by the Company at December 31, 2014, were approximately $489.
Transactions with Parent
The PSC Parent provides various management, financial, legal, information systems and human resources services to the Company. Such general and administrative expenses incurred at the PSC Parent are allocated to the Company based upon the Company's relative direct expense levels, excluding costs for purchased services, which the Company's management believes to be reasonable. Charges for these services amounted to $24,350 in 2014 (included in general and administrative expense).

9. Commitments and Contingencies
Leases
The Company leases many of its operating and office facilities for various terms under non-cancelable operating lease agreements. The leases expire in various years and provide for renewal options. In the normal course of business, it is expected that these leases will be renewed or replaced by leases on other properties.
The operating leases provide for increases in future minimum annual rental payments based on defined increases in the Consumer Price Index, subject to certain minimum increases. Several of these lease agreements contain provisions for periods in which rent payments are reduced. The total amount of rental payments due over the lease term is being charged to rent expense on a straight-line basis over the term of the lease. Also, the lease agreements generally require the Company to pay executory costs such as real estate taxes, insurance, and repairs.

14



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



Future minimum payments under non-cancelable operating leases for equipment and property with initial terms of one year or more consisted of the following at December 31, 2014:
2015
$
9,822

2016
7,275

2017
4,681

2018
2,668

2019
1,422

Thereafter
2,492

Total minimum lease payments
$
28,360

Rent expense related to operating leases amounted to $14,165 for the year ended December 31, 2014.
Legal Matters
The Company is involved in various claims and legal actions arising in the ordinary course of business, many of which are covered in whole or in part by insurance. 
Rodriguez v. Providence Community Corrections.  On October 1, 2015, seven individuals, on behalf of themselves and all others similarly situated, filed a complaint in the District Court for the Middle District of Tennessee, Nashville Division, Case No. 3:15-cv-01048 (the "Rodriquez Litigation"), against Providence Community Corrections, Inc. (now known as Pathways Community Corrections, Inc., or "PCC"). Rutherford County, Tennessee formerly contracted with PCC for the administration of misdemeanor probation, which involved the collection of court costs and fees from probationers. The complaint alleges, among other things, that PCC illegally assessed fees and surcharges against probationers and made improper threats of arrest and probation revocation if the probationers did not pay such amounts. The plaintiffs in the Rodriguez Litigation seek alleged compensatory, treble, and punitive damages, plus attorneys’ fees, for alleged federal and state constitutional violations, as well as alleged violations of the Racketeer Influenced and Corrupt Organization Act. PCC’s agreement with Rutherford County terminated effective December 29, 2015. On November 1, 2015, one month after the Rodriguez Litigation had been commenced, Molina acquired PCC from the PSC Parent pursuant to a membership interest purchase agreement. Molina has notified the PSC Parent that, for its failure to disclose the Rodriguez Litigation, Molina intends to seek indemnification from the PSC Parent under the membership interest purchase agreement for any liability arising from the Rodriguez Litigation.

10. Supplemental Condensed Consolidating Financial Information
Molina's principal operating subsidiaries are health maintenance organizations, which are required under applicable laws and related regulations to maintain levels of solvency, or capital, or net assets that would not be achieved if they guaranteed Molina's 5.375% Notes. Accordingly, only Molina's unregulated subsidiaries, which include the Company and certain of its subsidiaries (collectively, the Guarantors), guarantee the 5.375% Notes.
The 5.375% Notes are fully and unconditionally, and jointly and severally guaranteed by the Guarantors. Each 5.375 Notes guarantee is:
A general senior unsecured obligation of the Guarantor;
Equal in right of payment to all existing and future senior unsecured obligations of that Guarantor;

15



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



Effectively subordinate in right of payment to any existing or future secured obligations of that Guarantor to the extent of the value of the assets securing such obligations; and
Are senior in right of payment to any future subordinated obligations of that Guarantor.
The $700,000 principal amount of the 5.375% Notes represents the maximum potential amount of future payments (undiscounted) the Company could be required to make under the guarantee, with no limitation.
The following tables present supplemental condensed consolidating financial information as of and for the year ended December 31, 2014, for (1) the Company on a stand-alone basis (the Parent Guarantor), (2) the other guarantor subsidiaries of the Company on a combined basis (collectively, the Other PHS Guarantor Subsidiaries), (3) the non-guarantor subsidiaries of the Company on a combined basis (collectively, the Non-Guarantor PHS Subsidiaries), and (4) the Company, on a consolidated basis.
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED BALANCE SHEET
 
 
 
 
 
 
 
 
 
Assets
Cash and cash equivalents
$

 
$
18,613

 
$
7,709

 
$

 
$
26,322

Accounts receivable, net

 
37,037

 
5,352

 

 
42,389

Intercompany
67,540

 
86,981

 
33,646

 
(188,167
)
 

Prepaid expenses and other current assets

 
2,498

 
471

 

 
2,969

Property and equipment, net

 
9,697

 
1,738

 

 
11,435

Goodwill and intangible assets, net

 
8,033

 
657

 

 
8,690

Deferred income taxes

 
214

 
(36
)
 

 
178

Other assets

 
808

 
182

 

 
990

 
$
67,540

 
$
163,881

 
$
49,719

 
$
(188,167
)
 
$
92,973

Liabilities and Member's Equity
Accrued expenses
$

 
$
15,322

 
$
4,262

 
$

 
$
19,584

Accounts payable

 
2,472

 
348

 

 
2,820

Deferred revenue

 
263

 
209

 

 
472

Income taxes payable

 
237

 
51

 

 
288

Other long-term liabilities

 
1,488

 
781

 

 
2,269

Total liabilities

 
19,782

 
5,651

 

 
25,433

Member's equity
67,540

 
144,099

 
44,068

 
(188,167
)
 
67,540

 
$
67,540

 
$
163,881

 
$
49,719

 
$
(188,167
)
 
$
92,973



16



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2014
(In thousands)



 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF COMPREHENSIVE LOSS
 
 
 
 
 
 
 
 
 
Total revenue
$

 
$
290,975

 
$
71,665

 
$
(970
)
 
$
361,670

Operating expenses:
 
 
 
 
 
 
 
 

Service expense

 
158,811

 
44,060

 

 
202,871

General and administrative expense

 
138,531

 
32,715

 
(970
)
 
170,276

Provision for doubtful accounts

 
54

 
3,512

 

 
3,566

Depreciation and amortization

 
1,881

 
672

 

 
2,553

Asset impairment charge

 
2,815

 

 

 
2,815

Total operating expenses

 
302,092

 
80,959

 
(970
)
 
382,081

Income before income tax expense

 
(11,117
)
 
(9,294
)
 

 
(20,411
)
Provision for income taxes

 
(251
)
 
(49
)
 

 
(300
)
Comprehensive loss before equity in losses of subsidiaries

 
(11,368
)
 
(9,343
)
 

 
(20,711
)
Equity in net losses of subsidiaries
(20,711
)
 

 

 
20,711

 

Comprehensive loss
$
(20,711
)
 
$
(11,368
)
 
$
(9,343
)
 
$
20,711

 
$
(20,711
)

 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF CASH FLOWS
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$

 
$
9,456

 
$
(613
)
 
$

 
$
8,843

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of property and equipment

 
(1,948
)
 
(469
)
 

 
(2,417
)
Other, net

 
(45
)
 
(199
)
 

 
(244
)
Net cash used in investing activities

 
(1,993
)
 
(668
)
 

 
(2,661
)
Net increase (decrease) in cash and cash equivalents

 
7,463

 
(1,281
)
 

 
6,182

Cash and cash equivalents - beginning

 
11,150

 
8,990

 

 
20,140

Cash and cash equivalents - ending
$

 
$
18,613

 
$
7,709

 
$

 
$
26,322



17

Exhibit





























CONSOLIDATED FINANCIAL STATEMENTS
PROVIDENCE HUMAN SERVICES, LLC
Nine Months Ended September 30, 2015 and 2014





PROVIDENCE HUMAN SERVICES, LLC

Consolidated Financial Statements

Contents
Consolidated Financial Statements
 
 
 
Consolidated Balance Sheets
1
Consolidated Statements of Comprehensive Loss
2
Consolidated Statements of Cash Flows
3
Notes to Consolidated Financial Statements
4




PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED BALANCE SHEETS
(In thousands)
 
September 30,  2015
 
December 31,  2014
 
(unaudited)
 
 
ASSETS
 
 
Current assets:
 
 
 
Cash and cash equivalents
$
22,294

 
$
26,322

Accounts receivable, net of allowance of $9,638 and $4,756
43,336

 
42,389

Prepaid expenses and other current assets
4,095

 
2,969

Total current assets
69,725

 
71,680

Property and equipment, net
14,798

 
11,435

Goodwill
6,414

 
6,414

Intangible assets, net
1,676

 
2,276

Deferred income taxes
178

 
178

Other assets
956

 
990

 
$
93,747

 
$
92,973

LIABILITIES AND MEMBER'S EQUITY
 
 
Current liabilities:
 
 
 
Accounts payable and accrued liabilities
$
16,408

 
$
19,584

Medical claims and benefits payable
3,231

 
2,820

Deferred revenue
1,030

 
472

Income taxes payable
649

 
288

Total current liabilities
21,318

 
23,164

Note payable
600

 
600

Other long-term liabilities
1,844

 
1,669

Total liabilities
23,762

 
25,433

Member's equity
69,985

 
67,540

 
$
93,747

 
$
92,973

 

See accompanying notes.

1


PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In thousands)
 
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2015
 
2014
 
2015
 
2014
 
(unaudited)
Service revenue
$
81,646

 
$
82,287

 
$
273,057

 
$
273,607

Operating expenses:
 
 
 
 
 
 
 
Service expense
45,025

 
46,872

 
146,108

 
155,099

General and administrative expense
41,623

 
40,538

 
138,195

 
129,894

Provision for doubtful accounts
2,005

 
1,416

 
5,807

 
4,265

Depreciation and amortization
1,197

 
582

 
3,412

 
1,823

Total operating expenses
89,850

 
89,408

 
293,522

 
291,081

Loss before income taxes
(8,204
)
 
(7,121
)
 
(20,465
)
 
(17,474
)
Provision for income taxes
120

 
75

 
361

 
225

Comprehensive loss
$
(8,324
)
 
$
(7,196
)
 
$
(20,826
)
 
$
(17,699
)
 
See accompanying notes.

2


PROVIDENCE HUMAN SERVICES, LLC
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
 
Nine Months Ended September 30,
 
2015
 
2014
 
(unaudited)
Operating activities:
 
 
 
Comprehensive loss
$
(20,826
)
 
$
(17,699
)
Adjustments to reconcile comprehensive loss to net cash provided by operating activities:
 
 
 
Intercompany transactions forgiven by The Providence Service Corporation parent
23,271

 
26,000

Depreciation and amortization
3,412

 
1,823

Provision for doubtful accounts
5,807

 
4,265

Deferred income taxes

 
11

Changes in operating assets and liabilities, net of effects from acquisitions:
 
 
 
Accounts receivable, net
(6,754
)
 
(6,403
)
Prepaid expenses and other current assets
(1,126
)
 
(764
)
Accrued expenses
(3,643
)
 
3,626

Accounts payable
411

 
(256
)
Deferred revenue
558

 
(186
)
Income taxes
361

 
214

Net cash provided by operating activities
1,471

 
10,631

Investing activities:
 
 
 
Purchases of equipment
(5,708
)
 
(1,931
)
Other, net
209

 
(202
)
Net cash used in investing activities
(5,499
)
 
(2,133
)
Net (decrease) increase in cash and cash equivalents
(4,028
)
 
8,498

Cash and cash equivalents at beginning of period
26,322

 
20,140

Cash and cash equivalents at end of period
$
22,294

 
$
28,638


Supplemental cash flow information:
 
Nine Months Ended September 30,
 
2015
 
2014
 
(unaudited)
Details of business combinations:
 
 
 
Fair value of:
 
 
 
Assets acquired
$

 
$
5,178

Note payable to seller

 
(600
)
Contingent consideration liability incurred

 
(202
)
Net cash contributed by The Providence Service Corporation parent for the Company's business combinations
$

 
$
4,376






See accompanying notes.


3



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)



1. Basis of Presentation
Organization and Operations
Providence Human Services, LLC, a Delaware limited liability company (the Company, or PHS), in which The Providence Service Corporation (the PSC Parent) is the sole member. The Company provides accessible, outcome-based behavioral/mental health and social services with operations in 23 states and the District of Columbia. The Company's counselors, social workers and behavioral health professionals work with clients, primarily in the client's home or community, who are eligible for government assistance due to income level, disabilities or court order.
On November 1, 2015, 100% of the Company's member interest was acquired from the Parent by Molina Healthcare, Inc. (Molina). On November 10, 2015, Molina completed the private offering of $700 million aggregate principal amount of 5.375% senior notes (the 5.375% Notes). The 5.375% Notes are guaranteed by the Company and certain of its wholly owned subsidiaries. See Note 4, "Supplemental Condensed Consolidating Financial Information," for more information.
Segment Information
The Company's subsidiaries share similar characteristics with regard to the clients they serve, the nature of services provided, and the method by which services are delivered. The Company's subsidiaries are also subject to similar regulatory environments and long-term economic prospects; as such, the Company presents one reportable segment.
Consolidation and Interim Financial Information
The consolidated financial statements include the accounts of Providence Human Services, LLC and its subsidiaries. In the opinion of management, all adjustments considered necessary for a fair presentation of the results as of the date and for the interim periods presented have been included; such adjustments consist of normal recurring adjustments. All significant intercompany balances and transactions have been eliminated in consolidation. Financial information related to subsidiaries acquired during any year is included only for periods subsequent to their acquisition.
The consolidated results of operations for the current interim period are not necessarily indicative of the results for the entire year ending December 31, 2015. The unaudited consolidated interim financial statements have been prepared under the assumption that users of the interim financial data have either read or have access to the audited consolidated financial statements for the fiscal year ended December 31, 2014. Accordingly, certain disclosures that would substantially duplicate the disclosures contained in the December 31, 2014 audited consolidated financial statements have been omitted. These unaudited consolidated interim financial statements should be read in conjunction with the Company's December 31, 2014 audited consolidated financial statements.
Seasonality
The Company experiences lower client demand for its home and community based services during the holiday and summer seasons which generally results in lower revenue during those periods. However, operating expenses do not vary significantly with these changes. As a result, the Company typically experiences lower operating margins during the holiday and summer seasons.
Evaluation of Subsequent Events
The Company has evaluated subsequent events through the date these financial statements were available to be issued.

4



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)



2. Significant Accounting Policies
Fair Value of Financial Instruments
The carrying amounts of current assets, current liabilities and the note payable approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment.
Revenue Recognition
The majority of the Company's contracts are negotiated fee-for-service arrangements with payers. The Company has generally been successful in retaining its payer contracts. However, a significant number of the Company's payer contracts allow the payer to terminate the contract immediately for cause, such as for the Company's failure to meet the contract obligations. Additionally, these contracts typically permit the payer to terminate the contract at any time prior to the stated expiration date without cause, at will and without penalty to the payer, either upon expiration of a short notice period, typically 30 days, or immediately, in the event of federal or state appropriations supporting the programs serviced by the contract are reduced or eliminated.
Fee-For-Service (FFS) contracts. Revenue related to services provided under FFS contracts is recognized at the time services are rendered and collection is determined to be probable. Such services are provided at established billing rates. As services are rendered, contract-specific documentation is prepared describing each service, time spent, and billing code to determine and support the value of each service provided and billed. The timing and amount of collection are dependent upon compliance with the billing requirements specified by each payer. Failure to comply with these requirements could delay the collection of amounts due to the Company under a contract or result in adjustments to amounts billed.
The performance of the Company’s contracts is subject to the condition that sufficient funds are appropriated, authorized and allocated by each state, city or other local government. If sufficient appropriations, authorizations and allocations are not provided by the respective state, city or other local government, the Company is at risk for uncollectible amounts or immediate termination or renegotiation of the financial terms of the Company’s contracts.
Cost-based service contracts. Revenues from the Company’s cost-based service contracts are recorded based on a combination of allowable direct costs, indirect overhead allocations, and stated allowable margins on those incurred costs. These revenues are compared to annual contract budget limits and, depending on reporting requirements, reductions of revenue may be recorded for certain contingencies. The Company annually submits projected costs for the coming year, which assist the contracting payers in establishing the annual contract amount to be paid for services provided under the contracts. The Company submits monthly cost reports which are used by the payers to determine the need for any payment adjustments. Completion of the cost report review process may range from one month to several years. In cases where funds paid to the Company exceed the allowable costs to provide services under contract, the Company may be required to repay amounts previously received.
The Company’s cost reports are generally audited by payers annually. The Company periodically reviews its provisional billing rates and allocation of costs and provides for estimated payment adjustments. The Company believes that adequate provisions have been made in its consolidated financial statements for any material adjustments that might result from the outcome of any cost report audits. Differences between the amounts provided and the settlement amounts are recorded in the Company’s consolidated statement of income in the year of settlement. Such settlements have historically not been material.

5



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


Annual block purchase contract. The Company’s annual block purchase contract requires the Company to provide or arrange for behavioral health services to eligible populations of beneficiaries as defined in the contract. The Company must provide a complete range of behavioral health clinical, case management, therapeutic and administrative services. The Company is obligated to provide services only to those clients with a demonstrated medical necessity. The Company’s annual funding allocation amount may be increased when its patient service encounters exceed the contract amount; however, such increases are subject to government appropriation. There is no contractual limit to the number of eligible beneficiaries that may be assigned to the Company, or a specified limit to the level of services that may be provided to these beneficiaries if the services are deemed to be medically necessary. Therefore, the Company is at-risk if the costs of providing necessary services exceed the associated reimbursement.
The terms of the contract may be reviewed prospectively and amended as necessary to ensure adequate funding of the Company’s contractual obligations; however, there is no assurance that amendments will be approved or that funding will be adequate.
Income Taxes
The Company and its subsidiaries are included in the consolidated federal income tax returns of the PSC Parent. Federal income taxes are allocated to the Company in an amount generally equivalent to the amount that would be expensed by the Company as if it filed a consolidated federal return separate from the PSC Parent.
Deferred tax assets and liabilities are determined based on differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance which includes amounts for net operating loss and tax credit carryforwards, for which the Company has concluded that it is more likely than not that these net operating loss and tax credit carryforwards will not be realized in the ordinary course of operations. The Company recognizes interest and penalties related to income taxes as a component of income tax expense.
The provision for income taxes was recorded at an effective tax rate that is lower than the U.S. federal statutory rate because of valuation allowance against its deferred tax assets.
Recent Accounting Pronouncements
Income Taxes. The Company has early adopted Accounting Standards Update (ASU) 2015-17, Balance Sheet Classification of Deferred Taxes, which requires deferred tax assets and liabilities to be classified as non-current, in a classified statement of financial position. The adoption had no significant impact to the Company's consolidated balance sheet, and no impact to the statements of comprehensive loss and member's equity, and cash flows.
Revenue Recognition. In May 2014, the Financial Accounting Standards Board (FASB) issued ASU 2014-09 - Revenue from Contracts with Customers, which will supersede nearly all existing revenue recognition guidance under U.S. generally accepted accounting principles (GAAP). The core principal of ASU 2014-09 is that an entity should recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. 
In May 2016, the FASB issued ASU 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients, which amends certain aspects of ASU 2014-09, Revenue from Contracts

6



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


with Customers (Topic 606) Section A - Summary and Amendments That Create Revenue From Contracts With Customers (Topic 606) and Other Assets and Deferred Costs - Contracts With Customers (Subtopic 340-40). The amendments, which address transition, collectibility, non-cash consideration and the presentation of sales and other similar taxes, do not change the core principles of ASU 2014-09, but rather address implementation issues and are intended to result in more consistent application.
In April 2016, the FASB issued ASU 2016-10, Identifying Performance Obligations and Licensing, which amends certain aspects of ASC 606, Revenue from Contracts with Customers. ASU 2016-10 amends step two of the new revenue standard’s five-step model to include guidance on immaterial promised goods or services, shipping and handling activities and identifying when promises represent performance obligations. ASU 2016-10 also provided guidance related to licensing such as, but not limited to, sales-based and usage-based royalties and renewals of license that provide a right to use intellectual property.
In March 2016, the FASB issued ASU 2016-08, Revenue from Contracts with Customers - Principal vs. Agent Considerations, which amends the principal–versus–agent implementation guidance in ASC 606. ASU 2016-08 clarifies that an entity should evaluate whether it is the principal or agent for each specified good or service promised in a contract with a customer as defined in ASC 606. The entity must first identify each specified good or service to be provided to the customer and then assess whether it controls each specified good or service. The ASU also removed two of the five indicators used in evaluating control under the old guidance and re-frames the remaining three indicators.
In July 2015, the FASB affirmed its proposal to defer the effective date of ASU 2014-09 for all entities by one year. As a result, non-public business entities will apply the new revenue standard to annual reporting periods beginning after December 15, 2018. The Company intends to adopt this standard on January 1, 2018, however, because it is a wholly owned subsidiary of a public business entity. The Company is currently evaluating its plan for adoption and the impact to its revenue recognition policies, procedures and control framework, and the resulting impact to its financial position, results of operations and cash flows.
Leases. In February 2016, the FASB issued ASU 2016-02, Leases. ASU 2016-02 amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheets. ASU 2016-02 is effective for non-public entities for annual reporting periods beginning after December 15, 2019, and requires a modified retrospective transition approach. The Company intends to adopt this standard on January 1, 2019, however, because it is a wholly owned subsidiary of a public business entity. Early adoption is permitted; the Company is currently evaluating the potential effects of the adoption to its financial statements.
Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), and the American Institute of Certified Public Accountants, did not have, or are not believed by management to have, a material impact on the Company's present or future consolidated financial statements.

3. Commitments and Contingencies
Legal Matters
The Company is involved in various claims and legal actions arising in the ordinary course of business, many of which are covered in whole or in part by insurance.
Rodriguez v. Providence Community Corrections.  On October 1, 2015, seven individuals, on behalf of themselves and all others similarly situated, filed a complaint in the District Court for the Middle District of Tennessee, Nashville Division, Case No. 3:15-cv-01048 (the "Rodriquez Litigation"), against Providence Community

7



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


Corrections, Inc. (now known as Pathways Community Corrections, Inc., or "PCC"). Rutherford County, Tennessee formerly contracted with PCC for the administration of misdemeanor probation, which involved the collection of court costs and fees from probationers. The complaint alleges, among other things, that PCC illegally assessed fees and surcharges against probationers and made improper threats of arrest and probation revocation if the probationers did not pay such amounts. The plaintiffs in the Rodriguez Litigation seek alleged compensatory, treble, and punitive damages, plus attorneys’ fees, for alleged federal and state constitutional violations, as well as alleged violations of the Racketeer Influenced and Corrupt Organization Act. PCC’s agreement with Rutherford County terminated effective December 29, 2015. On November 1, 2015, one month after the Rodriguez Litigation had been commenced, Molina acquired PCC from the PSC Parent pursuant to a membership interest purchase agreement. Molina has notified the PSC Parent that, for its failure to disclose the Rodriguez Litigation, Molina intends to seek indemnification from the PSC Parent under the membership interest purchase agreement for any liability arising from the Rodriguez Litigation.

4. Supplemental Condensed Consolidating Financial Information
Molina's principal operating subsidiaries are health maintenance organizations, which are required under applicable laws and related regulations to maintain levels of solvency, or capital, or net assets that would not be achieved if they guaranteed Molina's 5.375% Notes. Accordingly, only Molina's unregulated subsidiaries, which include the Company and certain of its subsidiaries (collectively, the Guarantors), guarantee the 5.375% Notes.
The 5.375% Notes are fully and unconditionally, and jointly and severally guaranteed by the Guarantors. Each 5.375 Notes guarantee is:
A general senior unsecured obligation of the Guarantor;
Equal in right of payment to all existing and future senior unsecured obligations of that Guarantor;
Effectively subordinate in right of payment to any existing or future secured obligations of that Guarantor to the extent of the value of the assets securing such obligations; and
Are senior in right of payment to any future subordinated obligations of that Guarantor.
The $700,000 principal amount of the 5.375% Notes represents the maximum potential amount of future payments (undiscounted) the Company could be required to make under the guarantee, with no limitation.
The following tables present supplemental condensed consolidating financial information for (1) the Company on a stand-alone basis (the "Parent Guarantor"), (2) the other guarantor subsidiaries of the Company on a combined basis (collectively, the "Other PHS Guarantor Subsidiaries"), (3) the non-guarantor subsidiaries of the Company on a combined basis (collectively, the "Non-Guarantor PHS Subsidiaries"), and (4) the Company, on a consolidated basis.


8



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


 
As of September 30, 2015
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED BALANCE SHEET
 
 
 
 
 
 
 
 
 
Assets
Cash and cash equivalents
$

 
$
17,675

 
$
4,619

 
$

 
$
22,294

Accounts receivable, net

 
43,065

 
271

 

 
43,336

Intercompany
69,985

 
63,412

 
33,944

 
(167,341
)
 

Prepaid expenses and other current assets

 
3,527

 
568

 

 
4,095

Property and equipment, net

 
13,309

 
1,489

 

 
14,798

Goodwill and intangible assets, net

 
7,539

 
551

 

 
8,090

Deferred income taxes

 
214

 
(36
)
 

 
178

Other assets

 
793

 
163

 

 
956

 
$
69,985

 
$
149,534

 
$
41,569

 
$
(167,341
)
 
$
93,747

 
 
 
 
 
 
 
 
 
 
Liabilities and Member's Equity
Accrued expenses
$

 
$
13,546

 
$
2,862

 
$

 
$
16,408

Accounts payable

 
2,872

 
359

 

 
3,231

Deferred revenue

 
844

 
186

 

 
1,030

Income taxes payable

 
507

 
142

 

 
649

Other long-term liabilities

 
1,718

 
726

 

 
2,444

Total liabilities

 
19,487

 
4,275

 

 
23,762

Member's equity
69,985

 
130,047

 
37,294

 
(167,341
)
 
69,985

 
$
69,985

 
$
149,534

 
$
41,569

 
$
(167,341
)
 
$
93,747

 
As of December 31, 2014
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED BALANCE SHEET
 
 
 
 
 
 
 
 
 
Assets
Cash and cash equivalents
$

 
$
18,613

 
$
7,709

 
$

 
$
26,322

Accounts receivable, net

 
37,037

 
5,352

 

 
42,389

Intercompany
67,540

 
86,981

 
33,646

 
(188,167
)
 

Prepaid expenses and other current assets

 
2,498

 
471

 

 
2,969

Property and equipment, net

 
9,697

 
1,738

 

 
11,435

Goodwill and intangible assets, net

 
8,033

 
657

 

 
8,690

Deferred income taxes

 
214

 
(36
)
 

 
178

Other assets

 
808

 
182

 

 
990

 
$
67,540

 
$
163,881

 
$
49,719

 
$
(188,167
)
 
$
92,973

Liabilities and Member's Equity
Accrued expenses
$

 
$
15,322

 
$
4,262

 
$

 
$
19,584

Accounts payable

 
2,472

 
348

 

 
2,820

Deferred revenue

 
263

 
209

 

 
472

Income taxes payable

 
237

 
51

 

 
288

Other long-term liabilities

 
1,488

 
781

 

 
2,269

Total liabilities

 
19,782

 
5,651

 

 
25,433

Member's equity
67,540

 
144,099

 
44,068

 
(188,167
)
 
67,540

 
$
67,540

 
$
163,881

 
$
49,719

 
$
(188,167
)
 
$
92,973


9



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


 
Three Months Ended September 30, 2015
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF COMPREHENSIVE LOSS
 
 
 
 
 
 
 
 
 
Service revenue
$

 
$
69,549

 
$
12,097

 
$

 
$
81,646

Operating expenses:
 
 
 
 
 
 
 
 
 
Service expense

 
38,982

 
6,043

 

 
45,025

General and administrative expense

 
35,005

 
6,618

 

 
41,623

Provision for doubtful accounts

 

 
2,005

 

 
2,005

Depreciation and amortization

 
1,037

 
160

 

 
1,197

Total operating expenses

 
75,024

 
14,826

 

 
89,850

Loss before income tax expense

 
(5,475
)
 
(2,729
)
 

 
(8,204
)
Provision for income taxes

 
(90
)
 
(30
)
 

 
(120
)
Comprehensive loss before equity in losses of subsidiaries

 
(5,565
)
 
(2,759
)
 

 
(8,324
)
Equity in net losses of subsidiaries
(8,324
)
 

 

 
8,324

 

Comprehensive loss
$
(8,324
)
 
$
(5,565
)
 
$
(2,759
)
 
$
8,324

 
(8,324
)

 
Three Months Ended September 30, 2014
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF COMPREHENSIVE LOSS
 
 
 
 
 
 
 
 
 
Service revenue
$

 
$
65,032

 
$
17,255

 
$

 
$
82,287

Operating expenses:
 
 
 
 
 
 
 
 
 
Service expense

 
35,986

 
10,886

 

 
46,872

General and administrative expense

 
30,757

 
9,781

 

 
40,538

Provision for doubtful accounts

 
3

 
1,413

 

 
1,416

Depreciation and amortization

 
416

 
166

 

 
582

Total operating expenses

 
67,162

 
22,246

 

 
89,408

Loss before income tax expense

 
(2,130
)
 
(4,991
)
 

 
(7,121
)
Provision for income taxes

 
(63
)
 
(12
)
 

 
(75
)
Comprehensive loss before equity in losses of subsidiaries

 
(2,193
)
 
(5,003
)
 

 
(7,196
)
Equity in net losses of subsidiaries
(7,196
)
 

 

 
7,196

 

Comprehensive loss
$
(7,196
)
 
$
(2,193
)
 
$
(5,003
)
 
$
7,196

 
(7,196
)

10



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


 
Nine Months Ended September 30, 2015
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF COMPREHENSIVE LOSS
 
 
 
 
 
 
 
 
 
Service revenue
$

 
$
234,327

 
$
38,730

 
$

 
$
273,057

Operating expenses:
 
 
 
 
 
 
 
 
 
Service expense

 
127,539

 
18,569

 

 
146,108

General and administrative expense

 
117,635

 
20,560

 

 
138,195

Provision for doubtful accounts

 

 
5,807

 

 
5,807

Depreciation and amortization

 
2,935

 
477

 

 
3,412

Total operating expenses

 
248,109

 
45,413

 

 
293,522

Loss before income tax expense

 
(13,782
)
 
(6,683
)
 

 
(20,465
)
Provision for income taxes

 
(270
)
 
(91
)
 

 
(361
)
Comprehensive loss before equity in losses of subsidiaries

 
(14,052
)
 
(6,774
)
 

 
(20,826
)
Equity in net losses of subsidiaries
(16,037
)
 
$

 
$

 
16,037

 

Comprehensive loss
$
(16,037
)
 
$
(14,052
)
 
$
(6,774
)
 
$
16,037

 
$
(20,826
)

 
Nine Months Ended September 30, 2014
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF COMPREHENSIVE LOSS
 
 
 
 
 
 
 
 
 
Service revenue
$

 
$
215,426

 
$
58,181

 
$

 
$
273,607

Operating expenses:
 
 
 
 
 
 
 
 
 
Service expense

 
117,613

 
37,486

 

 
155,099

General and administrative expense

 
102,923

 
26,971

 

 
129,894

Provision for doubtful accounts

 
49

 
4,216

 

 
4,265

Depreciation and amortization

 
1,321

 
502

 

 
1,823

Total operating expenses

 
221,906

 
69,175

 

 
291,081

Loss before income tax expense

 
(6,480
)
 
(10,994
)
 

 
(17,474
)
Provision for income taxes

 
(188
)
 
(37
)
 

 
(225
)
Comprehensive loss before equity in losses of subsidiaries

 
(6,668
)
 
(11,031
)
 

 
(17,699
)
Equity in net losses of subsidiaries
(17,699
)
 
$

 
$

 
17,699

 

Comprehensive loss
$
(17,699
)
 
$
(6,668
)
 
$
(11,031
)
 
$
17,699

 
$
(17,699
)


11



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


 
Nine Months Ended September 30, 2015
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF CASH FLOWS
 
 
 
 
 
 
 
 
 
Net cash provided by (used) in operating activities
$

 
$
4,410

 
$
(2,939
)
 
$

 
$
1,471

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of property and equipment

 
(5,592
)
 
(116
)
 

 
(5,708
)
Other, net

 
245

 
(36
)
 

 
209

Net cash used in investing activities

 
(5,347
)
 
(152
)
 

 
(5,499
)
Net decrease in cash and cash equivalents

 
(937
)
 
(3,091
)
 

 
(4,028
)
Cash and cash equivalents - beginning

 
18,613

 
7,709

 

 
26,322

Cash and cash equivalents - ending
$

 
$
17,676

 
$
4,618

 
$

 
$
22,294


 
Nine Months Ended September 30, 2014
 
Parent Guarantor
 
Other PHS Guarantor Subsidiaries
 
Non-Guarantor PHS Subsidiaries
 
Eliminations
 
Consolidated
CONDENSED STATEMENT OF CASH FLOWS
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
$

 
$
12,927

 
$
(2,296
)
 
$

 
$
10,631

Investing activities:
 
 
 
 
 
 
 
 
 
Purchases of property and equipment

 
(1,452
)
 
(479
)
 

 
(1,931
)
Other, net

 
(137
)
 
(65
)
 

 
(202
)
Net cash used in investing activities

 
(1,589
)
 
(544
)
 

 
(2,133
)
Net increase (decrease) in cash and cash equivalents

 
11,338

 
(2,840
)
 

 
8,498

Cash and cash equivalents - beginning

 
11,151

 
8,989

 

 
20,140

Cash and cash equivalents - ending
$

 
$
22,489

 
$
6,149

 
$

 
$
28,638


5. Related Party Transactions
When the Company acquired Maple Services, LLC in August 2005, the PSC Parent’s former Chief Executive Officer, former Chief Financial Officer, and Chief Executive Officer of Human Services, became members of the board of directors of the not-for-profit organization (Maple Star Colorado, Inc.) formerly managed by Maple Services, LLC. Prior to Molina's acquisition of the Company on November 1, 2015, the members of Maple Star Colorado, Inc.’s board of directors included the PSC Parent’s Chief Executive Officer and Chief Financial Officer, and the Company's Chief Executive Officer. Maple Star Colorado, Inc. is a non-profit member organization governed by its board of directors and the state laws of Colorado in which it is incorporated. Maple Star Colorado, Inc. is not a federally tax exempt organization and neither the Internal Revenue Service rules governing IRC Section 501(c)(3) exempt organizations, nor any other IRC sections applicable to tax exempt organizations, apply to this organization. The Company provided management services to Maple Star Colorado, Inc. under a management agreement, the amounts for which were insignificant for the three and nine months ended September 30, 2015 and

12



PROVIDENCE HUMAN SERVICES, LLC
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2015
(In thousands)


2014. Amounts due to the Company from Maple Star Colorado, Inc. for reimbursable expenses and management services provided to it by the Company at September 30, 2015 and 2014, were insignificant.
Transactions with Parent
The PSC Parent provides various management, financial, legal, information systems and human resources services to the Company. Such general and administrative expenses incurred at the PSC Parent are allocated to the Company based upon the Company's relative direct expense levels, excluding costs for purchased services, which the Company's management believes to be reasonable. Charges for these services amounted to $5,690 and $5,607 in the three months ended September 30, 2015 and 2014, respectively and $20,286 and $19,334 in the nine months ended September 30, 2015 and 2014, respectively (included in general and administrative expense).


13

moh-20160728.xml
Attachment: XBRL INSTANCE DOCUMENT


moh-20160728.xsd
Attachment: XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT


moh-20160728_cal.xml
Attachment: XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT


moh-20160728_def.xml
Attachment: XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT


moh-20160728_lab.xml
Attachment: XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT


moh-20160728_pre.xml
Attachment: XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT